Scholars' Mine
Doctoral Dissertations

Student Theses and Dissertations

2010

Borate based bioactive glass scaffolds for hard and soft tissue
engineering
Steven B. Jung

Follow this and additional works at: https://scholarsmine.mst.edu/doctoral_dissertations
Part of the Materials Science and Engineering Commons

Department: Materials Science and Engineering
Recommended Citation
Jung, Steven B., "Borate based bioactive glass scaffolds for hard and soft tissue engineering" (2010).
Doctoral Dissertations. 2075.
https://scholarsmine.mst.edu/doctoral_dissertations/2075

This thesis is brought to you by Scholars' Mine, a service of the Missouri S&T Library and Learning Resources. This
work is protected by U. S. Copyright Law. Unauthorized use including reproduction for redistribution requires the
permission of the copyright holder. For more information, please contact scholarsmine@mst.edu.

BORATE BASED BIOACTIVE GLASS SCAFFOLDS FOR HARD AND SOFT
TISSUE ENGINEERING
by
STEVEN B. JUNG

A DISSERTATION
Presented to the Faculty of the Graduate School of the
MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY
In Partial Fulfillment of the Requirements for the Degree

DOCTOR OF PHILOSOPHY
in
MATERIALS SCIENCE AND ENGINEERING
2010
Approved by

Delbert E. Day, Advisor
Mohamed N. Rahaman
Richard K. Brow
Roger F. Brown
David Henthorn

ii

iii
PUBLICATION DISSERTATION OPTION
The body of the dissertation has been compiled in the format of peer reviewed
journals for eventual publication. The main body has been divided into six papers in the
following order. The first paper, “Preliminary Evaluation of Bioactive Borate Glass
Fiber Scaffolds for Mammalian Tissue Regeneration,” was written for publication in the
Journal of Biomedical Materials Research Part B Applied Biomaterials, and consumes
pages 15 to 57. The second paper, “Potential Toxicity of Bioactive Borate Glasses InVitro and In-Vivo,” was written to Acta Biomaterialia and consumes pages 58 to 99. The
third paper, “Angiogenic Bioactive Borate Glasses,” was written to Acta Biomaterialia
and consumes pages 100 to 144. The fourth paper, “Bone Growth on Bioactive Borate
Glass Scaffolds,” was written for submission to the Acta Biomaterialia and consumes
pages 145 to 185. The fifth paper, “Conversion of Bioactive Borate Glasses In-Vivo,”
was written for submission in Acta Biomaterialia and consumes pages 186 to 247. The
sixth paper, “Bioactive Borate Glass Fibers for the Treatment of Wounds” was written for
submission to Journal of Biomedical Materials Research Part B Applied Biomaterials
and consumes pages 248 to 273.
Three papers not included in the main body of the dissertation are given in the
appendix. The first paper, “Bioactive Glass Scaffolds for Soft Tissue Engineering,” was
written to provide supplemental information. The second paper, “Comparison of SelfBonded Three Dimensional Bioactive Glass Fiber Scaffolds After In-Vivo Implantation
in Rats,” was accepted for publication in the proceedings of the Pacific Rim 8 Conference
(June 2009, Vancouver Canada). The third paper, “Conversion Kinetics of Silicate,
Borosilicate, and Borate Bioactive Glasses to Hydroxyapatite,” was published in the
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European Journal of Glass Science and Technology B - Physics and Chemistry of
Glasses (Vol 50, Issue 2, pages 85 to 88).
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ABSTRACT
The main objectives of this dissertation were to evaluate bioactive borate glass
scaffolds for hard and soft tissue applications and determine the potential toxicity of the
borate glasses on the adjacent and systemic tissues. Porous randomly oriented fiber
scaffolds composed of bioactive borate glass were implanted in subcutaneous soft tissue
sites and in calvaria defects of laboratory rats and no signs of toxicity (necrotic tissue,
increase in macrophages or other immune cells) were detected in any of the adjacent
tissues (hard or soft). Systemic organs (kidney and liver) of laboratory rats implanted
with bioactive borate scaffolds were analyzed for possible systemic toxicity and no
adverse effects were found beyond normal incidental changes. Bone was found to grow
statistically better (p<0.05) in bioactive borate glass scaffolds when compared to similar
scaffolds composed of borosilicate and silicate based bioactive glasses. For the first time,
elements were added to a bioactive glass for the purposes of promoting angiogenesis.
The elements copper and zinc were shown to significantly increase the number of blood
vessels (p<0.05) present in the soft tissue inside bioactive borate glass scaffolds when
compared to the un-doped scaffolds. Bioactive borate glass fibers were also
demonstrated as a new material that may be useful in the treatment of chronic wounds. A
full thickness cutaneous defect (15mm diameter) on the back of a laboratory rats were
healed in similar time (18 days), but with a higher quality scar than the control (untreated wound). The results from the full thickness cutaneous defect opens the door for
new potential uses of bioactive borate glass fibers such as the treatment of chronic
wounds and severe burns.

vi
ACKNOWLEDGEMENTS
I would like to thank my advisor, Dr. Delbert E. Day for his guidance and his
patience for the past nine years. Beyond the scholarly lessons and the life lessons, I think
the most important lessons he has instilled in me is that learning is a continuous process
and there is always a shortage of good people.
Without Dr. Roger Brown’s assistance and guidance, much of the in-vivo work
presented here would not have been possible. I would like to thank the rest of my
committee, Dr. Richard Brow, Dr. David Henthorn, and Dr. Mohamed Rahaman for the
helpful discussions, comments, and constructive suggestions throughout my education.
I would like to thank Dr. Keith Strassner (MS&T) for his staff, and Paul Fleischut
of Senniger Powers LLP that supported the patenting of the disclosed intellectual
property.
The following people helped me with completing my experiments or gave
guidance on the direction of my research, and I eternally thank you here in no particular
order: Dr. Vladimir Dusevich (UMKC), Dr. Lian Bi (UMKC), Dr. Lynda Bonewald
(UMKC), Jennifer Rosser (UMKC), Jackie Taylor (UMKC), Dr. Paul Cook (PCRMC),
Penny Taylor (PCRMC), Qiang Fu (MS&T), Vernon Modglin (MS&T).
I cannot say enough about the support I have received from my parents. They
have done everything from encourage me to go to graduate school to watch my dog while
I was off travelling the world. Last but not least, I need to thank my best friend Rachel
Kluesner for her support and encouragement over the last four years. I don’t think I
could have done this without you.

vii
TABLE OF CONTENTS
PUBLICATION DISSERTATION OPTION……………………………………………iii
ABSTRACT………………………………………………………………………………v
ACKNOWLEDGEMENTS………………………………………………………………vi
LIST OF ILLUSTRATIONS………………………………………………………...….xvi
LIST OF TABLES……………………………………………………………….....xxxviii
SECTION
1. PURPOSE OF DISSERTATION…………………………………………………1
2. BACKGROUND………………………………………………………………….2
2.1. TISSUE ENGINEERING WITH BIOACTIVE GLASS…………………….2
2.2. PAST WORK ON BORATE CONTAINING GLASSES FOR IN-VIVO
USE…………………………………………………………………………...3
2.3. BORATE GLASSES SUITABLE FOR MAKING SCAFFOLDS………….5
2.4. SOURCES OF BORON, MAMMALIAN INTERACTION, AND
INTAKE……………………………………………………………………...6
2.5. THE NEED FOR IMPROVED ANGIOGENESIS IN TISSUE
ENGINEERING SCAFFOLDS AND WOUND CARE…………………….7
2.6. POTENTIAL BENEFITS OF DOPING BIOACTIVE GLASS WITH
BIOLOGICAL TRACE ELEMENTS……………………………………….9
2.7. SOFT TISSUE INTERACTIONS WITH BIOACTIVE BORATE
GLASSES…………………………………………………………………..10
2.8. REFERENCES……………………………………………………………..11
PAPER
1. PRELIMINARY EVALUATION OF BIOACTIVE BORATE GLASS FIBER
SCAFFOLDS FOR MAMMALIAN TISSUE REGENERATION……………..15
1.1. ABSTRACT…………………………………………………………………15

viii
1.2. INTRODUCTION…………………………………………………………..15
1.3. MATERIALS AND METHODS……………………………………………21
1.3.1.

Glass and Fiber Preparation……………………………………..21

1.3.2.

Scaffold Preparation………………………………………….….21

1.3.3.

Scaffold Porosity………………………………………………...21

1.3.4.

Scaffold Sterilization and Implantation…………………………22

1.3.5.

X-Ray Diffraction……………………………………………….22

1.3.6.

Micro Raman……………………………………………………23

1.3.7.

Scanning Electron Microscopy……………………….…………23

1.3.8.

Scaffold Recovery, Fixation, and Dehydration…………………23

1.3.9.

Sample Preparation and Staining (Histology)…………….……..24

1.3.9.1. Hematoxylin and Eosin (H&E) Staining Protocol…………..24
1.3.9.2. Periodic Acid Schiff (PAS) Staining Protocol………………25
1.3.9.3. Verhoeff’s Van Gieson (VVG) Staining Protocol…………..25
1.4.RESULTS……………………………………………………………………26
1.4.1.

93B3 Scaffold Removal……………………………………...….26

1.4.2.

Backscattered SEM of a Sectioned 93B3 Scaffold After Four
Weeks In-Vivo……………………………………………………26

1.4.3.

X-Ray Diffraction of a 93B3 Scaffold after Four Weeks InVivo………………………………………………………………27

1.4.4.

Micro Raman of a Reacted 93B3 Fiber after Four Weeks Invivo………………………………………………….………...….27

1.4.5.

Histological and Vascular Assessment of Soft Tissue….……….27

1.4.6.

Hematoxylin and Eosin Stain (H&E)…………………………...28

1.4.7.

Verhoeff’s Van Gieson Stain (VVG)……………………………29

ix
1.4.8. Periodic Acid Schiff Stain (PAS)………………………………..29
1.5. DISCUSSION AND CONCLUSIONS…………………………………….30
1.6. REFERENCES……………………………………………………………...38
2. POTENTIAL TOXICITY OF BIOACTIVE BORATE GLASSES IN-VITRO
AND IN-VIVO…………………………………………………………………….58
2.1. ABSTRACT…………………………………………………………………58
2.2. INTRODUCTION…………………………………………………………..59
2.3. MATERIALS AND METHODS……………………………………………63
2.3.1.

Scaffold and Disk Preparation…………………………………..63

2.3.2.

Growth of MLOA5 Cells on Bioactive Glass Disk……………..64

2.3.3.

Subcutaneous Scaffold Implantation……………………………64

2.3.4.

Subcutaneous Scaffold and Organ Removal, Tissue Processing,
and Histology Slide Preparation…………………………………65

2.3.5.

Tissue Processing and Histology Slide Preparation……………..65

2.3.6.

Tissue Assessment………………………………………………66

2.3.7.

Calvaria Implant Experiment……………………………………66

2.4. RESULTS…………………………………………………………………...66
2.4.1.

In-vitro MLOA5 Cell Culture (As-made and Pre-reacted)……..66

2.4.2.

13-93B3 Scaffold and Tissue Removal…………………………67

2.4.2.1. Assessment of Scaffold after Four Weeks In-vivo……..……67
2.4.2.2. Assessment of Kidney and Liver……………………..……..68
2.5. DISCUSSION…………………………………………….…………..…….69
2.5.1.

In-vivo Analysis of Potential Boron Toxicity from Bioactive
Borate Glass Scaffolds………………………………..…………69

2.5.2.

Subcutaneous Scaffold Removal……………….….……………70

x
2.5.3.

Histological Analysis of Tissues………………………….……..70

2.5.4. Bone Response to Bioactive Glasses in Rat Calvaria……………71
2.5.5.

In-vitro Analysis of Potential Boron Toxicity from Bioactive
Borate Glass Disks………………………………………………72

2.5.6. Correlation between the Sprague Dawley (SD) Rat Model and
Humans…………………………………………………………..73
2.6. CONCLUSIONS……………………………………………………………75
2.7. REFERENCES……………………………………………………………...77
3.

ANGIOGENIC BIOACTIVE BORATE GLASSES…………………………..100
3.1. ABSTRACT………………………………………………………………..100
3.2. INTRODUCTION…………………………………………………………101
3.3. MATERIALS AND METHODS…………………………………………..104
3.3.1.

Glass Melting and Scaffold Preparation……………………….104

3.3.2.

Scaffold Seeding with Mesenchymal Stem Cells (MSC)……...105

3.3.3.

Scaffold Implantation………………………………………….105

3.3.4.

Scaffold Removal………………………………………………106

3.3.5.

Tissue Processing………………………………………………106

3.3.6.

Histology Slide Preparation……………………………………106

3.3.7.

Histological Assessment……………………………………….107

3.3.7.1. Blood Vessel Analysis after Six Weeks In-Vivo – Copper
Additions…………………………………….…………….107
3.3.7.2. Blood Vessel Analysis – Minor Element Additions
(H&E)……………………………………….……………..108
3.4. RESULTS……………………………………………………………….…108
3.4.1.

Scaffold Removal………………………………………………108

xi
3.4.2.

Histology……………………………………………………….110

3.4.2.1. Histology – 4 Weeks (H&E)……………………………….110
3.4.2.2. Blood Vessel Analysis – 6 Weeks (H&E)…………………111
3.4.2.3. Histology and Vessel Analysis – 6 Weeks (PAS)…………111
3.4.2.4. Blood Vessel Analysis – Minor Elements Addition
(H&E)…………………………………………………..….112
3.5. DISCUSSION……………………………………………………………..113
3.5.1.

Scaffold Removal and In-vivo Biocompatibility………………113

3.5.2.

Angiogenic Analysis of In-Vivo Scaffolds - Blood Vessel
Analysis Six Weeks (H&E) and (PAS)………………………...114

3.5.3. Blood Vessel Analysis of Scaffolds Doped With Selected
Metal Ions………………………………………………..……..116
3.6. CONCLUSIONS…………………………………………………………..117
3.7. REFERENCES…………………………………………………………….119
4. BONE GROWTH ON BIOACTIVE BORATE GLASS SCAFFOLDS………145
4.1. ABSTRACT………………….…………………………………………….145
4.2. INTRODUCTION…………………………………………………………146
4.3. MATERIALS AND METHODS…………………………………………..148
4.3.1.

Glass Melting, Scaffold Preparation, and Sterilization…...……148

4.3.2.

Calvaria Defect Model…………………………………………150

4.3.2.1. Scaffold Porosity…………………………………………...150
4.3.2.2. Scaffold Implantation in Rat Calvaria……………………..150
4.3.2.3. Micro-CT Analysis of In-Situ Scaffolds…………………..151
4.3.3.

Subcutaneous Model…………………………………………..151

4.3.3.1. Scaffold Seeding with Mesenchymal Stem Cells………….151

xii
4.3.3.2. Scaffold Implantation……………………………………...151
4.3.3.3. Scaffold Removal and Tissue Processing………………….152
4.3.3.4. Histology Slide Preparation and Histological Assessment...153
4.3.3.5. Bone-like Material Analysis……………………………….154
4.3.3.6. Scanning Electron Microscopy Analysis (SEM)…………..154
4.4. RESULTS………………………………………………………………….154
4.4.1.

Calvaria Defect Experiment……………………………………154

4.4.2. Bone Growth in Bioactive Glass Scaffolds Implanted in Rat
Calvaria (12 Weeks)…………………………………………....155
4.4.3. Subcutaneous Implantation Experiment – Doped Scaffolds.…..155
4.4.3.1. Scaffold Removal…………………………………………..155
4.4.3.2.Osteoinductivity of Scaffolds (Sanderson Rapid Bone
Stain)………………………………….…………………..…156
4.4.3.3. Histology of Un-Seeded Scaffolds…….…………………..156
4.4.3.4. Histology of MSC Seeded Scaffolds………………………156
4.5. DISCUSSION……………………………………………………………..160
4.5.1.

Calvaria Bone Regeneration………………………………...…160

4.5.2.

Gene Expression Triggered By Bioactive Glass…………..…..160

4.5.3.

Potential Toxicity of the Boron Containing Glasses…………...163

4.5.4.

Osteoinductive Bone-like Tissue Formation Analysis..……….163

4.6. CONCLUSIONS………………………………………………………….164
4.7. REFERENCES…………………………………………………………….166
5.

IN-VIVO REACTION OF BIOACTIVE BORATE GLASSES DOPED
WITH SELECTED METAL IONS…………………………………………….186
5.1.ABSTRACT………………………………………………………………..186

xiii
5.2. INTRODUCTION………………………………………………………...187
5.3. MATERIALS AND METHODS………………………………………….189
5.3.1.

Glass Melting and Scaffold Preparation……………………….189

5.3.2.

Scaffold Implantation………………………………………….190

5.3.3.

Scaffold Removal………………………………………………190

5.3.4.

Scaffold Processing…………………………………………….190

5.3.5.

X-Ray Diffraction (XRD)……………………………………...191

5.3.6.

Scanning Electron Microscopy Analysis (SEM)………………192

5.3.7.

Micro-Raman Analysis……………………….………………..192

5.3.8.

X-ray Fluorescence (XRF)……………………………………..192

5.4. RESULTS………………………………………………………………….193
5.4.1.

Sectioned As-Made Scaffold Composed of Randomly
Oriented Fibers for SEM Reference…………………………....193

5.4.2.

Evaluation of Scaffolds As Recovered from Subcutaneous
Tissue……………………………………….…………………..193

5.4.3.

X-ray Diffraction (XRD)………………………………………194

5.4.4.

Microstructure Analysis of Reacted 13-93B3 Fibers (Four
weeks In-Vivo)……………………………………………….…194

5.4.5.

Chemical Analysis of Reacted Scaffolds (Four or Six
Weeks In-Vivo)…………………………………………………195

5.4.6.

Micro-Raman of In-Vivo Reacted Fibers………………………198

5.4.7.

X-ray Fluorescence (XRF) of Fibers After In-Vivo Reaction….200

5.5. DISCUSSION…………………………...…………………………………201
5.5.1.

Scaffold Evaluation and Tissue Analysis during Scaffold
Removal………………………………………………………...201

5.5.2.

Reaction of Metal Ion Doped Borate Scaffolds In-Vivo……….202

xiv

5.5.3.

Microstructure Analysis of Reacted Bioactive Borate Glass
Fibers (Layered Microstructure)……………………………….205

5.5.4.

Reaction of Metal Ion Doped Bioactive Glasses………………207

5.5.5.

Role of Metal Ions in Calcium Phosphate Formation………….208

5.6. CONCLUSIONS…………………………………………………….…….209
5.7. REFERENCES…………………………………………………………….211
6. THE TREATMENT OF WOUNDS WITH BIOACTIVE BORATE GLASS
FIBERS…………………………………………………………………………248
6.1. ABSTRACT………………………………………………………………..248
6.2. INTRODUCTION………………………………………………………....249
6.3. MATERIALS AND METHODS………………………………………….252
6.3.1.

Preparation and Sterilization of Bioactive Glass Fibers……….252

6.3.2.

Animals…………………………….…………………………..252

6.3.3.

Surgical Procedure…………………………………………….252

6.3.4.

Cutaneous Wound Recovery, Fixation, and Dehydration…….253

6.3.5.

Sample Embedding and Slide Preparation……………………253

6.3.6.

Wound Healing Assessment………………………….………..254

6.3.7.

Histological Staining – Hematoxylin and Eosin (H&E)………254

6.3.8.

Scanning Electron Microscopy (SEM)………………………...254

6.4. RESULTS……………………………………………………………….…255
6.4.1.

Histological Assessment of the Wound Sections (H&E)……...255

6.4.2.

Wound Healing Assessment………………………….………..256

6.5. DISCUSSION AND CONCLUSIONS…………………………..………..257
6.6. REFERENCES…………………………………………………………….262

xv
SECTION
3. CONCLUSIONS………………………………………………………………..…274
4. FUTURE WORK…………………………………………………………………..276
APPENDICES
A. POTENTIAL TOXICITY OF BIOACTIVE BORATE GLASSES
IN-VITRO AND IN-VIVO……………………………………………………….278
B. ANGIOGENIC BIOACTIVE BORATE GLASSES….………………………….282
C. BIOACTIVE GLASS SCAFFOLDS FOR SOFT TISSUE REGENERATION....295
D. COMPARISON OF SELF-BONDED THREE DIMENSIONAL
BIOACTIVE GLASS FIBER SCAFFOLDS AFTER IN-VIVO
IMPLANTATION IN RATS……………………………………………………..308
E. CONVERSION KINETICS OF SILICATE, BOROSILICATE, AND BORATE
BIOACTIVE GLASSES TO HYDROXYAPATITE……………………………338
VITA……………………………………………………………………………………350

xvi
LIST OF ILLUSTRATIONS
PAPER 1
Figure 1.

Optical micrograph of an as-made 93B3 scaffold after heating for
45 minutes at 575oC. The scaffold has a nominal diameter and
thickness of 7 ± 0.1mm and 2 ± 0.2mm respectively with an average
open porosity of 51 ± 2%, n=12………………………………………...41

Figure 2.

Schematic showing scaffold implantation sites on the back of a rat.
Implantation sites were approximately 15mm wide by 15mm long.
The red line indicates the cut made in the skin, and the dotted arch
represents the opening made under the skin………………………..…...42

Figure 3.

Image showing the implantation of a 93B3 scaffold in the
subcutaneous tissue. The hair was removed, and the skin has been
cleaned and disinfected. The orange color on the back of the rat is
from iodine……………………………………………………………...43

Figure 4.

Optical image of a 93B3 scaffold prior to removal from rat
subcutaneous tissue. The skeletal muscle (SM) and subcutaneous
tissue (ST) are labeled as well as vessels (black arrows) growing in
the adjacent tissue. The scaffold was soft to the touch and the fibers
were white indicating they had reacted with the body fluids……..…….44

Figure 5.

SEMBSE micrograph of a cross sectioned 93B3 scaffold after four
weeks in the subcutaneous site in a rat. The soft tissue (dark gray) is
surrounding reacted fibers (light gray) is dark gray. Many of the 93B3
fibers reacted with body fluids and became hollow…..…………………45

Figure 6.

A series of higher magnification SEM micrographs of reacted
13-93B3 fibers after four weeks in the subcutaneous site in a rat.
Figure 6A of a sectioned fiber showing the inner hollow region and
the wall of the reacted fiber. Figure 6B is a magnified view of the
hollow core of the reacted 93B3 fiber in Fig 6A. There is no evidence
of any of the original glass remaining in the fiber, and the inner
surface is covered with calcium phosphate nodules. Figure 6C is a
magnified view of the nodules. Each nodule consists of a porous
structure of nanocrystals and those are shown in Fig 6D. The
crystals in Fig 6D are approximately 50nm in length and have a
needle-like shape consistent with the shape reported for crystalline
hydroxyapatite……………………………………………….…………..46

xvii

Figure 7.

XRD pattern for a 93B3 scaffold after four weeks in-vivo. The
pattern matches hydroxyapatite, PDF card# 72-1243 (vertical lines).
The peaks are relatively broad because the hydroxyapatite is
nanocrystalline……………………………………………….……...…...47

Figure 8.

Optical image of a 93B3 fiber reacted in rat subcutaneous tissue
for four weeks, mounted in PMMA, and cross sectioned. The outer
perimeter of the fiber is denoted by a dashed line, and the center
and outer edge are labeled as indicated. The four locations inside
the fiber were analyzed by micro raman and the spectra are shown
in Fig 9………………………………………………….…………….…48

Figure 9.

Micro raman spectra for a 93B3 fiber that was implanted in rat
subcutaneous tissue for four weeks. The peaks associated with
HA are indicated by the dashed lines at (431cm-1 (PO43- v2),
965cm-1 (PO43- v1), 1065 to 1070cm-1 (CO32- v1) and 1076cm-1
PO43- v3) and the solid lines are for the mounting medium PMMA.
At the top of Fig 9, the spectrum for PMMA mounting medium is
shown. The spectrum for the outer edge of the reacted 93B3 fiber
is labeled 1, and the center 4………………………………………….…49

Figure 10.

Optical micrograph of the cross-section of an as-made 93B3
scaffold. The darker gray circular or ellipsoidal shapes are
self-bonded, solid and unreacted, glass fibers and the light colored
region is transparent epoxy. The fibers have irregular shapes due
to the random orientation of the fibers and the self bonding of several
fibers that took place during heat treatment………………….…………..50

Figure 11.

Optical micrograph of an H&E stained section of a 93B3 scaffold
that was implanted in rat subcutaneous tissue for four weeks. The
93B3 fibers have reacted with the rat body fluids and become hollow.
Soft tissue has infiltrated nearly all of the open porosity within the
scaffold as shown by the purple tissue, and several of the hollow
fibers have soft tissue in the hollow core as well………………………...51

Figure 12.

Optical micrographs of H&E stained sections from a 93B3

xviii
scaffold implanted in the subcutaneous site in a rat for four weeks.
Cell nuclei are blue, cytoplasm connective tissue and extra cellular
matrix (ECM) are purple or red and red blood cells (RBC) are bright
red. Figure 12A shows a section with multiple hollow fibers (F),
some of which contain soft tissue (purple). There is also an organized
line of red blood cells as pointed out by the arrows indicating a small
blood vessel. Figure 12B shows a section with a larger vessel in the
center of the image as indicated by the white arrows. There is
a large amount of red blood cells (pink dots) in the vessel. The
fibers (F) have significantly reacted to HA……………………………....52
Figure 13.

Optical micrographs of H&E stained sections from a 93B3
scaffold implanted in a subcutaneous tissue for four weeks. Cell
nuclei are blue, cytoplasm connective tissue and extra cellular
matrix (ECM) are purple or red and red blood cells (RBC) are bright
red. Figure 13A shows a reacted 93B3 fiber which has been cut
parallel to the longitudinal fiber direction, and the sides of the fiber
have been labeled with (F). There is soft tissue (purple) and red
blood cells (white arrow) inside the hollow cavity of the fiber.
Figure 13B has a fiber that has been cut perpendicular to the
longitudinal fiber direction, and inside the fiber is soft tissue and
red blood cells (arrows) indicating blood vessels are present inside
the fiber…………………………………………………………………..53

Figure 14.

Optical micrographs of VVG stained sections from a 93B3
scaffold implanted in a subcutaneous site for four weeks. Cell
nuclei are brown to black, connective tissue is pink to red, and
red blood cells (RBC) are yellow, and elastin is black. Several
fibers, denoted by (F), are shown in Fig 14A; but much of the HA
debonded during staining. There is a vessel in the center of the
image (black arrow) as the elastin in the vessel is black, and there
are several red blood cells in the center of the vessel (yellow).
Figure 14B shows a hollow fiber (F) at the center of the image
with a vessel in its hollow core (white arrow). There is a second
vessel below, indicated by a black arrow that is in the void formed
between two self-bonded fibers………………………………….………54

Figure 15.

Optical micrographs of PAS stained sections from a 93B3

xix
scaffold implanted in a subcutaneous tissue for four weeks.
Connective tissue is light green, and red blood cells (RBC) are
bright green, vessel lining is blue, hydroxyapatite is purple, and
macrophages are brown. Figure 15A has stained positive for several
blood vessels (arrows) as the blue rings are surrounding bright green
RBC. There are several macrophages throughout the tissue, circled;
however they are not congregating around the scaffold material (F).
Figure 15B has a hollow fiber (F) in the center of the image (dashed
circle) with a vessel inside the void (arrow). There is also a fiber to
the left of the image cut parallel to the longitudinal fiber direction
(parallel dashed lines) that has a vessel that was growing down the
hollow void (arrow)…………………………...………………………....55
Figure 16.

Optical micrographs of PAS stained sections from a 93B3
scaffold implanted in a subcutaneous tissue for four weeks.
Connective tissue is light green, and red blood cells (RBC) are bright
green, vessel lining is blue, hydroxyapatite is purple, and macrophages
are brown. Figure 16A shows has several fibers denoted by (F),
however much of the HA washed off during staining. The hollow
fiber in the center of the image has a vessel that grew 700 to 800µm
down the hollow void of the reacted 93B3 fiber. Figure 16B shows a
magnified view of the vessel, and the lining has been indicated by a
series of arrows. The vessel has a significant number of red blood
cells (RBC) present inside it………………………………………..........56

Figure 17.

Effect of mRNA uptake compared to boric acid concentration
for human placental cells compared to the estimated boric acid
concentrations from a reacting 93B3 scaffold in a sleeping
(0.1ml/min*g) and active rats (0.4ml/min*g). According to the
estimated boric acid concentrations from the scaffolds, and the effect
seen from in-vitro cell culture experiments, there could be a
stimulatory growth effect similar to a growth factor from the reacting
93B3 scaffolds…………………………………………………………...57

PAPER 2
Figure 1.

Methods and testing conditions for boron toxicity in-vitro and in-vivo…82

Figure 2.

In-vitro and in-vivo data for boric acid toxicity in mg/kg/day. The
green regions represent no toxicity, the green to red fade regions
show where inhibition begins, and all red shows where cell death
occurs…………………………………………………………………….83

Figure 3.

Schematic showing how toxic conditions could develop

xx
(pH, B concentration, etc) and affect the immediate surroundings
of a highly reactive material during in-vitro static conditions,
in-vitro dynamic or pre-reacted conditions, or in-vivo. The circle
labeled (G) represents a glass disk, fiber, sphere, or particle……………84
Figure 4.

Weight loss data for a soda lime borate glass showing the initial
fast weight loss (24 hrs), followed by a decreasing weight loss which
was attributed to the precipitation of calcium phosphate on the glass
surface [7]…………………………………………………………..……85

Figure 5.

Steps in manufacturing a scaffold composed of randomly oriented
glass fibers. The as-made fibers (100 to 300µm diameter, 2 to
3mm long) are shown in (A). The mold used for holding the fibers
(70mg) during the heat treatment (575oC to 690oC depending on
glass composition, for 45 minutes) is shown in (B). An as-made
scaffold (nominal dimensions of 7mm diameter, 2mm thick)
composed of self bonded randomly oriented fibers is shown in
(C)………………......................................................................................86

Figure 6.

Proliferation of MLOA5 cells after 24 hours at 37oC on unpolished
as-cut bioactive glass disks and pre-reacted bioactive glass disks.
[13]. * p<0.001 when compared to control…………………..…………..87

Figure 7.

Schematic showing the implant sites located on the back of a rat.
The red lines are sites where the skin was cut (15mm) and the dotted
line represent the approximate implant site (20mm long). Up to 16
borate glass scaffolds, four per site, were implanted in a ...……………..88

Figure 8.

Appearance of a subcutaneous site containing three 13-93B3
scaffolds after four weeks in subcutaneous tissue. The scaffolds are
labeled with an S and arrows are pointing to tissue rich with blood
vessels surrounding two of the scaffolds (red tissue)………………...….89

Figure 9.

Representative photographs of the livers recovered from rats
implanted with up to sixteen 13-93B3 scaffolds (70mg each). The
number at the side of each image corresponds to the number of
13-93B3 scaffolds implanted in that rat; control (0), (4), (8), (12),
and (16)…………………………………………………………..………90

xxi
Figure 10.

Representative photographs of the kidneys recovered from rats
implanted with up to sixteen 13-93B3 scaffolds (70mg each). The
number at the side of each image corresponds to the number of
13-93B3 scaffolds implanted in that rat; control (0), (4), (8), (12),
and (16)……………………………………………………………….….91

Figure 11.

Cross section of a glass scaffold composed of randomly
oriented bioactive glass fibers that have been infiltrated with
transparent epoxy which provides a reference for the histological
images. The fibers (gray) are circular or elliptical depending on the
orientation, and the fibers that have bonded to other fibers in the
plane of the cross section look like complex geometrical shapes.
The epoxy occupies what were initially open, interconnected pores
of the scaffold……………………………………………………………92

Figure 12.

H&E stained section of a 13-93B3 scaffold implanted in
subcutaneous tissue for four weeks (A). The section is >90% filled
with soft tissue and the fibers have all reacted. A magnified view of
box B, located at the center of the scaffold, is shown in (B). There are
two fibers that have reacted as indicated by the arrows pointing to the
center of the fibers. Healthy soft tissue has attached to the inner and
outer surfaces of the fibers. A magnified view of the scaffold at the
outer edge is shown in (C), where two fibers that have reacted and are
surrounded by soft tissue……………………………………….………..93

Figure 13.

H&E stained section of a control liver and a liver section from a rat
with four to sixteen 13-93B3 scaffolds (70mg each) implanted in
subcutaneous tissue. The estimated boric acid concentration present
in the rat with 16 scaffolds was
126mg/kg/day……………………………………………………………94

Figure 14.

Photomicrograph of an H&E stained section of the renal cortex
from a control rat (A). Figure 14B is a magnified view of the renal
cortex showing the tubular epithelium and a glomerulus (a capillary
tuft where blood begins the filtering process to form urine)…………….95

Figure 15.

Total bone growth into randomly oriented porous bioactive
glass scaffolds (S), (45S5 was loose particulate (P) form (100 to
200µm)) after 12 weeks in rat calvaria (n=4) as determined by
histomorphometry analysis. The 13-93B3 scaffolds generated
twice as much bone as the 13-93 or 13-93B1 scaffolds and had
statistically more bone *(p<0.05), personal communication [16]…….....96

Figure 16.

Quantitative measurement of DNA produced by MC3T3-E1 cells
cultured for four days on as-made disks of 45S5 (0B), pre-reacted

xxii
45S5-3B, and as-made 45S5-3B glass disks after four days of
culture. The pre-reacted 45S5-3B glass contained ~2x the DNA as
the as-made glass [6]. * p<0.05, ** p<0.01 as compared to 45S5.……..97
Figure 17.

Quantitative measurement of DNA from MC3T3-E1 cells for
45S5 (0B), 45S5-1B, 45S5-2B, and 45S5-3B glass disks after four
days of culture under static (black) and dynamic conditions (gray).
The dynamic condition significantly improved the amount of viable
cells for all the boron containing glasses after four days of culture as
indicated by the red lines [6]. * p<0.05, ** p<0.01 as compared with
45S5……………………………………………………………………...98

Figure 18.

Estimation of how much 13-93B3 glass could be implanted in a
human based off of the histological analysis of the kidney and liver
from Sprague Dawley rats. Eight to 50 pounds was magnified to
make reading the graph at lower weights easier…………………………99

PAPER 3
Figure 1.

Examples of as-made bioactive borate glass scaffolds doped with
CuO in amounts from 0.1wt% to 2wt%. Each scaffold was 7mm in
diameter and 2mm thick………………………………………………..125

Figure 2.

Appearance of bioactive borate scaffolds doped with CuO, after
two weeks in subcutaneous sites in rats, for evaluation of vascular
growth (unseeded)……………………………………………………...126

Figure 3.

Bioactive borate scaffolds doped with increasing amounts of
CuO, implanted in subcutaneous sites in rats (four weeks) for
evaluation of vascular growth (unseeded). The circles are to guide
the eye…………………………………………………………...……..127

Figure 4.

Appearance of 13-93B3, B3 Cu-1, and B3 Cu-3 borate glass
fiber scaffolds with and without 50,000 seeded mesenchymal stem
cells after a six week implantation in a subcutaneous site…...…………128

Figure 5.

Digital micrographs of borate glass scaffolds (original dimensions –
7mm diameter, 2mm thick) doped with 0.40% CuO, 2.0% SrO, 1.0%
ZnO, and 0.4% Fe2O3 (wt%) after six weeks in a subcutaneous site.
The top row of scaffolds was seeded with 50,000 mesenchymal stem
cells (MSC) and the bottom row was unseeded………………………...129

Figure 6.

Optical micrograph of the cross section of an as-made randomly
oriented fiber scaffold infiltrated with PMMA. The due to the fiber
orientation, many of the fibers look ellipsoidal, and several fibers

xxiii
fused together during the heat treatment………………………………..130
Figure 7.

H&E stained sections of the six week subcutaneously implanted
13-93B3 (A), B3 Cu-1 (B), and B3 Cu-3 (C) scaffolds seeded with
50,000 mesenchymal stem cells. The colored boxes (left) are an
indication of the number of blood vessels present in each of the
areas…………………………………………………………………….131

Figure 8.

An example of an H&E stained tissue section with blood vessels
marked (black arrow), and often have red blood cells inside (red or
pink). Blood vessels have a purple defining edge……………………..132

Figure 9.

Schematic showing how the PAS stained tissue sections (CuO
doped) were analyzed. The dashed line represents the section of
tissue analyzed, typically close to the center of the section, used for
blood vessel analysis. As indicated by the schematic, reacted fibers
(white) were often in the line of tissue analyzed and since the
scaffolds were approximately the same porosity, no correction was
required…………………………………………………………………133

Figure 10.

Optical micrographs of PAS stained tissue section from a
B3 Cu-3 bioactive glass fiber scaffold implanted six weeks. The
arrows point to blood vessels (purple ring) and the objects in the
vessels are stained red blood cells
(green)……………………………..……………………………………134

Figure 11.

Example of an H&E section used for the blood vessel analysis
(H&E). The dashed lines in the top image show the areas across the
scaffold that were analyzed, and the total number of vessel for each
line of tissue are shown (72, 73, and 32, respectively). The individual
tissue sections are shown below (A to C) and several of the largest
blood vessels are pointed out with arrows to guide the reader. Bar =
1mm…………………………………………………………………….135

Figure 12.

Optical images showing a B3 Cu-5 scaffold after six weeks walled
off in subcutaneous tissue, Fig 12A. A thick fluid was present inside
the site, Figs. 12B and 12C, and the remainder of the scaffold
removed from the site is shown in 12D. All images come from the
same rat……...……………………………………………………….....136

Figure 13.

Optical micrographs of stained sections (H&E) from a 13-93B3
scaffold after four weeks in-vivo. Many of the fibers (F) are reacted,
and some contain tissue. ……………………………….….…………..137

Figure 14.

Optical micrographs of B3 Cu-1 scaffold sections (H&E) that
were removed from rat subcutaneous tissue after four weeks in-vivo

xxiv
and stained with H&E stain. Many of the fibers (F) are hollow, and
some contain tissue……………………………………………………..138
Figure 15.

Optical micrographs of B3 Cu-5 scaffold sections (H&E) that
were removed from rat subcutaneous tissue after four weeks in-vivo
and stained with H&E stain. Large blood vessels (V) have been
identified throughout the tissue…………………………………………139

Figure 16.

Area % of blood vessels measured from PAS stained tissue
sections from bioactive borate glass scaffolds (doped with CuO) after
six weeks in-vivo. N=3. Differences considered significant if
*(p<0.05)………………………………………………………………..140

Figure 17.

Total number of blood vessels measured for H&E stained
borate glass scaffold tissue sections doped with minor elements
(Cu or C = copper, S = Strontium, Z = Zinc, and F = iron) after six
weeks in-vivo. * p<0.05, N=3………………………………………….141

Figure 18.

Average area for vessels in 20 randomly selected boxes across
an H&E stained histology section for the borate glass fiber scaffold,
13-93B3 (no CuO), B3 Cu-1 (0.1wt% CuO), and B3 Cu-3
(0.4wt% CuO) (left side, red triangle). The total number of vessels
measured for each scaffold is plotted on the right hand y-axis
(black diamonds)……………………………..…………………………142

Figure 19.

Total vascular area calculated from 20 randomly chosen areas
in H&E stained sections for the 13-93B3 (0wt% CuO), B3 Cu-1
(0.1wt% CuO), and B3 Cu-3 (0.4wt% CuO) scaffolds…………………143

Figure 20.

Cross section of a 13-93 fiber scaffold that had been
implanted in subcutaneous tissue of a rat for two weeks. Ten areas
of tissue examined for blood vessels are indicated by the arrows.
The section was stained with Sanderson Bone Stain. Personal
communication [42]………………………………………………….…144

PAPER 4
Figure 1.

Schematic showing the scaffold placement in the calvaria of a rat.
The scaffolds implanted measured 4mm in diameter as shown in
Fig 1. Each scaffold was placed between the surrounding sutures
and the sinus was avoided to reduce surgical complications…..…….…170

Figure 2.

Schematic showing the subcutaneous scaffold implant sites located
on the back of a rat. A scaffold was placed above each of the front
shoulders and above both hind legs as indicated. The cut (red line)

xxv
made in the skin was approximately 20mm wide and the pocket
made under the skin (dotted line) is about 20mm long. The dashed
line represents the spine as a reference………………………………...171
Figure 3.

Optical micrograph of a cross sectioned randomly oriented bioactive
glass fiber scaffold. The fibers are gray and look like circular or
elliptical depending on the fiber orientation…………………………....172

Figure 4.

Micro-CT images of the top and bottom of porous randomly
oriented fiber scaffolds composed of bioactive glass fibers (13-93,
13-93B1, 13-93B3) and 45S5 particulates (100 to 200µm) after 12
weeks in 4mm rat calvaria defects. The scaffold and bone are labeled
for the 13-93 scaffold for the top, bottom, and cross sectioned views.
Note that the 13-93B3 scaffold is not visible in the bottom image
(left). Bone had completely grown across the bottom of the 13-93B3
scaffold [23]…………………………………………………………….173

Figure 5.

Average bone growth across the top and bottom of the
implanted scaffolds or particulates (45S5) after 12 weeks in rat
calvaria (4mm original defect). Scaffold porosity was ~50% for
each scaffold………………………………………………………..…..174

Figure 6.

Total bone growth into randomly oriented porous bioactive glass
scaffolds (S), (45S5 was in particulate (P) form (100 to 200µm))
after 12 weeks in rat calvaria (n=4) as determined by
histomorphometry analysis. Statistical significance represented by
*(p<0.05), [23]……………………………………………….…………175

Figure 7.

Bioactive borate glass scaffolds doped with minor elements after
six weeks in rat subcutaneous tissue. The top row shows scaffolds
seeded with 50,000 MSCs, and the bottom row shows unseeded
scaffolds…………………………………………………………...……176

Figure 8.

Histological sections of a Cu-3 (A), CS (B), CSZ (C), and
CSZF (D) unseeded scaffolds after six weeks in subcutaneous
tissue, stained with Sanderson Rapid Bone Stain and counterstained
with acid fuchsin. The arrows in Fig 7B indicate the presence of
bubbles……………………………………………………………...…..177

Figure 9.

Fig 9A is a representative image of a Cu-3 scaffold, seeded with
50,000 MSCs, after six weeks in subcutaneous tissue, stained with
Sanderson Rapid Bone Stain and counterstained with acid fuchsin…....178

Figure 10.

SEMBSE image of a cross sectioned Cu-3 fiber scaffold
(Fig 10A) that was seeded with 50,000 mesenchymal stem cells

xxvi
(MSC) and implanted in the subcutaneous tissue of a rat for six
weeks………………………………………………………….………...179
Figure 11.

Fig 11A is a representative image of a CS scaffold, seeded with
50,000 MSCs, after six weeks in subcutaneous tissue, stained with
Sanderson Rapid Bone Stain and counterstained with acid fuchsin……180

Figure 12.

SEMBSE image of a cross sectioned CS fiber scaffold that was
seeded with 50,000 mesenchymal stem cells (MSC) and implanted
subcutaneously in the back of a rat for six weeks. Arrows denote
unreacted glass……………………………………………..…………...181

Figure 13.

Fig 13A is a representative image of a CSZ scaffold, seeded
with 50,000 MSCs, after six weeks in subcutaneous tissue, stained
with Sanderson Rapid Bone Stain and counterstained with acid
fuchsin. Box B shows osteoid mixed with bone-like material (B-O)
next to a reacted fiber (F). The two circles in Fig 13B are
surrounding osteocytes that have become completely surrounded by
mineralized matrix. The (B-O) mixture in Fig 13C shows bone-like
material in the presence of reacted fibers (F) and soft tissue (S)…….....182

Figure 14.

SEMBSE image of a cross sectioned CSZ fiber scaffold that
was seeded with 50,000 mesenchymal stem cells (MSC) and
implanted subcutaneously in the back of a rat for six weeks………...…183

Figure 15.

Fig 15A shows the only CSZF scaffold, seeded with 50,000 MSCs,
after six weeks in subcutaneous tissue, stained with Sanderson Rapid
Bone Stain and counterstained with acid fuchsin………………………184

Figure 16.

SEMBSE image of a cross sectioned CSZF fiber scaffold that was
seeded with 50,000 mesenchymal stem cells (MSC) and implanted
subcutaneously in the back of a rat for six weeks. The majority of the
fibers have fully reacted and formed a multilayered fiber made of two
distinct materials, center white and outer edge gray………..…..………185

PAPER 5
Figure 1.

Figure 1A shows some chopped fiber 2 to 3mm in length, 100 to
300µm in diameter, used for making scaffolds. Figure 1B shows a
ceramic mold used to hold the fibers during the heat treatment.
Figures 1C and 1D are examples of an as-made 13-93B3 and Cu-3
scaffolds that weighs 70mg and has dimensions of 7mm in diameter
and 2mm thick. Scaffold porosity is 50±2%...........................................215

xxvii
Figure 2.

Schematic showing the subcutaneous scaffold implant sites located
on the back of a rat. The dashed line represents the spine as a
reference………………………………………………………………...216

Figure 3.

Bioactive borate glass scaffolds doped with minor elements after
implantation in rat subcutaneous tissue. The images show a
representative scaffold after six weeks in subcutaneous tissue for
the Cu-3, CS, CSZ, and CSZF scaffolds and a 13-93B3 was
implanted four weeks………………………………………………...…217

Figure 4.

Optical micrograph of a cross sectioned randomly oriented bioactive
glass fiber scaffold. The fibers are gray and look like circular or
elliptical depending on the fiber orientation. The scaffold was
impregnated with PMMA as indicated to support the fibers during
the sectioning and polishing……………………………………….…....218

Figure 5.

XRD patterns for randomly oriented borate bioactive glass fiber
scaffolds with added minor elements implanted in rat subcutaneous
tissue for six weeks (13-93B3 was implanted four weeks). Scaffolds
had an original mass of 70mg and were 7mm in diameter and 2mm
thick. Cu or C = copper, S = strontium, Z = zinc, F = iron……………219

Figure 6.

SEMBSE micrograph of a cross sectioned 13-93B3 scaffold after
four weeks in the subcutaneous tissue of a rat. The soft tissue
(dark gray) is surrounding reacted fibers are light gray……………..….220

Figure 7.

High magnification SEM micrographs of reacted 13-93B3 fibers
after four weeks in the subcutaneous tissue of a rat. Figure 7A of a
sectioned fiber showing the hollow center and the wall of the reacted
fiber. Figure 7B is a magnified view of the surface of the hollow
reacted 13-93B3 fiber in Fig 7A. Figure 7C is a magnified view of
the nodules in Fig 7B. Each nodule consists of a porous
nanocrystalline structure as shown in Fig 7D. Figure 7D shows the
surface of a porous nodule………………………………….…………..221

Figure 8.

SEM micrograph of a 13-93B3 scaffold cross section after four
weeks in-vivo. The cross sections of two reacted fibers (arrows) are
further analyzed in Figs 9 to 11………………………………..……….222

Figure 9.

SEM micrographs of a reacted 13-93B3 fiber in rat subcutaneous
tissue for four weeks………………………………………..…………..223

Figure 10.

Appearance of the cross section of the smaller reacted 13-93B3
fiber (four weeks in-vivo) in Fig 8……………………………..……….224

xxviii
Figure 11.

SEM micrographs of the layered microstructure present at the
center of the reacted 13-93B3 fiber in Fig 10. Figure 11A shows
several layers, but here a thick strut (arrow) is present connecting
the layers. The image in Fig 11B is of a single layer, and it is
apparent that the layers are polycrystalline and composed of
nanocrystals……………………………………………………………..225

Figure 12.

SEMBSE image of a cross sectioned Cu-3 fiber scaffold that
was implanted in the subcutaneous tissue of a rat for six weeks…….…226

Figure 13.

SEMBSE image of a cross sectioned CS fiber scaffold
implanted subcutaneously in the back of a rat for six weeks. A
majority of the fibers are excavated (partially hollow) from reaction
with body fluids………………………………………………………...227

Figure 14.

SEMBSE image of a CS fiber implanted subcutaneously in the back
of a rat for six weeks. The Ca/P ratio of the fiber at the three spots is
shown in the figure………………..……………………………………228

Figure 15.

SEMBSE image of a cross sectioned CSZ fiber scaffold that was
implanted subcutaneously in the back of a rat for six weeks…………...229

Figure 16.

SEMBSE image of a CSZ fiber (Fig 16) implanted subcutaneously
in the back of a rat for six weeks………………………..…………...…230

Figure 17.

SEMBSE image of a cross sectioned CSZF fiber scaffold that
was implanted subcutaneously in the back of a rat for six weeks……...231

Figure 18.

EDS phase map of CSZF reacted fiber after six weeks in rat
subcutaneous tissue. The SEMBSE image is shown bottom right of
the image for reference…………………………………………………232

Figure 19.

SEMBSE image of a CSZF fiber implanted subcutaneously in the
back of a rat for six weeks……………………...………………………233

Figure 20.

Optical image of a 13-93B3 fiber reacted in rat subcutaneous tissue
for four weeks, mounted in PMMA, and cross sectioned. The outer
perimeter of the fiber is denoted by a dashed line, and the center and
outer edge of the fiber are labeled as indicated. The four spots inside
the fiber were analyzed by micro raman and the spectra are shown in
Fig 21…………………………………………………………..……….234

xxix
Figure 21.

Micro raman spectra for a 13-93B3 fiber that was implanted in rat
subcutaneous tissue for four weeks. The peaks associated with HA
are indicated by the dashed lines at (431cm-1 (PO43- v2), 965cm-1
(PO43- v1), 1065 to 1070cm-1 (CO32- v1) and 1076cm-1 PO43- v3)
and the solid lines are for the mounting medium
PMMA……………………………………………………………..….235

Figure 22.

Micro-raman analysis of a Cu-3 fiber that reacted while in contact
with rat subcutaneous tissue for six weeks. The spot size of the
laser was 2µm, and is approximated by the size of the indicator
diamonds…………………………………………………………...…236

Figure 23.

Micro-raman analysis of a Cu-3 fiber that reacted while in contact
with rat subcutaneous tissue for six weeks. The light gray lines
represent peaks associated with PMMA, and the pattern for PMMA
is at the top of the figure………………………………….…………….237

Figure 24.

Micro-raman analysis of a CS fiber that reacted while in contact
with rat subcutaneous tissue for six weeks. The fiber was measured
at five spots from the outer edge (1) to the center (5) and the spectra
are shown in Fig 25. The red line through the image has no meaning
and was an artifact of the micro-raman software. The spot size of the
laser was 2µm, and is approximated by the size of the indicator
diamonds……………………………………………………………..…238

Figure 25.

Micro-raman analysis of a CS fiber that reacted while in contact
with rat subcutaneous tissue for six weeks. The light gray lines
represent peaks associated with PMMA, and the spectrum for
PMMA is shown at the top of the figure………………………………..239

Figure 26.

Micro-raman analysis of a CSZ fiber that reacted while in contact
with rat subcutaneous tissue for six weeks. The spot size of the laser
was 2µm, and is approximated by the size of the indicator diamonds....240

Figure 27.

Micro-raman analysis of a CSZ fiber that reacted while in contact
with rat subcutaneous tissue for six weeks. The micro-raman spectra
for each of the 10 spots are shown above, outer edge (1 E) to the
center (10 C). The peaks associated with calcite, (CaCO3), are
indicated with a dashed line at 711/cm-1 and 1085/cm-1……………….241

Figure 28.

Micro-raman analysis of a CSZF fiber that reacted while in contact
with rat subcutaneous tissue for six weeks. The fiber was measured
at six spots from the outer edge (1) to the center (6). The red line
through the image has no meaning and was an artifact of the
micro-raman software. The spot size of the laser was 2µm, and is
approximated by the size of the indicator diamonds………………...…242

xxx

Figure 29.

Micro-raman analysis of a CSZF fiber that reacted while in contact
with rat subcutaneous tissue for six weeks. The micro-raman spectra
for spots one to six are shown above, outer edge (1 E) to the center
(6 C). Calcite had peaks present in spectra four to six which are
indicated with a dashed line at 711/cm-1 and 1085/cm-1…...…………..243

Figure 30.

XRF spectra for the as-made bioactive borate glasses doped with
minor elements. Cu or C = copper, S = strontium, Z = zinc, F = iron.
The arrow in Fig 30A is indicating a peak associated with the polymer
binder used to mount XRF sample. It is noted that the CS, CSZ, and
CSZF patterns for Sr overlap in Fig 30B……………………………….244

Figure 31.

XRF spectra for each type of bioactive borate glass scaffold doped
with minor elements that were implanted in subcutaneous tissue of
rats for six weeks. Cu or C = copper, S = strontium, Z = zinc,
F = iron. The arrow in Fig 31A is indicating a peak associated with
the polymer binder used to mount XRF sample………………………..245

Figure 32.

High magnification SEMBSE image of the reacted CSZF fiber
(six weeks in-vivo)…………..………………………………………….246

Figure 33.

Schematic relating how hydroxyapatite formation is inhibited by
the presence of six coordinated ions in aqueous environments 37-38,50...247

PAPER 6
Figure 1.

Optical photograph of as-formed 93B3 fibers (300nm to
5µm diameter)…………………………………………………………..264

Figure 2.

SEM micrographs of the as-made 93B3 fiber. The image in Fig 2B
is a higher magnification of the fibers, which range in diameter from
submicron to micron (as labeled)………………………...……………..265

Figure 3.

Schematic of the wound placement on the rats…………………………266

Figure 4.

Photograph of a Sprague Dawley rat showing the full thickness
cutaneous defects. Fig 4A shows both freshly formed wounds
(15mm diameter) just posterior to the front shoulders. Figure 4B
shows the wound after being treated with 93B3 fiber (white material)...267

xxxi
Figure 5.

Progression of wound closure for the full thickness subcutaneous
wounds. The times shown are (A) 4 days, (B) 7 days, (C) 11 days,
(D) 15 days, (E) 18 days, and (F) 22 days. The control is on the left
side and the 93B3 fiber filled wound is on the right. The
approximate original wound size is shown by the dashed circles
in Fig 5F………………………………………………………………...268

Figure 6.

Histological sections of the full thickness cutaneous control wounds
after 22 days (H&E)…………………………………………………….269

Figure 7.

Histological sections of the full thickness cutaneous 93B3 bioactive
glass filled wounds after 22 days (H&E). The black line at the top of
each tissue section denotes where there is unhealed tissue. The double
ended arrows show the gap in the subcutaneous tissue and the vertical
indicate granulation tissue……………………………………………....270

Figure 8.

Histological assessment of a 93B3 filled full thickness cutaneous
wound after 22 days…………………….………………………………271

Figure 9.

Comparison of the original wound (%) vs. time for the control (blue)
and the wound treated with the 93B3 fiber pad (red)………………..…272

Figure 10.

Average gap in the subcutaneous tissue and average thickness
of the granulation tissue present in the 22 day sections. The control
is blue and the 93B3 fiber treated (red)……………………………..….273

APPENDIX A
Figure 1.

Photomicrograph of an H&E stained section of the renal cortex
from a rat that contains protein casts and tubular degeneration
(Fig 1A). Figure 1B is a magnified view of the renal cortex showing
a folded glomerulus as indicated by the vertical arrow, renal tubes
(horizontal arrows) and mononuclear inflammation characterized as
tubular degeneration (dashed circle)………………………………...….279

Figure 2.

Photomicrograph of an H&E stained section of the renal medulla
from a rat that contains nephrocalcinosis (arrows) and a large blood
vessel on the left of the image (Fig 2A). Figure 2B is a magnified
view of the renal medulla showing nephrocalcinosis as indicated by
the white arrow and renal tubules (horizontal arrows)…...…………….280

xxxii
Figure 3.

Photomicrograph of an H&E stained section of the renal cortex from
a rat that contains protein casts and tubular degeneration (Fig 3A).
Figure 3B is a magnified view of the renal cortex showing three
protein casts (P), tubular degeneration due to loss of the epithelial
eosinophilia (dashed circle), and gold/brown pigment indicative of
infiltrates of mononuclear inflammatory cells…...……………………..281

APPENDIX B
Figure 1.

H&E stained section of a Cu-3 scaffold (1 of 3) used for the blood
vessel analysis. The three strips counted in this section are indicated
by the dashed lines in the whole section and a magnified view of the
strips is shown below. The number of vessels from each strip were
14 (A), 8 (B), and 11(C), respectively. The original scaffold diameter
was 7mm………………………………………………………..………283

Figure 2.

H&E stained section of a Cu-3 scaffold (2 of 3) used for the blood
vessel analysis. The three strips counted in this section are indicated
by the dashed lines in the whole section and a magnified view of the
strips is shown below. The number of vessels from each strip were
24 (A), 32 (B), and 32(C), respectively. The original scaffold
diameter was 7mm…………………………………………...…………284

Figure 3.

H&E stained section of a Cu-3 scaffold (3 of 3) used for the blood
vessel analysis. The three strips counted in this section are indicated
by the dashed lines in the whole section and a magnified view of the
strips is shown below. The number of vessels from each strip were
33 (A), 35 (B), and 37(C), respectively. The original scaffold
diameter was 7mm…………………………………………………..…285

Figure 4.

H&E stained section of a CS scaffold (1 of 3) used for the blood
vessel analysis. The three strips counted in this section are indicated
by the dashed lines in the whole section and a magnified view of the
strips is shown below. The number of vessels from each strip were
32 (A), 27 (B), and 39(C), respectively. The original scaffold
diameter was 7mm…………………………………………………..…286

Figure 5.

H&E stained section of a CS scaffold (2 of 3) used for the blood
vessel analysis. The three strips counted in this section are indicated
by the dashed lines in the whole section and a magnified view of the
strips is shown below. The number of vessels from each strip were
11 (A), 45 (B), and 21(C), respectively. The original scaffold
diameter was 7mm…………………………………………………..…287

xxxiii
Figure 6.

H&E stained section of a CS scaffold (3 of 3) used for the blood
vessel analysis. The three strips counted in this section are indicated
by the dashed lines in the whole section and a magnified view of the
strips is shown below. The number of vessels from each strip were
47 (A), 45 (B), and 35(C), respectively. The original scaffold
diameter was 7mm……………………………………………………...288

Figure 7.

H&E stained section of a CSZ scaffold (1 of 3) used for the blood
vessel analysis. The three strips counted in this section are indicated
by the dashed lines in the whole section and a magnified view of the
strips is shown below. The number of vessels from each strip were
64 (A), 38 (B), and 33(C), respectively. The original scaffold
diameter was 7mm………………………………………………...…...289

Figure 8.

H&E stained section of a CSZ scaffold (2 of 3) used for the blood
vessel analysis. The three strips counted in this section are indicated
by the dashed lines in the whole section and a magnified view of the
strips is shown below. The number of vessels from each strip were
72 (A), 73 (B), and 32(C), respectively. The original scaffold
diameter was 7mm…………………………………………...…………290

Figure 9.

H&E stained section of a CSZ scaffold (3 of 3) used for the blood
vessel analysis. The three strips counted in this section are indicated
by the dashed lines in the whole section and a magnified view of the
strips is shown below. The number of vessels from each strip were
51 (A), 34(B), and 52(C), respectively. The original scaffold
diameter was 7mm…………………………………………………...…291

Figure 10.

H&E stained section of a CSZF scaffold (1 of 3) used for the blood
vessel analysis. The three strips counted in this section are indicated
by the dashed lines in the whole section and a magnified view of the
strips is shown below. The number of vessels from each strip were
58 (A), 45(B), and 45(C), respectively. The original scaffold
diameter was 7mm………………………………….......………………292

Figure 11.

H&E stained section of a CSZF scaffold (2 of 3) used for the blood
vessel analysis. The three strips counted in this section are indicated
by the dashed lines in the whole section and a magnified view of the
strips is shown below. The number of vessels from each strip were
59 (A), 80(B), and 78(C), respectively. The original scaffold
diameter was 7mm………………………………………………...……293

xxxiv
Figure 12.

H&E stained section of a CSZF scaffold (3 of 3) used for the blood
vessel analysis. The three strips counted in this section are indicated
by the dashed lines in the whole section and a magnified view of the
strips is shown below. The number of vessels from each strip were
37 (A), 51(B), and 52(C), respectively. The original scaffold
diameter was 7mm…………………………………………………...…294

APPENDIX C
Figure 1.

Image of a 13-93 random fiber scaffold. The scaffold measures
7mm in diameter and 2mm thick and has an open porosity of 50%
and a compressive strength of 5MPa……………………..…………….303

Figure 2.

SEM micrographs of a 13-93 random oriented fiber scaffold.
Figure 2a shows the random orientation of the fibers and the
rounded end of the fibers due to the heat treatment. Figure 2b is a
higher magnification image showing the bonding between the
fibers………………………………………………………………...….304

Figure 3.

Schematic showing the scaffold placement in the subcutaneous
tissue. Image in lower right hand corner shows a scaffold being
implanted under the skin………………………………………………..304

Figure 4.

Image of a 13-93 scaffold after two weeks in-vivo. The tissue
under A is the subcutaneous tissue under the skin, B is the scaffold,
and C is the skeletal muscle. The scaffold has no changed
dimensions from the original, and is now red from soft tissue and
vascular growth…………………………………………………………305

Figure 5.

Histology sections from the 13-93 scaffold implanted two weeks
in subcutaneous tissue. Fig 5a is a H&E stained section showing the
soft tissue (pink) surrounding the glass fibers (white and labeled with
an F). The vertical arrows are pointing out blood vessels with red
blood cells inside of them (pink dots). Fig 5b is a PAS stained tissue
section, and here the soft tissue is purple and the tubules of the vessels
is a dark purple (horizontal arrow). The red blood cells are green
making the vessels more visible (vertical arrows). The glass fibers
are labeled with an F……………………………………………...…….305

xxxv
Figure 6.

SEMBSE images of 13-93 glass fibers implanted in a subcutaneous
site for four, nine, and twenty eight weeks. Fig 6a shows the reacted
edge of the four week implanted fiber where A is the hydroxyapatite
layer, B is silica gel, and C is unreacted glass. The total reaction layer
is 10 to 12µm thick. Fig 6b is an image of a nine week implanted
fiber showing a reaction layer of non-uniform thickness of about
30µm. Fig 6c is an image of a fractured fiber that was implanted for
28 weeks. The total reaction layer is approximately 90µm. The
surface layer A is the HA, B is a silica gel layer, and C is residual
material consisting of SiO2, CaO, and P2O5…………………..……….306

Figure 7.

SEMBSE images of a 13-93 scaffold implanted in subcutaneous
tissue for 28 weeks that is coated with collagen fibrils. Fig 7a shows
a fractured scaffold surface with collagen strings coating and
connecting the glass fibers. Fig 7b is a higher magnification image
of the collagen showing the unique 64nm periodicity of the
material…………………………………………………………………307

APPENDIX D
Figure 1.

Schematic showing implantation sites for subcutaneous implantation
of the S100 and S30 scaffolds in the back of a rat…………..………….315

Figure 2.

SEM images of the 13-93 fibers in the S100 scaffold (a), and S30
scaffold (c) after 45 minutes at 720oC. The bonding between 13-93
glass fibers in a S100 scaffold is shown in (b) and a 13-93 fiber
bonded to 45S5c fiber in S30 scaffold in (d). [26]……...……………...318

Figure 3.

Appearance of glass fiber scaffolds before and after subcutaneous
in vivo implantation for four weeks. (a) S100 scaffold prior to
implantation, (b) S100+ after four weeks in- vivo, (c) S30+ after four
weeks in-vivo. Red circle is 7mm in diameter and denote the starting
diameter of the scaffolds……………………………………….……….320

Figure 4.

Optical micrograph of randomly selected location in the stained
cross section of scaffolds after three or four weeks in-vivo. Soft tissue
(blue) and bone tissue (red) formation. (a) S100 three weeks, (b)
S100 four weeks, (c) S100+ three weeks, (d) S100+ four weeks…...….321

Figure 5.

Optical micrograph (100X) of the cross-section of a S100+ scaffold
seeded with mesenchymal stem cells after four weeks in-vivo. Tissue
has been stained where blue denotes soft tissue and red denotes bone
(hard) tissue…………………………………………………………......322

xxxvi
Figure 6.

Optical micrograph (400X) of S100+ scaffold cross-section.
S100+ scaffold was seeded with mesenchymal stem cells and
implanted four weeks subcutaneously in the back of a rat and stained
for soft (blue) and bone (red) tissue……………………………………323

Figure 7.

Optical micrograph (100X) of the cross-section of S30 scaffolds
after three and four weeks in-vivo and stained for soft (blue) and bone
(red) tissue formation. (a) S30 three weeks, (b) S30 four weeks,
(c) S30+ three weeks, (d) S30+ four weeks…………………..………...324

Figure 8.

Optical micrograph (100X) of S30+ scaffold cross-section after
four weeks in-vivo. The S30+ scaffold was seeded with
mesenchymal stem cells and implanted four weeks subcutaneously
in the back of a rat and stained for soft (blue) and bone (red) tissue.
The darker, textured fibers are crystallized 45S5c fibers, where the
glassy 13-93 fibers are transparent and featureless……………………..326

Figure 9.

Optical micrograph (400X) of cross-section of the box labeled (9)
in Fig. 8. S30+ scaffold was seeded with mesenchymal stem cells
and implanted four weeks subcutaneously in the back of a rat and
stained for soft (blue) and bone (red) tissue…………...……………….327

Figure 10.

Seeded S30+ scaffold after four weeks in-vivo. (a) Optical
micrograph (400X) of a portion of the cross-section of a S30+
scaffold. (b) SEM-BSI of same area as shown as (10a). The X’s
indicate reacted regions on the fibers, the y’s indicate areas of new
bone, and the Z’s are areas of PMMA infiltrated soft
tissue…………………………………………………..………………..328

Figure 11.

(a) SEM-BSI of a 13-93 glass fiber after four weeks in-vivo. (b)
Composition (weight % oxide) obtained from SEM-EDS of a reacted
13-93 fiber at the locations A, B, and C. Composition for 13-93 glass
given in Table1…………………………………………………………330

Figure 12.

(a) SEMBSI of 45S5c fiber four weeks in-vivo (from an S30
scaffold seeded with msc cells). (b) Compositional analysis (weight
% oxide) obtained from SEM-EDS of reacted 45S5c fiber as a
function of position. Composition of 45S5 glass is shown in
Table 1……………………………………………………………...…..332

xxxvii
APPENDIX E
Figure 1.

Accumulated weight loss percent(11-12) for the 0B, 1B, 2B, and 3B
glasses during the first 1800 hours of reaction in 0.02M K2HPO4
solution at 37oC. The dashed horizontal lines denote the maximum
weight loss for each glass. The 0B and 2B glasses lost 42%, 1B lost
35%, and 3B lost 57%, respectively…………………………………...347

Figure 2.

Normalized weight loss (α) vs. time for the 0B, 1B, 2B,
and 3B glasses.(12)………………………………………………………348

Figure 3.

Normalized weight loss (α) vs. time for the 0B (crosses),
1B (triangles), 2B (squares), and 3B (diamonds) glasses compared
with the Contracting Volume Model (solid lines) and 3-D Diffusion
Model (dashed lines). The CVM is a good fit of the data for the first
30 hours for all four glasses, but after 50 hours, the 3-D Diffusion
Model is a better fit for the slower reacting 0B, 1B, and 2B glasses
(dashed lines)…………………………………………………………...348

Figure 4.

Reaction Constant (k) vs. Mole % B2O3 for the 0B, 1B, 2B, and
3B glasses reacted at 37oC in 0.02M K2HPO4 solution………..……….349

xxxviii
LIST OF TABLES
PAPER 1
Table 1.

Nominal Bioactive Glass Compositions (wt%).…………………………40

PAPER 2
Table 1.

Bioactive Glass Compositions (wt%)……………………………………79

Table 2.

Toxic Effect of BA Concentration In-vitro and In-vivo………………….80

Table 3.

Histological Results for Sprague Dawley Rats Implanted with 13-93B3
bioactive Glass Fiber Scaffolds (70mg) for Four Weeks………………...81

PAPER 3
Table 1.

Compositions of Bioactive Glasses (wt%)……………………………..122

Table 2.

Statistical Analysis for PAS Blood Vessel Analysis of CuO Doped
Bioactive Borate Glasses (6 weeks In-vivo)……………………………123

Table 3.

Student t Test Results for Blood Vessel Analysis…………………...…124

PAPER 4
Table 1.

Bioactive Glass Compositions (wt%)…………………………………..168

Table 2.

Results of Bone-like Tissue Formation (Sanderson Rapid Bone Stain)..169

PAPER 5
Table 1.

Bioactive Glass Compositions (wt%)…………………………………..214

PAPER 6
Table 1.

Statistical Significance Between the Control and 93B3 Filled
Wounds For Wound Closure, the Gap in Subcutaneous Tissue at
22 Days, and the Thickness of Granulation Tissue at 22 Days as
Determined by the Student t Test………………………………….……263

APPENDIX D
Table 1.

Compositions of Some Bioactive Glasses in mol% and wt% (parentheses
denote wt%)………………………………………….…………………313

xxxix
APPENDIX E
Table 1.

Nominal Composition of Glasses Used in Weight Loss
Experiment(11-12)……………………………………..………………….347

1. PURPOSE OF DISSERTATION

The purpose of this dissertation was to evaluate bioactive borate glass scaffold
composed of randomly oriented glass fibers in-vivo to determine potential toxicity in
adjacent and systemic tissues, compare borate glasses to silicate based bioactive glasses
such as 45S5 and 13-93 as a bone repair material, improve the angiogenic propetties of
bioactive glass, study the reaction of the borate glasses in-vivo, and experiment with
using bioactive borate glass as a soft tissue wound healing material.
Borate glasses react considerably faster than silicate glasses when in the presence
of body fluids or an aqueous solution such as simulated body fluid. The increased
reaction rate is thought to be an advantage in that the glass converts to hydroxyapatite
faster, and can then be remodeled by the body sooner for complete removal of the
implant material. Unfortunately, the scientific community has limited interest in borate
glasses because of poor performance by static in-vitro cell culture. Borate glasses are
thought to be toxic to cells and adjacent tissue due to the fast release of alkali and
localized alterations in pH. The present work uses animal models and histological
evaluations of adjacent and systemic tissues along with indirect toxicity measurements
such as bone growth to evaluate borate glass toxicity.
Angiogenesis (blood vessel formation) is another critical aspect of this research in
that scaffolds, particularly larger load bearing scaffolds made from metal and/or ceramics
do not stimulate blood vessel formation and therefore do not promote tissue growth.
Borate glasses react fast and may be used as a delivery vehicle for ions that can promote
endothelial cell migration into the interconnected pores inside the scaffolds to improve
tissue growth.

2

2. BACKGROUND

2.1. TISSUE ENGINEERING WITH BIOACTIVE GLASS
Tissue engineering is the process of using materials (natural or synthetic) to
mimic or replace the natural function of damaged or diseased tissue. Devices composed
of plastic, metal, glass and ceramics, along with donor tissues are used to treat or replace
almost any part of the body. One subset of materials used for tissue engineering are
silicate based bioactive glasses such as 45S5 (wt%, 45% Si0 2, 24.5% Na 20, 24.5% CaO,
1
6% P20 5) as they have been known to bond to bone and soft tissue for almost 40 years .
Bioactive glasses are useful materials for tissue engineering due to the high degree of
biocompatibility with the body.
Bioactive glasses and glass-ceramics have been used in clinical applications
2
including periodontal repair , inner ear replacement

3

,

and filler for bone cement

45
•

to

name a few. Three dimensional scaffolds composed ofbioactive glasses in a variety of
microstructures have recently been under investigation for bone defects for load bearing
and non-load bearing applications 6 ' 10 .
Soft tissue fi·om several mammalian species has been known to bond to 45S5 and
similar silicate based bioactive glasses for decades 11 . The emphasis in the past has been
placed primarily on bioactive glasses bonding to bone, so the soft tissue analysis was
usually based on bond interface with the glass, or if the tissue merely grew adjacent to the
g Iass w1t'h no bond'mg 1112
· .
Researchers have started to look into the possible angiogenic effects ofbioactive
glasses such as 45S5 coated with vascular endothelial growth factor (VEGF) for

3
increasing the vascular network inside of a scaffold

13

•

Further study on 45S5 as a

proangiogenic material has demonstrated that it is angiogenic in low concentrations and
has been hypothesized to up regulate VEGF production fi·om the soluble reaction
products when co-cultured with human microvascular endothelial cells in-vitro

14

•

These

angiogenic findings on bioactive glasses such as 45S5 make them interesting materials
for soft tissue engineering applications as they are relatively unexplored for soft tissue
applications such as wound care.
Silicate based bioactive glasses however have been shown to react relatively
slowly in-vivo taking months to years to fully react to hydroxyapatite (HA)

15

The rate at

•

which silicate bioactive glasses convert to HA (stoichiometric composition is
Ca 10(P04 )6(0H) 2) and is relatively slow, on the order of months to years depending on
the size of the bioactive glass particle and the glass composition

16

•

Due to this slow

reaction rate, faster reacting bioactive glasses containing boron have been developed with
significantly faster reaction rates than silicate glasses

17

.

Borate based bioactive glasses

submerged in phosphate solutions convert to HA similar to silicate based bioactive
glasses, but at a much faster rate

17 18
• •

2.2. PAST WORK ON BORATE CONTAINING GLASSES FOR IN-VIVO USE
Borate based bioactive glasses have been studied for several in-vivo applications
including, bone replacement, a treatment for osteoarthritis, and drug delivery systems 19 .
Richard implanted patticles of a 45S5 borate analog (complete exchange of boron for
silica) in rat femurs and the glass converted to hydroxyapatite at a significantly
accelerated rate and bone grew in and attached to the glass particles 20 . Han
Vanderspiegel 22 , Huang

19

,

21

,

and Fears 23 investigated the use of hydroxyapatite shells

4
converted fi·om borate based glasses to act as rate controlled drug delivery systems in the
body.
White 24 and Conzone 25 •26 demonstrated the application of using irradiated borate
based glass microspheres for treatment of osteoatthritis and other in-vivo radiotherapies.
The borate glasses degraded without radiation leakage as the glasses converted to
chemically durable rare eatth phosphate materials. Zhao et al implanted similar
dysprosium lithium borate glasses in rat livers and repmted no toxicity after two weeks
in-vivo

27

•

Jai et al.

28

made pellets composed of borate glass particles ( <50J1m) mixed with

four and eight weight percent teicoplanin for the treatment of osteomyelitis. The pellets
released approximately 80% of the teicoplanin within 15 days in-vitro, and the
compressive strength decreased fi·om 22 MPa to about 12 MPa after six days in PBS
solution. The in-vivo results from New Zealand White rabbits were comparable to what
was seen in-vitro, as the teicoplanin released in a controlled manner and the implants had
sufficient load bearing strength. No toxic effects were seen in the adjacent bone from the
borate glass as the glass converted to HA and suppmted the growth of new bone into the
scaffolds.
Liu et al.

29

treated osteomyelitis in the tibia of New Zealand White rabbits with a

scaffold consisting of borate glass particles and a polymer binder loaded with
Vancomycin. After eight weeks in-vivo, no observable tissue damage or inhibition of
bone growth was present at the implant sites. Approximately 80% of the osteomyelitis
infected tibia tested negative for the infection after eight weeks. The outer perimeter of

5
the scaffolds had visible vascular growth that was claimed to have been participating in
the bone regeneration.
8ioactive silicate glasses, such as 45S5, have been modified with up to 3wt%
8 2 0 3 with positive results

IJ.Jo.

Particles of 45S5 with 2wt% added 8 2 0 3 had

significantly increased the amount of bone present after 15 days post-implantation in the
intramedullary canal of a rat tibia, and the Ca/P ratio surrounding the boron doped
particles was significantly higher than 45S5 glass particles

30

•

Similar results were

repotted for a series of silicate glasses with up to 3wt% 8 2 0 3 added. Direct bone
bonding of the surface of the glass particles and rabbit bone was present, and a well
defined calcium phosphate layer was reported at the surface of the particles after eight
weeks 11 •

2.3. BORATE GLASSES SUIT ABLE FOR MAKING SCAFFOLDS
The borate glass studied by Richard

20

was successful for growing bone and

reacting to form hydroxyapatite in-vivo. Huang, through in-vitro weight loss
experiments, showed that this glass could react significantly faster than the well known
and widely studied silicate based 45S5 glass 17 • Jung showed that the reaction kinetics of
the borate glass was approximately five times greater than that of the silicate glass 18 . The
borate glass reacted in a controllable and continuous manner until complete reaction of
the glass, while the silicate based 45S5 reaches a point where the mechanism of the
hydroxyapatite conversion reaction changes and the reaction kinetics decrease
significantly

17 8
,1 •

The borate based 45S5 glass crystallizes easily upon heating and

cannot be heat treated to form a three dimensional scaffold without crystallizing. The

6

borate analog of 45S5 was therefore deemed unusable as a scaffold material. Therefore,
a new material had to be found that was more suitable for thermal processing.
Another bioactive glass known as 13-93 is a silicate based glass containing
53wt% Si02 along with materials such as MgO and K2 0 that allows for glass fibers to be
pulled and can be heat treated to make three dimensional scaffolds 6 •9 •31 • The 13-93 glass
was modified similarly to the 45S5 glass where all the silica was replaced by boron 17 •32 ,
and this glass is now known as 13-9383 (wt%, 53%8 20 3 , 20% CaO, 12% K20, 6%
Na20, 5% MgO, and 4% P20 5). The 13-9383 glass exhibits reaction kinetics similar to
the 45S5 analog glass

33

,

and, can be easily pulled into glass fibers. It can be heat treated

to form a three dimensional porous scaffold

33

.

2.4. SOURCES OF BORON, MAMMALIAN INTERACTION, AND INTAKE
Boron is an element that most humans ingest on a daily basis. Fruits, vegetables,
and nuts are humans' greatest source for boron 34 -36 , as boron is a trace element required
for cell wall formation in most plants 34 • Ground water has relatively little boron as
determined by the World Health Organization, as the range of boron in water is typically
between 0.1 and 0.3mg/L, however, this depends on the water source 34 • Ingestion of
boron usually takes place as boric acid, either fi·om water or food sources, and meat and
dairy products tend to be poor sources of boron 34 • Boron can be inhaled; however, this is
not a significant source of intake, except for people that work in borosilicate glass
production or other industrial process that involves large amounts of airborne borate
materials

34 36
' .

Absorption of boron through the skin is also limited unless there is an

open wound or severely abraded section of skin, then boric acid will enter the body 36•37 •

7
Humans and animals metabolize boron, or boric acid, similarly 34 . Typically,
greater than 90% of ingested boric acid is excreted through urine, and this takes place
relatively quickly, usually in the first 96 hours after ingestion 34·36 . Boric acid distributes
equally throughout most soft tissues, however, boron when administered at a dose of
9000ppm boric acid to male Fischer rats, has been repmted to accumulate up to
approximately 20 times normal levels in bone 38 .
Little is known about the interactions boron has with humans. Few human studies
about boron exist, but boron is a known trace element that is present in human cadaver
bones

3941

. Several investigators have suspected boron as an essential trace element to

bone fimctionality and/or metabolism; however, this has not yet been proven 4246 . No
data has been repmted linking boron to cancer in humans 36 , and no animal experiments
have adequately addressed any potential link

36

. An estimated value of0.2mg/kg-day of

boron has been established fi·om data of several animal studies as maximum average
lifetime ingestion; however, this number is not based off of human data 36 . Animal
models comparing ingested boric acid in rats versus control rats has determined a
benchmark dose level (BMDL) of 55mg/kg/day of boric acid. This means that
55mg/kg/day of boric acid correspond to the level of boric acid required to induce an
adverse response as compared to the control animals 35 .

2.5. THE NEED FOR IMPROVED ANGIOGENESIS IN TISSUE ENGINEERING
SCAFFOLDS AND WOUND CARE
Angiogenesis is the process by which blood vessels are formed in the body.
Wounds need sustained blood flow to deliver nutrients and growth factors needed for

. o f t1ssues
.
repair
a Iong Wit. h a means to remove waste pro ducts

47 ·48 .

Th e maximum
.

distance tissue can survive is approximately I 00 to 200fim from a blood vessel, so new

8
blood vessel formation is necessary for wounds to heal 47 . Specific to placing artificial
materials such as bioactive glass scaffolds in the body, tissues cannot grow into and fill
the scaffold until a network of blood vessels have first penetrated the scaffold or at least
are promoted to penetrate the scaffold as surrounding tissues infiltrate. The importance
of vascularization on wound healing is significant and should not be ignored

47

.

Vascular

endothelial growth factor has been isolated as one of the most important signals for
wound healing. Several growth factors natural to the body have been identified as
impottant to wound healing, however, none are as prevalent or have the long-term
stimulatory effects for vascular growth as VEGF 48 •
Bone is a vascular material and among its obvious structural function, red blood
cells are produced inside the marrow cavity of bone. Bone cells require a relatively high
oxygen supply for growth and natural function, as all osteocytes are located within
200J.im of a blood capillary 49 • Scaffolds are important for growth of damaged bone
because bones grow entirely by apposition 49 • Bone needs a preexisting surface in which
osteocytes can attach and form a calcified bone matrix 49 • Several methods of improving
vascularization of engineered scaffolds are currently under investigation including
growth factors, the addition of trace elements, co-culturing of cells on the scaffold, and
in-vivo prevascularization.

Rouwkema repotted that bone growth could be enhanced simply by co-culturing
endothelial cells (the cells that line blood vessels) with mesenchymal stem cells to form
vessels at the same time as bone47 • Another method Rouwkema repotted was to do a
procedure called in-vivo prevascularization. A scaffold is placed it in the vicinity of an
artery or a vascular tissue such as muscle of the patient long enough for the attery or

9
vascular tissue to penetrate the scaffold, then the scaffold is surgically removed and
placed in the bone defect site47 • This implies that if a vascular network is in place when
bone growth is initiated, then the bone can grow faster due to the increased oxygen and
nutrients being supplied.
Previous work completed by multiple researchers has confirmed that cettain
elements such as copper and tin may be beneficial for the promotion of angiogenesis 48 •50.
53

•

Copper ions released in the vicinity of engineered scaffolds, usually in the form of a

copper sulfate salt, have increased vascularization in calcium phosphate

53

and

hyaluronan-based hydrogel 54 scaffolds. A major benefit of copper ion release for
increasing vascular density is that it is a much more cost effective method as opposed to
attachment of expensive growth factors like VEGF

47

•

2.6. POTENTIAL BENEFITS OF DOPING BIOACTIVE GLASS WITH
BIOLOGICAL TRACE ELEMENTS
Several elements at physiological levels are used to trigger or control reactions in
the body that are required for living. Trace elements such as zinc, boron, strontium,
copper, and iron have been studied for specific biological responses and are all elements
found in human cadaver bone 41 . Endothelial cell migration has been stimulated by
copper ions

55

(angiogenesis)

and the presence of copper is required for blood vessel formation
56

•

Zinc is a cofactor responsible for keratinocyte migration during wound

healing which promotes re-epithelialization and improves epithelial cell apoptosis
Zinc oxide is also useful in decreasing blood clotting time

58

.

57

•

Boron, in the form of boric

acid (I to I OmM concentrations), significantly increased mRNA uptake of human
placental cells similar to what would be expected if a growth factor were present

59

•

Strontium, >99% located in the skeleton 60 , has been shown to have severe implications

10

on bone mineralization. Finally, iron is part of several enzymes and is present in bone
marrow and red blood cells 61 • The release of these ions from bioactive glass is
hypothesized to locally promote these biological functions when released at physiological
concentrations.

2.7. SOFT TISSUE INTERACTIONS WITH BIOACTIVE BORATE GLASSES
Borate based bioactive glasses have not been investigated for soft tissue use;
however they have traits that make them attractive such as fast reaction rates

18

,

and

controllable and continuous reaction to completion when in the presence of body fluids.
The previously mentioned in-vivo animal data for bioactive borate glasses in bone repair
indicated that immune response is likely to be minimal and bone bonded directly to the
surface of the reacted borate glass particles 28 •29 •33 • The release of trace elements from a
bioactive borate glass may further promote the formation of blood vessels in soft tissue
and the calcium (a potential regulator in wound healing) might be beneficial to the
treatment of wounds and stimulate the release of growth factors

62

.
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1.1 ABSTRACT
After four weeks in rat subcutaneous tissue, scaffolds composed of randomly
oriented, self-bonded bioactive glass fibers with an open and interconnected porosity of
51 ± 2% were completely reacted to nanocrystalline carbonated hydroxyapatite (HA) and
the interconnected pores had become significantly infiltrated with soft tissue. The
bioactive borate glass fibers reacted to form hollow HA channels that soft tissue and
blood vessels infiltrated. Histological staining with both the PAS and VVG stains
positively stained vessels from the 93B3 scaffolds. The PAS stain also positively stained
macrophages which were sparsely present throughout the adjacent soft tissue; however,
there was no negative immune reaction due to the presence of the reacted scaffold (HA).
Fibers composed of bioactive borate glass could have future applications as blood vessel,
bone, or other tissue guides, as porous scaffolds for hard and soft tissue regeneration, or
for wound care of soft tissue.

1.2

INTRODUCTION
Boron is an element that most humans ingest on a daily basis from fruits,

vegetables, and nuts 1-3. Boron is a trace element required for cell wall formation in most
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plants 1. Ground water has a relatively low boron concentration as determined by a study
done by the World Health Organization. The boron concentration in water is typically
between 0.1 and 0.3mg/L, but, this depends on the water source 1. Ingestion of boron
usually occurs as boric acid (BA), either from water or food sources. Meat and dairy
products tend to be poor sources of boron 1. Boron can be inhaled, but, this is not a
significant source of intake, except for persons working in borosilicate glass production
or other industrial environments where large amounts of airborne borate materials are
produced 1-4. Absorption of boron through the skin is also limited unless there is an open
wound or severely abraded section of skin, then BA will enter the body 3,5.
Humans and animals metabolize boron, or boric acid, similarly 1. Typically,
greater than 90% of the ingested BA is excreted through urine, usually in ~96 hours after
ingestion 1,3. Boric acid distributes equally throughout most soft tissues, but, when boron
was administered at a dose of 9000ppm BA to male Fisher rats, it was reported to
accumulate up to approximately 20 times normal levels in bone 6.
Little is known about the interaction boron has in humans. Few human studies
about boron exist, but it is a known trace element that is present in human cadaver bones
7-9

. Several investigators have suspected boron to be an essential trace element to bone

functionality and/or metabolism, but, this has not yet been proven 10-14. No data has been
reported linking boron to cancer in humans 3, and no animal experiments have adequately
addressed any potential link 3. An estimated value of 0.2mg/kg-day of boron has been
established from several animal studies as the maximum average lifetime ingestion, but,
this number is not based on human data 3. A study of airborne boron ingestion for
humans working with borax (a mixture of three sodium tetraborate materials, Na2B4O7,
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Na2B4O7-5H2O, and Na2B4O7-10H2O) found that the average boron consumption 27.90
mg/day or 1.9mg/kg/day of BA, no progressive accumulation of boron was observed in
the test subjects 4.
Studies on the developmental toxicity of BA in mice (248 to 1003mg/kg/day),
rabbits (62.5 to 250mg/kg/day), and rats (78 to 539mg/kg/day), found that there were
measurable increases in the weight of the kidney and liver, and renal lesions were formed
in mice 15. These reported levels of BA were associated with lower fetal weights and
higher fetal mortality in all species. The occurrence of wavy ribs in rats was also
observed, but this was attributed to significant decreases in fetal weight 15. Animal
models comparing ingested boric acid in rats versus control rats determined the
benchmark dose level (BMDL) was 55mg/kg/day of BA. This represents the amount of
BA required to induce an adverse response as compared to the control animals 2.
Borate based bioactive glasses have been studied for several in-vivo applications
including, bone replacement, a treatment for osteoarthritis, and drug delivery systems 16.
Richard implanted particles of a borate glass in rat femurs and the glass converted to
hydroxyapatite (HA) at a significantly higher rate than silicate glasses and bone grew and
attached to the glass particles 17. White 18 and Conzone 19,20 demonstrated the application
of using radioactive borate glass microspheres for treating osteoarthritis and other in-vivo
radiotherapies. The radioactive borate glasses degraded without radiation leakage as the
glasses converted to a chemically durable rare earth phosphate material that prevented the
release of the radioisotope. Han 21, Vanderspiegel 22, Huang 16, and Fears 23 investigated
the use of hydroxyapatite shells converted from borate based glass microspheres to act as
rate controlled drug delivery systems in the body.
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Jai et al. 24 used pellets composed of borate glass particles (<50µm) mixed with
four and eight weight percent teicoplanin to treat osteomyelitis. The pellets released
approximately 80% of the teicoplanin within 15 days in-vitro, and the compressive
strength decreased from 22 MPa to ~12 MPa after six days in phosphate buffered saline
(PBS) solution. The in-vivo results from New Zealand White rabbits were comparable to
what was seen in-vitro, as the teicoplanin was released in a controlled manner and the
implants had sufficient load bearing strength. No toxic effects were seen in the bone
adjacent to the borate glass as the glass converted to HA and supported the growth of new
bone into the scaffolds.
Liu et al. 25 treated osteomyelitis in the tibia of New Zealand White rabbits with a
scaffold consisting of borate glass particles and a polymer binder loaded with
Vancomycin. After eight weeks in-vivo, no observable tissue damage or inhibition of
bone growth was detected at the implant sites. Approximately 80% of the osteomyelitis
infected tibia tested negative for the infection after eight weeks. The outer perimeter of
the scaffolds had visible vascular growth that was claimed to have participated in bone
regeneration.
Bioactive silicate glasses, such as 45S5 (Table 1), have been modified with up to
3wt% B2O3 with positive results in-vivo 26,27. Particles of 45S5 with 2wt% added B2O3
had increased the amount of bone present after 15 days post-implantation in the
intramedullary canal of a rat tibia, and the Ca/P ratio of the bone surrounding the boron
doped particles was significantly higher than the Ca/P ratio in the 45S5 glass particles 26.
Direct bone bonding of the surface of the glass particles and rabbit bone was present, and
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a well defined calcium phosphate layer was reported at the surface of the boron doped
glass particles after eight weeks in-vivo 27.
Soft tissue from several mammalian species has been known to bond to 45S5 and
similar silicate based bioactive glasses for decades 27. The emphasis in the past has been
primarily on bioactive glasses bonding to bone, so the soft tissue analysis was usually
based on whether or not the tissue bonded with the glass, or if the tissue merely grew
adjacent to the glass without forming a bond 27,28.
More recently, researchers have looked into the possible angiogenic effects of
bioactive glasses such as 45S5 coated with vascular endothelial growth factor (VEGF) for
increasing the vascular network inside a scaffold 29. Further study on 45S5 as a
proagiogenic material has demonstrated that it is angiogenic in low concentrations and
has been hypothesized to up regulate VEGF production from the soluble reaction
products when co-cultured with human microvascular endothelial cells in-vitro 30. These
proangiogenic findings for silicate based bioactive glasses, such as 45S5, make them
interesting materials for soft tissue engineering applications as they are relatively
unexplored for soft tissue applications such as wound care.
Borate based bioactive glasses have not been investigated for soft tissue use; but
they have traits that make them attractive, such as higher reaction rates 31, and
controllable and continuous reaction to completion when in the presence of body fluids.
The previously mentioned in-vivo data for borate glasses in bone repair also indicate that
immune response is likely to be minimal 24,25,32.
The borate glass studied by Richard known as 45S5B1 (Table 1) 17 successfully
bonded to bone and reacted to form HA in-vivo. Huang, used in-vitro weight loss
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experiments to show that a 45S5B1 glass reacted significantly faster than the well known
and widely studied silicate based 45S5 glass 33. Jung et al analyzed the in-vitro weight
loss data from Huang and found that the reaction kinetics of the 45S5B1 glass was
approximately five times greater than that of the 45S5 31. The 45S5B1 glass reacted in a
controllable and continuous manner until the glass was completely reacted, while the
45S5 silicate glass reached a point where the mechanism for HA conversion reaction
changed and the reaction kinetics decreased significantly 31,33.
Through preliminary experiments, the 45S5B1 glass crystallized easily upon
heating and could not be heat treated to form a three dimensional porous scaffold without
crystallizing. The 45S5B1 glass was therefore deemed unusable as a scaffold material
and a new glass was needed that was more suitable for thermal processing.
Another bioactive glass known as 13-93 (Table 1) is a silicate based glass
containing 53wt% SiO2 along with materials such as MgO and K2O that allow glass
fibers to be pulled which can be heat treated to make three dimensional porous scaffolds
without crystallization 34-36. The 13-93 glass was modified similarly to the 45S5 glass by
replacing all the SiO2 with B2O3 33,37. This glass is hereafter referred to as 93B3 (Table
1). The 93B3 glass has reaction kinetics similar to the 45S5B1 glass 32, and, can be easily
pulled into fibers and can be heat treated to form a three dimensional porous scaffold 32.
The purpose of the present work was to investigate 93B3 glass fiber scaffolds in a
mammalian in-vivo environment to determine if these scaffolds would be useful in
treating hard and soft tissue defects.
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1.3.

MATERIALS AND METHODS

1.3.1

Glass and Fiber Preparation
The bioactive 93B3 glass (Table 1) was melted at 1050oC in a furnace for one

hour in a platinum crucible. The glass batch was made using reagent grade chemicals of
H3BO3, CaCO3, Na2CO3, MgCO3, NH4(H2PO4), and K2CO3. Fibers in the range of 100
to 300µm were hand pulled from the melt, collected, and broken into ~2 to 3mm lengths
which were used to manufacture porous randomly oriented fiber scaffolds.
1.3.2

Scaffold Preparation
Seventy milligrams of 93B3 glass fibers (weighed using a Sartorius model R200D

(Sartorius Corporation, Edgewood, NY) balance accurate to ±0.1mg) were placed inside
a cylindrical ceramic (mullite) mold. The molds holding the randomly oriented glass
fibers were placed into an oven preheated to 575oC, and heated for 45 minutes. After
heating, the molds were removed from the oven and cooled to room temperature. The
scaffolds, 7 ± 0.1 mm in diameter and 2 ± 0.2mm thick and were stored in a desiccator
until used. The scaffold shown in Fig 1 is representative of an as-made three dimensional
scaffold composed of self-bonded, randomly oriented 93B3 fibers.
1.3.3

Scaffold Porosity
The open, interconnected porosity of the scaffolds was measured using a liquid

displacement technique. The scaffolds were first weighed with a digital scale (Mettler
Toledo XS105 ±0.00001g) to obtain a dry weight (M1), and then submerged in kerosene
under vacuum for one hour to fill the open pores with kerosene. The scaffold was
weighed while suspended in kerosene (M2), and again while saturated with kerosene in
air (M3). The open porosity (Po) of the scaffold was calculated from Eqn.1.
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Po =

M 3 − M1
× 100%
M3 − M2

(1)

The open porosity of the 93B3 scaffolds was measured prior to implantation into the rats,
and the average open porosity calculated from 12 scaffolds by Eqn 1. was 51 ± 2%.
1.3.4

Scaffold Sterilization and Implantation
Scaffolds of 93B3 were dry heat sterilized in a fused silica glass vial covered with

aluminum foil by heating to 300oC in a small oven (Ney Vulcan 3-130) for four hours.
Once cool, the scaffolds were ready for implantation.
Two rats were used for the in-vivo subcutaneous experiment were Fisher 344 rats
(Fisher Scientific, St. Louis MO) between the age of 10 and 12 weeks. The rats were
anaesthetized with a mixture of isoflorine and oxygen and shaved to remove hair from the
base of the neck to the base of the tail. Loose hair was removed from the animal by
washing first with iodine and then 70% ethanol prior to incisions.
Figure 2 shows the location of the four implant sites, above each shoulder and
above each hind leg, on the back of the rat. A pocket ~15mm wide by 15mm long was
made under the skin at each site for scaffold placement. The image in Fig 3 shows a
scaffold being inserted into subcutaneous tissue. After implantation, the implant site was
gently compressed to remove air, and the incision was sealed with super glue. After all
four scaffolds were implanted; the rat was marked by labeling the ear, injected with 0.2ml
of penicillin, and placed on a heating pad and exposed to fresh air during recovery.
1.3.5

X-Ray Diffraction
A 93B3 scaffold was x-rayed (Scintag XDS 2000 using Cu Kα radiation with a

step scan mode with a 0.05o step) after four weeks in-vivo over the range of 10 to 70
degrees 2θ to determine what crystalline phase(s), if any, were present.
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1.3.6

Micro Raman
Micro Raman (LabRAM ARAMIS, Horiba Jobin Yvon) was used to analyze the

reacted 93B3 fibers from scaffolds implanted for four weeks in rat subcutaneous tissue.
A 50x objective was used to view the fibers, and the spectra were collected using a diode
laser (785nm) with a collection time of five seconds. LABSpec5 software was used to
capture the image and analyze the peak positions.
1.3.7

Scanning Electron Microscopy
An environmental scanning electron microscope ESEM (ESEM FEG XL30 from

FEI, Hillsboro, OR (Formerly Philips)) was used to image the cross section of a 93B3
scaffold implanted four weeks. The scaffold was sectioned with a razor blade to expose
the tissue and fibers located inside the scaffold. The scaffold section was coated with
approximately 100nm of Au/Pd to minimize charging effects.
1.3.8

Scaffold Recovery, Fixation, and Dehydration
After four weeks, the scaffolds were excised for histological and SEM analysis.

The animals were sacrificed in a sealed container filled with CO2. The scaffolds were
removed from the subcutaneous tissue and fixed in 5mL of 10% formalin solution (10:1
formalin to scaffold volume ratio) for four days. The scaffolds were then dehydrated
with a series of ethanol solutions from 70% to 100% in a microwave tissue processor
(EBSciences H2850 Microwave Processor). The microwave was set to 70% power, the
sample temperature was set to 37oC, and the microwave was operated for 2.5 minutes for
each solution. The scaffolds were in each solution for a minimum of 15 minutes
(including time in the microwave).
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1.3.9

Sample Preparation and Staining (Histology)
Dehydrated scaffolds were placed in a tissue processor (AutoTechnicon Model

2A) filled with fluid paraffin mounting wax (Paraplast Tissue Embedding Medium,
McCormick Scientific LLC) at 45oC for four hours to allow the wax to infiltrate the
scaffold and tissue. The scaffold was then mounted in a wax block for histological
sectioning with a paraffin mounting system (Leica EG 1150H). Sections, 18µm thick,
were cut with a microtome (Leica RM 2235 microtome) with TBS Shur/sharp blades,
(Triangle Biomedical Sciences, Durham NC) and floated on a water bath (Lipshaw
Electric Tissue Float, model number 375, Detroit MI) (40oC) prior to mounting on a glass
slide (Fisher Brand Superfrost microscope slides, St. Louis MO). Three to four tissue
sections were placed on a single slide, and dried overnight on a slide dryer (Fisher
Scientific slide warmer, St. Louis MO). The slides were stained with hematoxylin and
eosin (H&E), periodic acid schiff (PAS), and Verhoeff’s Van Gieson (VVG) to identify
soft tissues and verify the presence of blood vessels. Stained slides were viewed with an
optical microscope (Olympus BX50, Olympus Optical Co) at magnifications of 40, 200,
and 400X. Imaging software (DP Controller, Olympus Optical Co) was used to capture
images.
1.3.9.1 Hematoxylin and Eosin (H&E) Staining Protocol
H&E staining was completed in a Leica CV 5030 Autostainer XL. The slides
were immersed in 95% xylene, 5% ethanol for two minutes (two stations) and 100%
xylene for two minutes (two stations) to remove the wax. Each slide was dipped 15 times
in distilled water, and immersed in hematoxylin stain for three minutes. The slides were
washed in a series of four distilled water stations, one minute each, followed by 15 dips
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in acid alcohol and immersion in eosin stain for one minute. The slides were then
dewatered with a series of ethanol solutions, 80% for 30 seconds, 95% for one minute
(two stations), and 100% ethanol for one minute (three stations). The slides were
immersed in xylene for one minute (three stations) prior to mounting with a coverslip.
1.3.9.2 Periodic Acid Schiff (PAS) Staining Protocol
Prior to staining, slides were deparaffinized in xylene and hydrated in distilled
water. Sections were placed in 0.5% periodic acid solution for five minutes at room
temperature and then washed with a series of three washes in distilled water. Sections
were then placed in the Schiff reagent for 15 minutes followed by two washes in 0.55%
potassium metabisulfite to remove excess stain. Sections were rinsed in tap water for 10
minutes to develop color prior to a 30 second counter stain with 1% light green. Sections
were washed with tap water and then dehydrated in a 95% ethanol solution. Xylene was
used to remove all the alcohol prior to mounting with a synthetic resin. After staining,
blood vessels should be light blue, and red blood cells green.
1.3.9.3 Verhoeff’s Van Gieson (VVG) Staining Protocol
Slides were deparaffinized in xylene and hydrated in distilled water. Slides were
immersed in Verhoeff’s stain for 20 seconds and then washed in a series of distilled water
baths for one minute (three stations). Sections were placed in 2% ferric chloride until
elastic fibers were distinct and the background was colorless to light gray under
microscopic view. The sections were then rinsed in distilled water before immersion in
sodium thiosulfate for one minute. Sections were washed in tap water for five minutes
prior to counterstaining in Van Gieson stain for one minute. Sections were then
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dehydrated in a series of ethanol solutions, cleared with xylene, and mounted with a
coverslip.
1.4.

RESULTS

1.4.1

93B3 Scaffold Removal
Figure 4 shows a 93B3 scaffold after four weeks in-vivo before being removed

from the subcutaneous tissue. The area labeled SM is the skeletal muscle and the area
labeled ST is the subcutaneous tissue. Soft tissue had grown into the scaffold with
vessels (black arrows) visibly penetrating the outer perimeter. The originally transparent
(colorless) 93B3 fibers became white and the scaffold was soft to the touch, which
indicates that the fibers had reacted with body fluids to form amorphous calcium
phosphate (ACP) or possibly a crystalline calcium phosphate such as HA.
1.4.2

Backscattered SEM of a Sectioned 93B3 Scaffold After Four Weeks In-Vivo
The SEMBSE image in Fig 5 shows the cross section of a 93B3 scaffold after

four weeks in-vivo. The soft tissue is black, and the reacted fibers are a light gray.
Several of the fibers were broken while cutting; but, many of the fibers that did not break
are hollow as shown in Fig 5.
A fiber from the 93B3 scaffold which had fully reacted is shown in Fig 6. The
image in Fig 6A shows the end of a reacted fiber, as the fiber is cut perpendicular to its
longitudinal fiber axis. The center of the fiber has a relatively rough surface and does not
contain any original glass. Figure 6B shows a higher magnification of the hollow core of
the fiber where several nodules of calcium phosphate are present. The nodules are
magnified in Fig 6C, and are made of a porous network of nanocrystals. Figure 6D is a
magnified image of the nanocrystals in Fig 6C, and the needle-like structure is similar to
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that of HA. The crystals are approximately 50nm in length, and the overall structure is
highly porous.
1.4.3

X-Ray Diffraction of a 93B3 Scaffold after Four Weeks In-Vivo
The XRD pattern shown in Fig 7 is from a reacted 93B3 fiber scaffold after four

weeks in-vivo. The peaks present match those for HA (Ca10(PO4)6(OH)2) PDF card #721243, a mineral similar to that found in the inorganic component of bone. The broad
peaks in the XRD pattern are due to the nano-sized crystals of hydroxyapatite, see Fig
6D.
1.4.4

Micro Raman of a Reacted 93B3 Fiber after Four Weeks In-vivo
A reacted 93B3 fiber analyzed by micro raman and the four spots analyzed across

the fiber diameter are shown in Fig 8. A white dashed line has been added to show the
fiber perimeter more easily. The raman spectra are shown in Fig 9, position one is at the
outer edge of the fiber and position four at the center of the reacted fiber. The three
peaks associated with HA (431cm-1 (PO43- v2), 965cm-1 (PO43- v1), 1065 to 1070cm-1
(CO32- v1) and 1076cm-1 PO43- v3) 38 are denoted by dashed lines. The solid lines are due
the mounting medium (PMMA) as indicated by the spectra at the top of Fig 9.
Positions three and four located toward the center of the fiber in Fig 8 have the
highest intensities for the phosphate and carbonate peaks indicating a difference in the
amount of each species distributed throughout the fiber. The presence of a carbonate
peak at 1065 to 1070cm-1 (CO32- v1) indicates that the fibers are carbonated, similar to
natural bone. The difference in the amount of phosphate and carbonate measured could
be due to differences in the density of the reacted fiber.
1.4.5

Histological and Vascular Assessment of Soft Tissue
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A cross sectioned 93B3 glass scaffold prior to implantation into soft tissue would
look similar to that shown in Fig 10. The fibers (dark gray) are randomly oriented, so the
shape of the fibers (circular to elliptical), is dependant on the fiber orientation. Several
fibers are indicated with arrows, and the open space (porosity) in between the fibers
(lighter color) is filled with a transparent epoxy. The porosity in the scaffold is mostly
interconnected and there are few, if any, closed pores.
1.4.6

Hematoxylin and Eosin Stain (H&E)
The images of the 93B3 scaffold (four weeks in-vivo) stained with H&E in Fig

11, look significantly different from that in Fig 10. Soft tissue (purple) that has filled
essentially all of the interconnected pores between the fibers, and the fibers (originally
solid) have reacted with the body fluids and become hollow. The tissue throughout the
scaffold is healthy with no sign of any significant immune reaction or foreign body
reaction like a walling off of the entire scaffold or the individual fibers.
Figure 12A shows that blood vessels are present in both the soft tissue between
the fibers and in the soft tissue that had grown into what were the hollow cores of the
reacted fibers. The scaffold section in Fig 12A had fibers (F) that reacted and became
hollow that subcutaneous tissue had grown inside. There is an ordered line of red blood
cells at the center of the image in Fig 12A indicating a small blood vessel ~10µm in
diameter (white arrows). The image in Fig 12B shows a larger blood vessel in the center
of the image with significantly more red blood cells than in Fig 12A. The vessel lining is
denoted by the white arrows, is approximately 30 to 40µm in diameter and contains
numerous red blood cells.
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Figures 13A and 13B are images of H&E stained sections of a 93B3 scaffold that
had been implanted in the rat for four weeks. The two parallel purple regions marked (F)
that run from the top left to bottom right of the image in Fig 13A are the outer edges of a
reacted fiber, cut parallel to its longitudinal axis, to reveal a hollow core containing soft
tissue (purple) and red blood cells (red dots) as indicated by the white arrow. Another
fiber shown at the center of Fig 13B, which was cut perpendicular to its longitudinal axis,
contains both soft tissue and red blood cells (vertical arrows) in what appears to be a
blood vessel.
1.4.7

Verhoeff’s Van Gieson Stain (VVG)
The images in Fig 14A and 14B are from a sectioned 93B3 scaffold, implanted in

rat subcutaneous tissue for four weeks, which was stained with VVG (Verhoeff’s Van
Gieson) that stains specifically for elastic tissue, veins, arteries, and other vessels. The
cell nuclei and blood vessel lining (elastin) stains black, collagen or other connective
tissue is pink, and red blood cells are yellow.
The image in Fig 14A shows several reacted fibers (F) along with a circular
shaped vessel in the center of the image (black arrow) and a black rim (elastin) filled with
red blood cells (yellow dots). The image in Fig 14B, stained positive for a vessel, white
arrow at center, in the hollow void of a reacted fiber (F), and there is connective tissue
(pink) surrounding a black elastin ring (vessel wall) which contains red blood cells
(yellow dots). A second vessel at the bottom center of Fig 14B, between two fibers, is
shown by the black arrow. As is apparent from Figs. 14A and 14B, the dark color of the
nuclei can make it difficult to determine whether or not there was a positive stain for
elastic lining.
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1.4.8

Periodic Acid Schiff Stain (PAS)
The images in Fig 15A and 15B are images of sections from a 93B3 scaffold

implanted four weeks in a rat that were stained with Periodic Acid Schiff (PAS). The
PAS stain bonds to glucose residue in tissue. Glucose is present in muscle, liver, and red
blood cells, but vessel lining is also stained due to the diffusion of glucose from the red
blood cells to the surrounding tissue. Connective tissue is light green, red blood cells are
bright green, vessel lining is blue, macrophages are yellow or brown, and HA stains
purple.
The vessels in Fig 15A are marked by arrows. Several of the vessels contain the
bright green labeled red blood cells. There are also macrophages distributed throughout
the section, as denoted by the black circles in the tissue surrounding the reacted fibers.
Figure 15B shows a reacted fiber, cross sectioned perpendicular to its longitudinal axis,
in the center of the image (dashed circle). There is a vessel (blue circle) with red blood
cells (bright green) present in the hollow fiber (F) void as indicated by the black arrow.
1.5

DISCUSSION AND CONCLUSIONS
Upon removal of the 93B3 implanted scaffolds, soft tissue had penetrated deep

into the scaffolds, and several blood vessels had grown adjacent to the scaffold surface as
shown in Fig 13. There was no visible inflammation or infection surrounding the
scaffolds and there was no sign of fibrous tissue that is typically present surrounding an
object which the body considers a foreign body. This was an important indication that
the scaffold was not being rejected by the animal. The lack of inflammation surrounding
the scaffold upon excision agrees with work done by Richard using 45S5B1 glass
particles in contact with bone 17.
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The 93B3 scaffolds were no longer rigid when removed from the animals, as
much of the original mechanical strength was lost when the glass converted to the porous
HA. The soft tissue that had bonded to the fibers as it grew into the scaffold was holding
the reacted fibers together. While a decrease in strength is not necessarily a desirable
quality for bony defects, especially load bearing defects, the softening of the material
may be an advantage for the treatment of soft tissue such as muscle and skin.
The XRD patterns from the 93B3 scaffolds implanted for four weeks matched
HA, PDF card # 72-1243. The peaks are relatively broad due to the nano-sized crystals
of HA shown in Fig 6D. The needle-like nanocrystals of HA that formed in-vivo from
the 93B3 glass look similar to those from a silicate glass soaked in simulated body fluid
(SBF) for 30 days indicating that the borate glass reacts in a similar manner as the well
known and commercially used bioactive glasses 27. The HA is carbonated similar to
natural bone as shown by the micro raman in Fig 9.
The PAS stained sections in Figs 15A and 15B clearly show that blood vessels
were present in both the open pores of the scaffold and inside the hollow core of reacted
fibers. Macrophages were also identified, but, they were in the soft tissue and not
specifically surrounding any of the HA from the reacted glass. The presence of
macrophages in regenerating tissue is normal as they release growth factors required for
tissue growth.
The histological staining proved that soft tissue had significantly penetrated the
93B3 scaffold in four weeks and had filled not only the open pores of the scaffold, but
also the relatively large voids (50 to 150µm diameter) formed in the hollow fibers. The
relatively low chemical durability of the 93B3 glass releases calcium when in contact
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with body fluids and reacts with phosphate present in the body fluids to form
hydroxyapatite on the surface of the glass fiber. This reaction continues until the glass
fiber has fully degraded and released all of the calcium. The amount of calcium in the
glass determines the HA wall thickness that is formed when reacted with body fluids.
The reacted fibers shown in Fig 5 and Fig 11 show that almost all of the fibers
have become hollow, and most had soft tissue that had filled the hollow cavity. How the
soft tissue got inside the cavity is not well understood, but the tissue may have gained
access when the 93B3 fibers formed HA, lost mechanical strength, and fractured from the
regular movement and activities of the animal. Regardless of how the tissue entered the
hollow fiber cavities, both soft tissue and blood vessels were present. The fact that blood
vessels entered the hollow fibers and grew in the direction of the hollow cavity indicated
that these hollow fibers may have use as vascular or other tissue guides. Vessels were
present in several of the hollow fibers and stained with either VVG or PAS for
verification as shown in Figs 14, and 15.
One example of a vessel growing a significant distance (several hundred microns)
along the hollow core of a fiber is shown in Fig 16A and 16B. The hollow fiber (F) of
interest is the in the center of Fig 16A and has parallel dashed lines on either side of the
vessel. Many of the HA fibers were debonded from the slide during the staining process
and appear as white ellipses or circles depending upon the fiber orientation, but, the soft
tissue was well adhered to the glass slide. Figure 16B is a magnified view of the reacted
fiber in Fig 16A. The black horizontal arrows point to the blue vessel lining travelling
from one end of the fiber to the other. The vessel has a diameter of about 20 to 30µm and
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is approximately 700 to 800µm in length inside the hollow fiber. The exact length of the
vessel could not be determined due to the orientation of the fiber when it was cut.
Boron, although not entirely understood, is hypothesized to play an important role
in several developmental and biological functions. If boron is removed from the diet of a
developing animal such as a rat, there is a significant decrease in the animal’s size and
the bones are not well developed 14. Boron is in the diet of humans as it is found in most
vegetables and nuts 1-3. At low levels (1 to 20 mM BA) boron has been found to have a
positive effect on mRNA uptake of human placental cells in-vitro, which means that the
BA has a stimulatory effect on cell activity similar to a growth factor 39.
Assuming the 93B3 glass fibers reacted (lost weight) similarly to the way other
borate glasses have been shown to do in-vitro 33, and the fibers were fully reacted in four
weeks, it is possible to estimate the BA concentration in the adjacent tissue (tissue inside
scaffold). In estimating the BA concentration, blood flow rates were used which were
measurements of blood flow through rat adipose tissue 40. The weight of the rats used in
the present work was ~300g each.
The following is a description and background information required for making
the BA concentration calculations. The 93B3 as-made scaffolds each weighed ~70mg
prior to implantation. From Table 1, each scaffold was 53wt% B2O3 which means that a
93B3 scaffold contained 0.037 grams B2O3 or 0.066g BA (H3BO3), or 1.07E-3 moles of
BA as that is the form boron takes in an aqueous environment such as body. Assuming it
took four weeks, or 28 days, for the fibers to completely react and the fibers lost weight
(reacted) linearly over the time period, the BA release was 3.82E-5 moles per day.
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The Benchmark Dose Limit (BMDL) for boric acid as determined from a series of
animal experiments is 55mg/kg/day 2. A single 93B3 scaffold contained enough boron to
produce 66mg of BA when fully reacted, which divided equally over 28 days is
2.36mg/day of BA. When the weight of a rat (300g) is taken into account, the release of
H3BO3 from a scaffold is 7.87mg/kg/day. This simple calculation indicates that the
concentration of BA in a single 300g rat should have been well below the BMDL. A
300g rat should be able to tolerate over seven times the mass of a single 93B3 scaffold
(~500mg of glass) before any observable effect might be seen.
The concentration of BA in the vicinity of the infiltrated soft tissue was estimated
to determine the concentration of BA present. The tissue inside the scaffold was
estimated to be ~50mg just after the scaffold was removed by assuming complete
reaction of the glass to HA (weight loss) and the weight of the scaffold and infiltrated
tissue after removal from the subcutaneous tissue. The fluid flow through the scaffold
was assumed to be due to blood flow, so the highest average (0.4ml/min/gram of tissue)
and lowest (0.1ml/min/gram of tissue) flow rates from published data for rat adipose
tissue were used in determining the concentration range of BA in the tissue 40. The
highest flow rate was measured while the rats were active and feeding, while the lowest
was when the animals were sleeping.
Assuming the minimum flow rate for a 24 hour period, the amount of blood that
would pass through the tissue in the scaffold was calculated to be 7.2ml. This number
was calculated from Eqn 2.
Vol. of blood = Blood flow rate*Mass of tissue*Time
The calculation for the minimum flow rate is shown below:

(2)
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(1440min/day)(0.1ml/min*g)(1 day) (0.05g) = 7.2ml or 0.0072L
Taking the value calculated for the amount of BA released per day from a scaffold
(3.82E-5 moles/day) and dividing it by 0.0072L, the average concentration for an entire
day is 5.29mM BA.
A similar calculation was made for the highest flow rate. Assuming the highest
blood flow rate for a 24 hour period, the amount of blood that would pass through the soft
tissue was 28.8ml. The four times greater volume of blood lead to a BA concentration
that decreased by four times to the estimated concentration of 1.32mM BA.
The two concentrations calculated represent the highest and lowest BA
concentration would reach, with the actual value fluctuating depending on the activity of
the rats. The two calculated values have been compared to the in-vitro mRNA uptake
data from human placental cells cultured with low levels of BA as shown in Fig 17. The
total mRNA (nmol) uptake is plotted vs. concentration of BA in the culture media (mM),
and the two calculated values from the present work are denoted by vertical red lines.
The two concentrations fall in the stimulatory range (2 to 3X increase) BA had on the
mRNA uptake of human placental cells. This could be an indicator that the BA released
from the scaffolds may be having a positive effect on the nearby tissue. The increase in
the mRNA with the human placental cells was described as similar to the effect of a
growth factor would have on the cells, so the presence of BA in the tissue adjacent the
scaffold could have enhanced growth characteristics.
Based on these simple calculations and information from the literature, it is likely
that boron released from a scaffold could be expected to have a positive impact on the
surrounding tissue. The hypothesis of a positive interaction between the boron released
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from the 93B3 scaffolds and the soft tissue is confirmed by the histology in Figs 11 to 16.
Soft tissue had filled the open pores of the 93B3 scaffolds, tissue had bonded with the
reacted fibers, and blood vessels were growing not only in the open pores, but also inside
the hollow cores of many of the reacted fibers.
In conclusion, scaffolds composed of randomly oriented, bioactive 93B3 fibers
reacted with the body fluids in rat subcutaneous tissue to form a nanocrystalline
carbonated HA. The interconnected and open pores in the scaffolds nearly filled with
soft tissue after four weeks in-vivo. The initially solid glass fibers reacted in such a way
that they became hollow. Soft tissue as well as blood vessels infiltrated the hollow core
of the reacted fibers and the blood vessels tended to be oriented along the fiber axis.
Scaffolds composed of bioactive borate glass fibers could have uses for future
applications as tissue guides for blood vessels, bone, or other tissues.
Comparing published in-vitro data for the effect of BA on human placental cells
with calculations from the present work on the estimated concentrations of BA in nearby
tissue, the BA released from the 93B3 scaffolds falls in the range that was found to
stimulate mRNA uptake in human placental cells. The calculated concentration of boron
released from the 93B3 scaffolds is low compared to most published work studying the
effects of BA concentration on biological interaction. The effects of BA concentrations in
the range of those calculated (1 to 6mM) are still relatively unstudied, but could prove
stimulatory and essential for biological functions.
Both the PAS and VVG stains positively stained vessels from the 93B3 scaffolds.
The PAS stain appeared to be more useful as the colors of the vessel and the connective
tissue were sufficiently different for vessel verification; but the color scheme of the PAS
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was easier to interpret than the VVG. The PAS stain also positively stained macrophages
which is important to make sure the foreign material is not causing an immune reaction.
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TABLES

Table 1 -Nominal Bioactive Glass Compositions (wt0/o)
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Na 20

CaO

MgO
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0

24.5

24.5

0

0

6

0

45

24.5

24.5

0

0

6
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0

6

20

5

12

4

9383

0

53

6
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12

4

Glass
4585
458581
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FIGURES

Figure 1 – Optical micrograph of an as-made 93B3 scaffold after heating for 45 minutes
at 575oC. The scaffold has a nominal diameter and thickness of 7 ± 0.1mm and 2 ±
0.2mm, respectively, with an average open and interconnected porosity of 51 ± 2%,
n=12.
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Figure 2 – Schematic showing scaffold implantation sites on the back of a rat.
Implantation sites were approximately 15mm wide by 15mm long. The red line indicates
the incision made in the skin, and the dotted arch represents the opening made under the
skin.
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Figure 3 – Image showing the implantation of a 93B3 scaffold in the subcutaneous tissue.
The hair was removed, and the skin has been cleaned and disinfected. The orange color
on the back of the rat is from iodine.
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Figure 4 – Optical image of a 93B3 scaffold prior to removal from rat subcutaneous
tissue. The skeletal muscle (SM) and subcutaneous tissue (ST) are labeled as well as
vessels (black arrows) growing in the adjacent tissue. The scaffold was soft to the touch
and the fibers were white indicating they had reacted with the body fluids.
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Figure 5 – SEMBSE micrograph of a cross section of a 93B3 scaffold after four weeks in
the subcutaneous site in a rat. Soft tissue (dark gray) surrounds the reacted fibers (light
gray). Many of the reacted 93B3 fibers have become hollow.
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Figure 6 – A series of higher magnification SEM micrographs of reacted 93B3 fibers
after four weeks in the subcutaneous site in a rat. Figure 6A shows the cross section of a
reacted fiber having a hollow inner core. Figure 6B is a magnified view of the hollow
core of the reacted 93B3 fiber in Fig 6A. Figure 6C is a magnified view of the nodules.
Each nodule consists of a porous structure of nanocrystals and those are shown in Fig 6D.
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Figure 7 – XRD pattern for a 93B3 scaffold after four weeks in-vivo. The pattern
matches hydroxyapatite, PDF card# 72-1243 (vertical lines). The peaks are relatively
broad because of the nano sized hydroxyapatite crystals.
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Figure 8 – Optical image of a 93B3 fiber reacted in rat subcutaneous tissue for four
weeks, mounted in PMMA, and cross sectioned. The outer perimeter of the fiber is
denoted by a dashed line, and the center and outer edge are labeled as indicated. The four
locations inside the fiber were analyzed by micro raman and the spectra are shown in Fig
9.

49

Figure 9 – Micro raman spectra for a 93B3 fiber that was implanted in rat subcutaneous
tissue for four weeks. The peaks associated with HA are indicated by the dashed lines at
(431cm-1 (PO43- v2), 965cm-1 (PO43- v1), 1065 to 1070cm-1 (CO32- v1) and 1076cm-1
PO43- v3) and the solid lines are for the mounting medium PMMA. At the top of Fig 9,
the spectrum for PMMA mounting medium is shown. The spectrum for the outer edge of
the reacted 93B3 fiber is labeled 1, and the center 4.
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Figure 10 – Optical micrograph of the cross-section of an as-made 93B3 scaffold. The
darker gray circular or ellipsoidal shapes are self-bonded, solid and unreacted, glass
fibers and the light colored region is transparent epoxy.
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Figure 11 – Optical micrograph of an H&E stained section of a 93B3 scaffold that was
implanted in rat subcutaneous tissue for four weeks. The 93B3 fibers have reacted with
the rat body fluids and become hollow. Soft tissue (purple) has infiltrated nearly all of
the open porosity within the scaffold, and several of the hollow fibers have soft tissue in
the hollow core as well.
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Figure 12 – Optical micrographs of H&E stained sections from a 93B3 scaffold
implanted in the subcutaneous site in a rat for four weeks. Cell nuclei are blue,
cytoplasm connective tissue and extra cellular matrix (ECM) are purple or red and red
blood cells (RBC) are bright red. Figure 12A shows a section with multiple hollow fibers
(F), some of which contain soft tissue (purple). There is also an organized line of red
blood cells as pointed out by the arrows indicating a small blood vessel. Figure 12B
shows a section with a larger vessel in the center of the image as indicated by the white
arrows. There is a large amount of red blood cells (pink dots) in the vessel. The fibers
(F) have significantly reacted to HA.
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Figure 13 – Optical micrographs of H&E stained sections from a 93B3 scaffold
implanted in a subcutaneous tissue for four weeks. Cell nuclei are blue, cytoplasm
connective tissue and extra cellular matrix (ECM) are purple or red and red blood cells
(RBC) are bright red. Figure 13A shows a reacted 93B3 fiber which has been cut parallel
to the longitudinal fiber direction, and the sides of the fiber have been labeled with (F).
There is soft tissue (purple) and red blood cells (white arrow) inside the hollow cavity of
the fiber. Figure 13B has a fiber that has been cut perpendicular to the longitudinal fiber
direction, and inside the fiber is soft tissue and red blood cells (arrows) indicating blood
vessels are present inside the fiber.
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Figure 14 – Optical micrographs of VVG stained sections from a 93B3 scaffold
implanted in a subcutaneous site for four weeks. Cell nuclei are brown to black,
connective tissue is pink to red, and red blood cells (RBC) are yellow, and elastin is
black. Several fibers, denoted by (F), are shown in Fig 14A; but much of the HA
debonded during staining. There is a vessel in the center of the image (black arrow) as
the elastin in the vessel is black, and there are several red blood cells in the center of the
vessel (yellow). Figure 14B shows a hollow fiber (F) at the center of the image with a
vessel in its hollow core (white arrow). There is a second vessel below, indicated by a
black arrow that is in the void formed between two self-bonded fibers.
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Figure 15 – Optical micrographs of PAS stained sections from a 93B3 scaffold implanted
in a subcutaneous tissue for four weeks. Connective tissue is light green, and red blood
cells (RBC) are bright green, vessel lining is blue, hydroxyapatite is purple, and
macrophages are brown. Figure 15A has stained positive for several blood vessels
(arrows) as the blue rings are surrounding bright green RBC. There are several
macrophages throughout the tissue, circled; however they are not congregating around
the scaffold material (F). Figure 15B has a hollow fiber (F) in the center of the image
(dashed circle) with a vessel inside the void (arrow).
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Figure 16 – Optical micrographs of PAS stained sections from a 93B3 scaffold implanted
in a subcutaneous tissue for four weeks. Connective tissue is light green, and red blood
cells (RBC) are bright green, vessel lining is blue, hydroxyapatite is purple, and
macrophages are brown. Figure 16A shows has several fibers denoted by (F), however
much of the HA washed off during staining. The hollow fiber in the center of the image
has a vessel that grew 700 to 800µm down the hollow void of the reacted 93B3 fiber.
Figure 16B shows a magnified view of the vessel, and the lining has been indicated by a
series of arrows. The vessel has a significant number of red blood cells (RBC) present
inside it.
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Figure 17 - Effect of mRNA uptake compared to boric acid concentration for human
placental cells compared to the estimated boric acid concentrations from a reacting 93B3
scaffold in a sleeping (0.1ml/min*g) and active rats (0.4ml/min*g). According to the
estimated boric acid concentrations from the scaffolds, and the effect seen from in-vitro
cell culture experiments 39, there could be a stimulatory growth effect similar to a growth
factor from the reacting 93B3 scaffolds.
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2.1 ABSTRACT
The potential toxicity of a bioactive borate glass was evaluated using in-vivo
animal models in soft tissue and bone and from in-vitro cell culture experiments using
MLOA5 late osteoblast/early osteocytes cells. No toxicity was found between bioactive
borate glass and subcutaneous tissue, in the liver, and nothing beyond normal incidental
changes in rat kidney. Bone growth across porous scaffolds composed randomly oriented
borate glass fibers was significantly higher than for a scaffold composed of a borosilicate
glass or a silicate bioactive glass (13-93) fibers after 12 weeks in-vivo, p<0.05. In-vitro
cell culture testing of bioactive glasses showed that under static culture conditions, borate
glass disks tended to inhibit the growth of MLOA5 late osteoblast/early osteocyte cells,
but when the disks were pre-reacted (in culture medium or a dilute phosphate solution)
the cell proliferation is significantly increased to levels similar to 45S5 bioactive glass.
The present work, along with data from the literature, show that bioactive borate glasses
are biocompatible in-vivo and are not toxic to adjacent hard or soft tissues, or internal
systemic organs such as the kidney and liver, were unaffected at the relatively high,
estimated concentrations tested (<~126mg/kg/day). Based on the present results and
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literature data, boron released from the borate glasses in the form of boric acid was not
toxic in a dynamic environment such as the body and should be considered for use in
humans and other mammals for soft and hard tissue engineering applications.

2.2 INTRODUCTION
Silicate based bioactive glasses such as 45S5 (Table 1) have been known to bond
to bone and soft tissue for almost 40 years [1]. Bioactive silicate glasses are useful
materials for tissue engineering due to their high degree of biocompatibility in the body.
The rate at which silicate bioactive glasses convert to hydroxyapatite (HA) is relatively
slow, on the order of months to years depending upon the size of the bioactive glass
particle and its composition [2]. Due to this slow reaction rate, bioactive glasses
containing boron have been developed which react significantly faster with body fluids
than silicate glasses [3].
The effect of boron on cells and animals has been studied in-vitro and in-vivo to
determine its physiological role [4]. Boron has not been linked to any specific biological
function, but there is evidence that the absence of boron changes growth patterns in
animals and stimulates cell growth in-vitro [4, 5]. Determining the effect that a bioactive
borate glass has on cells and living tissue is a controversial issue due to the difference in
the experimental parameters. Typically, in-vitro cell cultures are static systems in which
cells are seeded, covered with culture medium, and depending on the experiment, not
disturbed for several days. The human body is a dynamic system where heavily buffered
fluids, relatively constant pH, are constantly moving and being replenished.
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Using a static culture environment to determine in-vivo biocompatibility for a
non-reactive material is trivial. As long as the material is un-reactive, the pH remains
relatively constant, and nothing changed in the system by the material, so the material
does not directly affect cell attachment and growth. When the material of interest is
reactive, differences between the static culture environment and in-vivo (dynamic)
become apparent. With a reactive material, the solution pH, the composition of the
media, and the material being studied may all be changing, and, thereby affect cell
attachment and growth. In a static environment, especially in regions adjacent to the
reactive material, there are no means of equilibration. Therefore, comparisons between
the static culture and in-vivo environments may not be representative.
The schematic in Fig 1 shows the conditions that have been used to evaluate
potential toxicity of a borate glass in-vitro and in-vivo. The in-vitro method has been
used mostly with static culture, but dynamic culture (continual or repetitious agitation)
has yielded some interesting improvements in cell proliferation [6]. Marion et al found
that pre-reaction of a bioactive borate glass also increased the in-vitro culture of cells [7].
In-vivo studies of the biocompatibility of borate based bioactive glasses are
limited, but animal studies where the potential toxicity of boric acid (BA) has been
studied are also relevant. Soft and hard tissues and internal organs of mice, rats, and
rabbits dosed with BA have been studied and the maximum limits to avoid toxicity in
adult and fetal animals have been determined [8]. It should be noted that there is a
relatively wide range of minimum toxicity limits between different animal species, so for
simplification, hereafter, the lowest toxicity level of a given group will be the assumed
toxic level for the entire group.
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The BA levels acceptable for ingestion by animals or added to cell culture are
shown in Fig 2 and the data and sources are listed in Table 2 [5, 6, 8-12]. The data in Fig
2 is labeled as non-toxic (green), if inhibition or toxicity is reported in animals (fade from
green to red), and red where extreme inhibition or cell death occurred. The static culture
of the cells had the lowest level of BA toxicity at 62mg/kg/day, or 1mM [6]. The
conversion from 1mM to mg/kg was made using 62g/mole for boric acid (H3BO3), and
dividing by 1000 to get 62mg/mM. An aqueous solution of boric acid is mostly water,
and one liter of water weighs 1kg, therefore, a 1mM solution of boric acid is equivalent to
62mg/kg.
One reason why static cell culture on reactive materials, such as bioactive borate
glasses, may not be the best method of determining in-vivo performance is illustrated by
the schematic in Fig 3. Three different conditions are simulated, in-vitro static, in-vitro
dynamic or pre-reacted, and in-vivo dynamic. The in-vitro dynamic or pre-reacted
conditions were grouped together because the toxicity gradients from each are thought to
be similar (i.e. a smaller potentially toxic region). As indicated by the dashed circle and
the color gradient, the area of cell inhibition in a static culture is in the liquid immediately
surrounding the material, for this example a glass disk (G). The majority of the culture
medium could be only minimally affected by the reaction of the glass with the culture
media.
In the dynamic in-vitro condition, the material dissolving from the glass becomes
diluted and is ideally distributed throughout the culture medium. This solution reduced
the potential toxicity of the reactive material and its effect on proliferation. The final
condition, in-vivo dynamic, shows a minimal gradient as the leached ions are transported
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from the glass surface by the fluids in the adjacent tissue and the blood flow. The BA is
removed from the body and high concentrations do not build up locally in the tissue
adjacent to the glass.
Borate glasses of the composition used in the present work react quickly, within a
few hours, with an aqueous solution like a phosphate solution or cell culture medium.
Weight loss data for a soda lime borate glass of is shown in Fig 4 [7]. Initially, the glass
loses almost 25wt% in the first 24 hours, but the rate decreases by a factor of four
between 30 and 120 hours due to the formation of calcium phosphate on the glass
surface. The weight loss in the first day is primarily due to the dissolution of sodium and
boron from the glass. This explains why pre-reaction of a bioactive borate glass for just a
few hours prior to a cell culture experiment can improve cell growth. Eliminating the
initially large influx of alkali and boron in the culture media and forming a calcium
phosphate layer on the glass surface helps to better simulate how cells might interact
during the more representative condition of the cells growing on a calcium phosphate
coated glass.
The objective in the present work was to evaluate the potential toxicity of
bioactive borate glass fiber scaffolds in-vivo. Like almost anything, toxicity has to do
with the amount or quantity of something ingested or the overall concentration that leads
to a negative outcome. Therefore, bioactive borate glass fiber scaffolds were implanted
in-vivo in soft and hard tissue of rats followed by a comprehensive histological analysis.
As a reference, comparisons with well known silicate based bioactive glasses were
included when appropriate.
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2.3.

MATERIALS AND METHODS

2.3.1

Scaffold and Disk Preparation
Reagent grade chemicals of SiO2, H3BO3, CaCO3, K2CO3, MgCO3, P2O5, and

Na2CO3 were used to prepare the bioactive glasses (Table 1). The raw materials were
weighed (±0.01), thoroughly dry mixed, and melted in a platinum crucible at
temperatures ranging from 1050 to 1400oC for one to two hours depending on the
composition. The glass was stirred with a silica rod several times to achieve a chemically
homogeneous melt.
Rods of 45S5, 13-93, 13-93B1, and 13-93B3 glass (Table 1) were cast into
graphite molds with an internal diameter of 10mm and annealed at temperatures between
450 and 550oC for two hours before slow cooling to room temperature. The rods were
cut into 1mm thick disks with a slow speed saw which were used for cell culture
experiments. The disks were rinsed with ethanol and acetone and stored in a dessicator
until used.
Fibers 100 to 300µm in diameter were hand pulled from the melt and broken into
2 to 3mm lengths (Fig 5A) which were used to manufacture porous, three dimensional,
randomly oriented fiber scaffolds. Seventy milligrams of glass fibers were weighed for
each scaffold and placed with a random orientation in a 7mm inside diameter ceramic
(mullite) cylindrical mold (Fig 5B). The molds were placed in a preheated oven at
selected temperatures between 575 to 695oC for 45 minutes, depending on the glass
composition, to allow the fibers to soften and thermally bond. The molds were then
removed from the oven and cooled to room temperature. Once cool, the scaffolds were
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removed from the molds and stored in an air tight desiccator. The as-made scaffolds had
nominal dimensions of 7mm in diameter and 2mm thick, see Fig 5C.
Prior to implantation or cell culture, the scaffolds and disks were dry heat
sterilized by placing them in a silica glass vial, covering the vial with aluminum foil, and
heating the vial to 300oC for four hours in an oven. The scaffolds or disks were slow
cooled to room temperature. Once cool the scaffolds or disks were ready for use.
2.3.2

Growth of MLOA5 Cells on Bioactive Glass Disk
MLOA5 late osteoblast/early osteocyte cells were cultured on as-cut (unpolished)

disks of 45S5, 13-93, 13-93B1, and 13-93B3 for 24 hours on un-reacted disks and prereacted disks (four hours in culture media) at 37oC, 5%CO2 atmosphere. The cells were
fixed, collected, and counted for comparison with the control (50,000 MLOA5 cells
cultured on the bottom of a single well of a 24 well plate). The cell culture experiments
were completed at the University of Missouri –Kansas City (UMKC) School of Dentistry
Department of Bone Biology [13].
2.3.3

Subcutaneous Scaffold Implantation
The schematic in Fig 7 shows the four implant sites in which a scaffold was

implanted in a Sprague Dawley rat above each shoulder and above each hind leg between
the subcutaneous tissue and the skeletal muscle. Since the scaffolds were implanted in
multiples of four, each site contained between one and four scaffolds. No scaffolds were
implanted in the control animals.
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2.3.4 Subcutaneous Scaffold and Organ Removal, Tissue Processing, and
Histology Slide Preparation
After four weeks, the scaffolds from the experimental group, a lobe of the liver,
and the left kidney from each rat were excised, photographed, and fixed in 10% formalin
for four days.
2.3.5

Tissue Processing and Histology Slide Preparation
After the tissues were fixed, they were dehydrated with a series of ethanol

solutions ranging from 70 to 100% ethanol [14] and a microwave irradiation technique
[15]. Each scaffold, kidney, or liver was submerged in a glass vial with 10ml of ethanol
solution, packed into an ice bath, placed in the microwave (EBSciences H2850
Microwave Processor) for 2.5 minutes at a power of 65% at 37±4oC, and after removal,
set at room temperature for at least 15 minutes. This process was followed for each
tissue in each ethanol solution.
As a control, a 13-93B3 fiber scaffold was embedded in a transparent epoxy and
cross sectioned to show an un-reacted fiber scaffold without any and is shown in Fig 11.
The glass fibers are circular or elliptical depending on the fiber orientation. Several of
the fibers have bonded together in the plane of the cross section, to form complex
geometrical shapes.
Each kidney, liver, and fiber scaffold was embedded with paraffin for
histological analysis with a tissue processor (AutoTechnicon Model 2A) filled with
paraffin mounting wax (Paraplast Tissue Embedding Medium, McCormick Scientific
LLC) at 45oC for four hours. The infiltrated tissue was mounted in a wax block with a
paraffin mounting system (Leica EG 1150H). Histological sections 18µm thick were cut
of the recovered scaffold to better keep in tact the reacted fibers with a microtome (Leica

66
RM 2235 microtome) with TBS Shur/sharp blades. The kidney and liver sections were
cut 6µm thick to improve the clarity of the sections. Each section was floated on a water
bath (Lipshaw Electric Tissue Float, model number 375, Detroit MI) at 40oC prior to
mounting the section on a glass slide (Fisher Brand Superfrost, St. Louis MO). Between
two and four tissue sections were mounted on each slide and dried over night (Fisher
Scientific slide warmer, St. Louis MO). Each of the tissues (scaffold, kidney, liver) was
stained with H&E stain (Phelps Country Regional Medical Center in Rolla MO). A
detailed protocol for the H&E staining procedure is available elsewhere [10].
2.3.6

Tissue Assessment
The kidney and liver sections were labeled generically and sent to Charles River

Research Animal Diagnostic Services Center (Wilmington, MA) for a blinded
pathological analysis. The scaffold sections were used to assess tissue infiltration and the
extent of the fiber reaction.
2.3.7

Calvaria Implant Experiment
Porous scaffolds composed of 13-93B3 fibers, 13-93B1 fibers, 13-93 fibers, and

particles of 45S5 glass (100 to 200µm in diameter) were implanted in a 4mm rat calvaria
defect (n=4) for 12 weeks. The growth of the bone was monitored in-situ with micro-CT
(computer tomography) analysis. The calvaria implant experiment was conducted at the
dental school at UMKC.
2.4.

RESULTS

2.4.1

In-vitro MLOA5 Cell Culture (As-made and Pre-reacted)
Data for the proliferation for MLOA5 cells after culture on as-made 45S5, 13-93,

13-93B1, 13-93B3, and the control (empty well) is shown in Fig 6 [13]. The control was

67
not significantly different (p<0.05) from 45S5, 13-93, and 13-93B1 disks which means
there is almost no difference between those glasses in a static culture. Compared to the
control, 13-93B3 had ~1/3 the cells and was significantly less (p<0.001) indicating that
the culture conditions inhibited cell growth when compared to the other glasses.
After incubating (pre-reacting) the as-made discs in the culture media for four
hours and then transferring the discs to fresh culture media, a similar proliferation
analysis was completed at 24 hours as shown in Fig 6 [13]. The number of MLOA5 cells
on the pre-reacted disks of each glass was higher than the as-made disks, but the cell
count on the 13-93B3 disks was noticeably higher.
2.4.2

13-93B3 Scaffold and Tissue Removal

2.4.2.1 Assessment of Scaffold after Four Weeks In-Vivo
Figure 8 shows a representative image of the 13-93B3 scaffolds during removal
from the subcutaneous tissue. Numerous blood vessels were visible at the outer edge
(perimeter) of several of the scaffolds as indicated by the arrows. All of the 160 scaffolds
implanted in the 16 rats were recovered. The particular rat in Fig 8 had a total of 12
scaffolds implanted, thus the site in Fig 8 has three scaffolds (S) present. The scaffolds
have soft tissue completely surrounding them and blood vessels are present at the
perimeter of the scaffolds (arrows). There was no inflammation or infection detected in
the vicinity of the scaffolds which indicated biological compatibility. The scaffolds had
lost their original rigidity indicating that they had reacted with body fluids. There was no
detectable change in the size or volume of the scaffolds after four weeks in-vivo.
A representative image of the reacted scaffolds stained with H&E is shown in Fig
12. The H&E stained section of a 13-93B3 scaffold reacted for four weeks in
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subcutaneous tissue is shown in Fig 12A. The scaffold is >90% filled with soft tissue and
the fibers that once looked like those in Fig 11 are now reacted. Magnified views of two
portions of the scaffold, box B at the center and box C at the outer edge in Figs 12B and
12C show the fibers were fully reacted throughout the scaffold.
2.4.2.2 Assessment of Kidney and Liver
A representative image of a liver and kidney from rats with zero to 16 scaffolds
implanted is shown in Figs 9 and 10, respectively. Each liver and kidney is labeled with
the number of scaffolds that were implanted in the rat. There were no noticeable
difference in the size or color between the control and livers from rats implanted with 1393B3 scaffolds (Fig 9), and no spots or other differences were seen at the surface of the
organs. No hardening or texture differences were noticeable in the livers. There was no
difference in size or color, and no spots or other noticeable differences on any kind were
noticed between the kidneys from animals implanted with up to sixteen 13-93B3
scaffolds and the control as shown by the images in Fig 10.
No pathological differences were reported between the control rats (no scaffolds)
and the rats implanted with up to sixteen 13-93B3 scaffolds (Table 3). An example of a
liver section from each condition (number of scaffolds) is shown in Fig 15.
The pathological report on the kidneys (Table 3) showed that 13 of 16 of the
scaffold implanted animals and 3 of 4 control animals showed at least one of the
following findings: tubular degeneration, protein casts, and nephrocalcinosis. All of
these findings were graded as minimal severity and the findings were described as normal
incidental changes not uncommon for adult rats. The tubular degeneration described
included one or more of the following changes; decreased epithelial eosinophilia,
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minimally dilated tubules, gold/brown pigment in tubules, and minimal infiltrates of
mononucleated inflammatory cells. These minor changes were not observed in the
control tissues, but the changes were described as minor. The nephrocalcinosis and
protein casts are considered frequent histological occurrences in rats as three of four of
the control animals had protein casts present. The findings described were either focal,
present in one spot, or multi focal, present in a few spots. None of the findings were
described as diffuse, (present throughout the much of the section), which is the most
severe gradation for a specific findings occurrence. An example of a kidney section with
no pathological abnormalities is shown in Fig 16. Examples of the observed pathological
changes are preserved in the appendix.
2.5.

DISCUSSION

2.5.1 In-vivo Analysis of Potential Boron Toxicity from Bioactive Borate Glass
Scaffolds
From the present work, no boron toxicity was observed in rat subcutaneous tissue,
or in systemic organs such as the kidney and liver at or below the estimated BA
concentration of ~126mg/kg/day. The estimated BA concentration was based on all the
boron being released as BA from sixteen scaffolds (70mg each) at a constant rate over a
28 day period. Conservatively speaking, the reaction was assumed to be finished in
approximately four weeks, but if the 13-93B3 scaffolds reacted in two weeks, the BA
concentration in the rats would have been ~250mg/kg/day. Regardless of the length of
time required for the scaffolds to fully react, the fact that there was no toxicity observed
in the liver, kidney, or in the subcutaneous tissue at the implant sites in the rats with up to
sixteen 13-93B3 scaffolds is the most significant point.
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As shown in Fig 17, the 13-93B3 bioactive borate glass scaffold implanted in rat
calvaria for 12 weeks supported significantly more bone growth (p<0.05) than silicate
based bioactive glass 13-93. The amount of bone growth into a scaffold is not a direct
measure of toxicity, but in-directly, the increase in bone growth in borate glass scaffolds
over well studied and clinically used silicate bioactive glasses would not be expected if
the scaffold was measurably toxic. A histomorphometry analysis of the bone tissue
surrounding the 13-93B3 scaffolds showed no evidence of an immune reaction (increased
presence of macrophages or immune cells) or necrotic tissues [16].
2.5.2

Subcutaneous Scaffold Removal
The scaffolds removed from the subcutaneous tissue looked similar to those

described by Jung et al in a previous experiment when 13-93B3 fiber scaffolds were
implanted in subcutaneous tissue for four weeks [10]. The scaffolds were infiltrated with
subcutaneous tissue and blood vessels were present in the surrounding and adjacent
tissues. The scaffolds lost their original rigidity and had reacted to form carbonated
hydroxyapatite (HCA) [10].
2.5.3

Histological Analysis of Tissues
The absence of any negative findings in the liver sections was not unexpected.

The importance of the liver to the functions of the body warranted the analysis, but,
Janku et al found no histological differences in borocaptate dosed animals when
compared to the control [17]. Heindel et al gave rats upwards of 330mg/kg/day of BA,
which is almost three times the estimated dose given in the present work, and no
histological changes were reported [8].
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The kidney was found to have incidental changes that are common in adult rats.
These changes occurred in the rats with 16 scaffolds and in the control rats indicating that
the boron released from the 13-93B3 glass, at the levels administered, had no immediate
effects on the kidneys. Heindel et al dosed rats with 330mg/kg/day and found that after a
histological analysis of the tissues there was no correlation between nephropathy and BA
dose [8]. Only a few of the animals showed signs of minimal histological changes from
the control and were considered normal changes [8].
The kidney was the organ that was originally considered to be at the highest risk
since >90% of BA is removed from the body through urine [18, 19]. No long term
effects would be expected since BA is removed from the body almost entirely after 96
hours of ingestion [18, 19]. A study of borax workers exposed to airborne borax found
that over the course of a single work week that boron was removed from the body daily
through urination and there was no progressive daily increase of boron concentration in
blood or urine [9]. Therefore, once the 13-93B3 glass has fully reacted, the boron
concentration of the body should decrease to normal levels within a few days.
2.5.4

Bone Response to Bioactive Glasses in Rat Calvaria
In the rat calvaria, the 13-93B3 scaffolds performed statistically better (p<0.05)

than the 13-93 or 13-93B1 glasses at promoting bone growth. Since about 50% more
new bone grew on the 13-93B3 glass scaffold as compared to 13-93 scaffold, the 1393B3 glass had a stimulatory effect on bone growth. It was not surprising to find that the
13-93B3 glass scaffold promoted bone growth statistically as well in rat calvaria as 45S5
and better than 13-93. Richard found previously that particles of the borate analog of
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45S5 (denoted 45S5-3B) also promoted bone growth as well as the 45S5 glass at 30 and
60 days in rat tibia [12].
2.5.5 In-vitro Analysis of Potential Boron Toxicity from Bioactive Borate Glass
Disks
Comparing the results of the as-made disks and the pre-reacted disks (Fig 6), it is
apparent that the reactivity of the glass disk and the ionic concentration adjacent to the
seeded cells affect the cell proliferation in-vitro. By leaching some of the alkali and
boron from the 13-93B3 disks prior to seeding the cells, the glass went from the lowest
number of cells after 24 hours to the highest, a 4-fold increase in cell number. Based on
weight loss data, the 13-93 is the slowest reacting glass followed by 13-93B1 and 45S5
which are about the same, and then the 13-93B3 glass which is the most reactive.
Increasing the pre-reaction time may continue to improve the proliferation rates of the
13-93B3 glass, but at some point the benefit will likely stop. Marion et al showed that
pre-reacting a soda lime borate glass improved cell proliferation of human mesenchymal
stem cells over the as-made glass, but complete reaction to HA did not promote cell
growth as much as the partially reacted glass [7]. It was found that the release of some
ions from the glass improved cell proliferation [7].
Three glasses, the well known 45S5, the borate analog of 45S5 known as 45S53B (Table 1), and a pre-reacted 45S5-3B glass were all cultured under static conditions
for four days. As shown in Fig 18, the 45S5 glass disk had the most cells (as measured
by total DNA), and the as-made 45S5-3B glass had significantly less cells present after
four days, p<0.01. In contrast, the pre-reacted 45S5-3B glass disks supported cell growth
almost as well as the less reactive 45S5 glass [6].
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In another experiment, a static culture was compared to dynamic culture for 45S5
and three borate containing glasses (45S5-1B, 45S5-2B, and 45S5-3B, Table 1). As
shown in Fig 19 the greatest difference between the static and dynamic conditions was
seen for the borate glass (45S5-3B) [6]. The static cell growth for the borate containing
glasses (1B, 2B, and 3B) decreases as the boron level and reaction rate increases. An
interesting result for the dynamic condition was the dramatic improvement in cell growth
(DNA) for all of the borate containing glasses. Only the borate glass (3B) was
statistically lower than the 45S5 glass after four days [6]. The two experiments (Figs 18
and 19) show how the experimental conditions (static vs. dynamic) can influence cell
culture data when bioactive glasses are being measured, especially higher reactive glasses
such as the borate glasses.
In Table 2, the 0.002M BA concentration caused a 40% decrease in cell number
according to Brown et al, but Richard reported an increase in cell proliferation. The
experiments conducted by Brown were static as were those by Richard, but Richard
counted cells every day for four days. The movement of the fluids that likely occurred
during the cell counting procedure by Richard may explain why the data disagree. The
dynamic environment in the culture dish while counting cells may have been enough to
significantly modify the proliferation of the cells.
2.5.6

Correlation between the Sprague Dawley (SD) Rat Model and Humans
Heindel et al found that of the SD rat, Swiss CD-1 mouse, and New Zealand

rabbit, the SD rat had the lowest tolerance for BA ingestion [8] and is therefore
determined to be the best of the three mammalian models for human comparison. The
fact that SD rats dosed with 16 scaffolds (1.12g of 13-93B3 glass, or 1.05g BA in body
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fluids assuming all boron from glass becomes BA) had no negative histological changes
in the kidney or liver when compared to the control indicates that bioactive borate glass
13-93B3 is not toxic to most mammals at or below estimated concentration
(126mg/kg/day) of BA. Using the estimated levels of BA administered to the SD rat and
assuming humans have equal tolerance to the 13-93B3 glass, the graph in Fig 20 was
made to show the amount of 13-93B3 glass a human could have implanted and be at the
same concentrations as in the rat experiment. The weight percent of glass used in the
calculations, determined by the 4, 8, 12, or 16 scaffolds per rat, was 0.09, 0.19, 0.28, and
0.37%, respectively, by assuming the weight of each scaffold was 70mg the weight of the
rat was fixed at 300g.
From the graph in Fig 20, ~170 grams (~1/3 pound) of 13-93B3 glass would need
to be implanted in a 100 pound person to reach the same BA concentration in their body
as the 300g SD rat containing 1.12 grams of 13-93B3 glass (16 scaffolds). For a person
weighing 200 pounds, the person could have almost 340g (~3/4 pound) of 13-93B3 glass
implanted (Fig 20) without exceeding the BA concentration of ~126mg/kg/day
(concentration equal to 16 scaffolds in a SD rat). The amount of bioactive glass used for
treatment in bone or periodontal defects is typically less than 10 grams which is ~15 to 30
times less than the levels described here.
Young children and developing new born babies may be more susceptible to
potential boron toxicity. Animal experiments have reported decreased weights in unborn
SD rats when the mother was given a BA dose exceeding 78mg/kg/day [8]. There is no
work to the author’s knowledge of BA doses given to developing animals that were
healthy when born to determine if the no adverse effect level (NOAEL) changes from
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prenatal to postnatal. In-vitro cell cultures (static) also begin to become inhibited cell
growth at 1mM concentration [6] (~62mg/kg/day of BA). Assuming a new born could
consume ~62mg/kg/day, (equivalent to 8 scaffolds in a 300g SD rat), an eight pound
baby could have ~6.7g of 13-93B3 glass implanted, which is approximately what an adult
might expect for most periodontal applications [20].

2.6.

CONCLUSIONS
Boron toxicity has been analyzed from multiple in-vitro cell culture conditions

and compared with animal toxicity reports. The present experiments were conducted to
determine what levels of boron are acceptable or potentially toxic. In-vitro data were
found to be highly dependent on the culture environment, static or dynamic, and the
condition of the glass (as-made or pre-reacted) and the glass composition. Therefore it is
suggested that in-vitro cell culture experiments be conducted in a dynamic or semidynamic system where the culture media is circulated similar to conditions in-vivo,
especially when working with highly reactive materials such as bioactive borate glasses.
In-vivo experiments with Sprague Dawley rats with up to 16 bioactive borate
glass 13-93B3 fiber scaffolds (70mg each) implanted for four weeks in subcutaneous
tissue fully reacted and the boron released caused no detectable histological changes in
the kidney or liver. Each SD rat remained healthy and no signs of inflammation or
infection were seen at the implant sites after four weeks. There were no negative
histological findings in the liver and only minor changes which were noted as incidental
changes normal for an adult rat, were noted in the kidneys. The open interconnected
pores of the 13-93B3 scaffolds were filled with soft tissue and there was no inflammation
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in the tissue adjacent to the scaffolds during the scaffold removal. Blood vessels had
grown next to the outer surface of the scaffolds and were seen in the adjacent tissue
during scaffold removal.
Scaffolds composed of 13-93B3, 13-93B1, 13-93 glass fibers, and loose particles
of 45S5 in rat calvaria for 12 weeks produced no adverse reactions. The rats were
monitored regularly, and no rats became sick or died due to the implantation of the
scaffolds. The 13-93B3 scaffold was found to have statistically more bone (p<0.05) than
both the 13-93 and 13-93B1 scaffolds by histomorphometry analysis and the bone
adjacent the reacted 13-93B3 scaffolds showed no signs of immune response or necrotic
tissue after 12 weeks. Therefore, bioactive borate glasses such as 13-93B3 should be
strongly considered for use in humans for hard and soft tissue engineering applications.
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Green – non toxic
Yellow – no change in cell number or minimum toxicity in-vivo
Red – cell death
* Static Cell Culture
** Semi-Dynamic Culture
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Table 3 - Histological Results for Sprague Dawley Rats Implanted with 13-938 3 bioactive
Glass Fiber Scaffolds (70mg) for Four Weeks
#of Scaffolds t>er Animal
Tissue Findin~
Kidney
Deqeneration, tubular
Protein casts, tubular
Nephrocalcinosis
Liver

16

16

16

+

+

+

1M
1M
1M

1M
1M

16

12

12

+

+

1M

12

12

8

8

+

+

+
1M

1M

1M
1M
1F

1M
1F

-

#of Scaffolds t>er Animal
8
8
4
4
4
4
Control Control Control Contro l
Tissue Finding
Kidnev
+
+
+
+
+
+
+
+
Deaeneration tubular
1M
1M
Protein casts tubular
1M
1M
1M
1M
1M
1M
1M
1M
Nephrocalcinosis
Liver
..
Key: - -negatiVe/no s1gn1ficant findmg; +- pos1t1ve/find1ng present; 1 - m1n1mal seventy; 2- m1ld seventy; 3 =moderate seventy; 4marked severdy; F =focal; M = multifocal; D =diffuse.

-

-
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FIGURES

Figure 1 – Methods and testing conditions for boron toxicity in-vitro and in-vivo.
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Figure 2 – In-vitro and in-vivo data for boric acid toxicity in mg/kg/day. The green
regions represent no toxicity, the green to red fade regions show where inhibition begins,
and all red shows where cell death occurs.
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Figure 3 – Schematic showing how toxic conditions could develop (pH, B concentration,
etc) and affect the immediate surroundings of a highly reactive material during in-vitro
static conditions, in-vitro dynamic or pre-reacted conditions, or in-vivo. The circle
labeled (G) represents a glass disk, fiber, sphere, or particle.
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Figure 4 – Weight loss data for a soda lime borate glass showing the initial fast weight
loss (24 hrs), followed by a decreasing weight loss which was attributed to the
precipitation of calcium phosphate on the glass surface [7].
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Figure 5 – Steps in manufacturing a scaffold composed of randomly oriented glass fibers.
The as-made fibers (100 to 300µm diameter, 2 to 3mm long) are shown in (A). The mold
used for holding the fibers (70mg) during the heat treatment (575oC to 690oC depending
on glass composition, for 45 minutes) is shown in (B). An as-made scaffold (nominal
dimensions of 7mm diameter, 2mm thick) composed of self bonded randomly oriented
fibers is shown in (C).
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Figure 6 – Proliferation of MLOA5 cells after 24 hours at 37oC on unpolished as-cut
bioactive glass disks and pre-reacted bioactive glass disks. [13]. * p<0.001 when
compared to control.
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Figure 7 – Schematic showing the implant sites located on the back of a rat. The red
lines are sites where the skin was cut (15mm) and the dotted line represent the
approximate implant site (20mm long). Up to 16 borate glass fiber scaffolds, four per
site, were implanted in a rat.
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Figure 8– Appearance of a subcutaneous site containing three 13-93B3 scaffolds after
four weeks in subcutaneous tissue. The scaffolds are labeled with an S and arrows point
to tissue rich with blood vessels surrounding two of the scaffolds (red tissue).
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Figure 9– Representative photographs of the livers recovered from rats implanted with up
to sixteen 13-93B3 fiber scaffolds (70mg each). The number at the side of each image
corresponds to the number of 13-93B3 fiber scaffolds implanted in the rat; control (0),
(4), (8), (12), and (16).
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Figure 10 – Representative photographs of the kidneys recovered from rats implanted
with up to sixteen 13-93B3 fiber scaffolds (70mg each). The number at the side of each
image corresponds to the number of 13-93B3 fiber scaffolds implanted in the rat; control
(0), (4), (8), (12), and (16).
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Figure 11 – Cross section of a glass scaffold composed of randomly oriented bioactive
glass fibers that have been infiltrated with transparent epoxy which provides a reference
for the histological images. The fibers (gray) are circular or elliptical depending on the
orientation, and the fibers that have bonded to other fibers in the plane of the cross
section look like complex geometrical shapes. The epoxy occupies what were initially
open, interconnected pores of the scaffold.
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Figure 12 – H&E stained section of a 13-93B3 scaffold implanted in subcutaneous tissue
for four weeks (A). The section is >90% filled with soft tissue and the fibers have all
reacted. A magnified view of box B, located at the center of the scaffold, is shown in
(B). There are two fibers that have reacted as indicated by the arrows pointing to the
center of the fibers. Healthy soft tissue has attached to the inner and outer surfaces of the
fibers. A magnified view of the scaffold at the outer edge is shown in (C), where two
fibers that have reacted and are surrounded by soft tissue.
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Figure 13 – H&E stained section of a control liver and a liver section from a rat with four
to sixteen 13-93B3 scaffolds (70mg each) implanted in subcutaneous tissue. The
estimated boric acid concentration present in the rat with 16 scaffolds was 126mg/kg/day.
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Figure 14 – Photomicrograph of an H&E stained section of the renal cortex from a
control rat (A). Figure 14B is a magnified view of the renal cortex showing the tubular
epithelium and a glomerulus (a capillary tuft where blood begins the filtering process to
form urine).
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Figure 15 – Total bone growth into randomly oriented porous bioactive glass scaffolds
(S), (45S5 was loose particulate (P) form (100 to 200µm)) after 12 weeks in rat calvaria
(n=4) as determined by histomorphometry analysis. The 13-93B3 scaffolds generated
twice as much bone as the 13-93 or 13-93B1 scaffolds and had statistically more bone
*(p<0.05), personal communication [16].
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Figure 16 – Quantitative measurement of DNA produced by MC3T3-E1 cells cultured for
four days on as-made disks of 45S5 (0B), pre-reacted 45S5-3B, and as-made 45S5-3B
glass disks after four days of culture. The pre-reacted 45S5-3B glass contained ~2x the
DNA as the as-made glass [6]. * p<0.05, ** p<0.01 as compared to 45S5.
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Figure 17 – Quantitative measurement of DNA from MC3T3-E1 cells for 45S5 (0B),
45S5-1B, 45S5-2B, and 45S5-3B glass disks after four days of culture under static
(black) and dynamic conditions (gray). The dynamic condition significantly improved
the amount of viable cells for all the boron containing glasses after four days of culture as
indicated by the red lines [6]. * p<0.05, ** p<0.01 as compared with 45S5.
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Figure 18 – Estimation of how much 13-93B3 glass could be implanted in a human based
off of the histological analysis of the kidney and liver from Sprague Dawley rats. Eight
to 50 pounds was magnified to make reading the graph at lower weights easier.
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3.1 ABSTRACT
Porous scaffolds composed of randomly oriented bioactive borate glass fibers
doped with copper, strontium, zinc and iron were implanted in laboratory rats for up to
six weeks to study the biological and angiogenic response. No inflammation or infection
was detected at any of the implant sites with a CuO concentration at or below 0.4wt%.
Scaffolds made from fibers containing (0.1 to 2wt%) CuO had a marked increase in
blood vessels surrounding the scaffolds after two and four weeks in-vivo. After six
weeks, a blinded histological blood vessel analysis (PAS) of the tissue present in the
scaffolds showed that 0.4wt% CuO produced a statistically significant increase in blood
vessel area compared to the un-doped scaffold. It was also found that seeding the
scaffolds with mesenchymal stem cells also increased the number of blood vessels
present in the subcutaneous implants. In a second experiment, the angiogenic effect of
strontium, zinc, and iron was evaluated in scaffolds doped with 0.4wt% CuO. Upon
retrieval of the scaffolds, significant numbers of blood vessels were present in the
adjacent tissues and an analysis of the infiltrated tissues showed that the addition of zinc
to the copper doped bioactive glass produced a significant increase (p<0.05) on the
number of blood vessels present.
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3.2.

INTRODUCTION
Bioactive glasses were first introduced by Hench in 1969 with the well known

silicate based 45S5 (Table 1) [1]. Since then, several silicate based bioactive glasses such
as 45S5, 13-93, S53P4 (Table 1), and other compositions have been widely studied for
bone [1-4] and soft tissue [2, 5] applications. Some of these applications include
replacement of bones in the middle ear [6], treatment of periodontal defects [6, 7], and
periodontal implants [6].
In the last 10 years, three dimensional porous scaffolds composed of bioactive
glass [8-14], calcium phosphates such as hydroxyapatite [15-18], and carbonates such as
calcium carbonate [17, 18] have been studied for bone augmentation. Unfortunately, the
inability to promote vascularization in many of these materials has limited their use [19].
In-vitro performance of porous scaffolds in a regularly agitated culture dish or in a
perfusion chamber are not necessarily a good estimate of what may be expected in-vivo
since the nutrients are constantly being replenished to the cells [19]. The approximate
diffusion limit for oxygen and most nutrients is 100 to 200µm from a blood capillary
[19], therefore successful in-vivo performance of a scaffold requires a vascular network
that can provide an adequate blood supply [19].
In general, porous scaffolds for tissue regeneration have not performed as well as
hoped [19]. Current scaffolds made from materials such as titanium, hydroxyapatite, or
even bioactive glass such as 45S5 lack the ability to stimulate angiogenesis (blood vessel
formation), which is the key component required for tissue regeneration [19]. Several
methods of improving the vascularization of scaffolds have been investigated including
attaching vascular endothelial growth factor [20], coating scaffolds with copper
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containing salts [21, 22], in-vitro pre-vascularization [19], and in-vivo pre-vascularization
[19].
Unfortunately, all of the previously mentioned methods of promoting
angiogenesis have drawbacks. Growth factors are expensive and have limited usefulness
in treating wounds as several growth factors are required at specific time points for
enhanced healing, but only a few growth factors are approved by the Food and Drug
Administration (FDA) for clinical use [23]. In-vitro procedures are time consuming and
must be planned in advance of the surgery. In-vivo pre-vascularization requires multiple
surgeries which increases the possibility of infection and also requires a significant
amount of planning and time. The dissolution of copper containing salts, while shown to
promote blood vessel growth [21], has the potential to dissolve too quickly, especially in
large scaffolds, and dissipate before the full beneficial effect of copper has occurred.
Of the previously discussed methods for promoting angiogenesis in scaffolds, the
release of metal ions such as copper, is effective, relatively inexpensive, and requires a
single surgical procedure. The role and requirement of copper ions for angiogenesis has
been well documented in-vitro and in-vivo. Hu et al showed that copper ions in the
concentration of 5 to 500µM promoted the growth and proliferation of human endothelial
cells in-vitro [24]. The addition of metal ions such as copper and tin to cell culture media
has been shown to promote endothelial cell migration [25]. Barralet et al increased the
vascular density inside a calcium phosphate scaffold by releasing copper sulfate. Copper
ions released from a hyaluronan based hydrogel promoted blood vessel formation in soft
tissue [22]. The addition of copper chelators (blockers) has a negative effect on tumors,

103
essentially decreasing the microvascular density and decreasing the amount of copper
stimulated enzymes available for tumor growth [26].
Other trace elements such as zinc, boron, strontium, and iron have been studied
for specific biological responses and are elements found in human cadaver bone [27].
Zinc serves as a cofactor responsible for keratinocyte migration during wound healing
which promotes re-epithelialization and also improves epithelial cell resistance to
apoptosis [28]. Zinc oxide has also been shown to decrease blood clotting time in-vitro
[29]. Boron, in the form of boric acid, added in the concentration of 1 to 10mM to
cultures of human placental cells caused a significant increase in mRNA uptake that was
described as similar to what would be expected of a growth factor [30].
Greater than 99% of the strontium in the human body is located in the skeleton
[31]. Rats given strontium in quantities >4g/l in food and water showed signs of
disturbed bone mineralization, and it is speculated that this is due to the larger size of
strontium compared to calcium [31]. Strontium in relatively low doses, <4g/l of food and
water had increased bone formation rates and increased trabecular bone density [31].
Iron is a constituent of several enzymes, bone marrow, and red blood cells [32], and a
deficiency of iron in the body can lead to anemia [32]. Iron oxide may also be useful in
increasing blood clot formation rates [29].
In the present work, four of the most abundant minor elements found in human
bone have been systematically doped into the 13-93B3 glass for the purposes of
promoting angiogenesis. With the exception of copper, the amounts of the trace elements
was based on the relative abundance of the trace elements in human cadaver bone [27].
The elements were added to the 13-93B3 glass consecutively, copper (C or Cu), copper +
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strontium (CS), copper + strontium+ zinc (CSZ), and copper + strontium + zinc + iron
(CSZF). Fibers of each glass were thermally bonded to form porous scaffolds that were
implanted in the subcutaneous tissue of rats for six weeks. The scaffolds were removed
after durations between two and six weeks and the tissue analyzed for the presence of
blood vessels.

3.3.

MATERIALS AND METHODS

3.3.1

Glass Melting and Scaffold Preparation
The borate glass compositions present in Table 1 were made from homogeneous

mixtures of reagent grade chemicals which were melted in a platinum crucible at 1065oC
for one hour. Fibers, with a diameter ranging from 100 to 300µm, were pulled, by hand,
from the melt. These fibers were broken into 2 to 3mm lengths which were used to
prepare porous scaffold composed of randomly oriented fibers.
Approximately 70mg of fiber was placed in a cylindrical ceramic mold (mullite)
with an internal diameter of 7mm. The molds were placed in an oven at 575oC for 45
minutes, after which the molds were removed and cooled to room temperature. Once
cool, the scaffolds were removed from the molds and were ready for use. Examples of
the as-made scaffolds doped with up to 2wt% CuO have the nominal dimensions of 7mm
in diameter and 2mm thick are shown in Fig 1.
Prior to implantation of the as-made scaffolds or cell seeding with mesenchymal
stem cells (MSCs), the scaffolds were dry heat sterilized. The scaffolds were placed in a
silica glass vial, covered with a loose fitting aluminum foil top, heated in an oven to
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300oC for four hours, and cooled to room temperature. Once cool, the scaffolds were
ready for either cell seeding with MSCs or implantation.
3.3.2

Scaffold Seeding with Mesenchymal Stem Cells (MSC)
Mesenchymal stem cells were recovered from the long bones of sacrificed Fisher

344 rats. The cells were cultured in-vitro to separate the stem cells from bone marrow
prior to seeding the scaffolds. Half of the scaffolds were seeded with 50,000 MSCs, the
other half were unseeded. The cells were cultured on the scaffolds for approximately 12
hours to allow the cells to attach to the glass fibers prior to the implantation.
3.3.3

Scaffold Implantation
Five scaffolds made from each type of glass seeded with MSCs and five unseeded

as-made scaffolds were implanted in subcutaneous tissue of Fisher 344 rats for six weeks.
The scaffolds were implanted randomly to remove any bias from a single rat. Each rat
had four implant sites, two above the shoulders and two above the back legs, which
contained a single scaffold for a total of four scaffolds per rat. The back of each rat was
shaved with clippers to remove hair from the implant sites and washed with iodine and
then 70% ethanol to disinfect the rats prior to surgery. During surgery, the rats were
anesthetized with isoflourine.
An incision approximately 20mm in length was made completely through the
cutaneous tissue perpendicular to the spine with a pair of surgical scissors. Next, a clamp
was inserted into the incision and gently opened to form an opening between the
cutaneous tissue and the skeletal muscle. The opening was made approximately 15 to 20
mm long. The scaffold was then inserted toward the back of the cutaneous opening and
the skin was closed with superglue.
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After all four scaffolds were implanted; each rat was injected with 0.2ml of
penicillin (0.1ml per hind leg). The ears of each rat were labeled and they were placed on
a heating pad in a cage with access to fresh air during recovery. Two rats were caged
together, had access to food pellets and tap water, and were on a light schedule of 12
hours light, 12 hours dark.
3.3.4

Scaffold Removal
After two, four, or six weeks, respectively, the rats were sacrificed by CO2

inhalation and the scaffolds were removed for analysis. The scaffolds were placed in 5ml
of 10% formalin solution for four days to fix the tissue.
3.3.5

Tissue Processing
After the scaffolds were fixed, they were dehydrated with a series of ethanol

solutions by a microwave dehydration technique (EBSciences H2850 Microwave
Processor) [33]. The microwave was operated at 70% power, and sample temperature
was set to 37±4oC, for 2.5 minutes for each solution. Each scaffold was immersed in
each ethanol solution for a minimum of 15 minutes including microwave time.
3.3.6

Histology Slide Preparation
The dehydrated scaffolds were placed in a tissue processor (AutoTechnicon

Model 2A) filled with fluid paraffin mounting wax (Paraplast Tissue Embedding
Medium, McCormick Scientific LLC) at 45oC for four hours for wax infiltration of the
scaffold and tissue. Each scaffold was mounted in wax for histological sectioning with a
paraffin mounting system (Leica EG 1150H). Sections 18µm thick were cut with a
histological microtome (Leica RM 2235 microtome) with TBS Shur/sharp blades,
(Triangle Biomedical Sciences, Durham NC). The cut sections were floated on a water
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bath (Lipshaw Electric Tissue Float, model number 375, Detroit MI) (40oC) prior to
mounting on a glass slide (Fisher Brand Superfrost microscope slides, St. Louis MO).
Three to four tissue sections were placed on a single glass slide, and dried overnight
(Fisher Scientific slide warmer, St. Louis MO). Stained slides were viewed with a
microscope (Olympus BX50, Olympus Optical Co) at magnifications of 40, 100, and
400X and imaging software (DP Controller, Olympus Optical Co) was used for image
capture.
A scaffold composed of randomly oriented fibers was embedded in poly methyl
methacrylate (PMMA) for use as a reference for the histology sections. The plastic
embedded fiber scaffold was sectioned with a slow speed saw and a diamond coated
blade and polished with 320, 400, 600, 800, and 1200 grit silicon carbide paper. An
image of the polished scaffold section is shown in Fig 6. The fibers appear round if the
longitudinal axis of the fiber is perpendicular to the plane of the image and ellipsoidal if
the fiber is cut at an angle to its longitudinal axis.
3.3.7

Histological Assessment

3.3.7.1 Blood Vessel Analysis after Six Weeks In-Vivo – Copper Additions
Scaffolds of 13-93B3, B3 Cu-1 and B3 Cu-3, seeded with MSCs and implanted
for six weeks in subcutaneous tissue, were sectioned 18µm thick, and stained with
hematoxylin and eosin stain (H&E), procedure described in detail elsewhere [34], for a
blood vessel analysis. The blood vessels present in each tissue section were counted in
20 randomly selected spots, which predominantly encompassed soft tissue, to determine
the number of vessels present and to calculate the average blood vessel diameter.
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Blood vessel formation was assessed from a blinded analysis of tissue sections
from the seeded (msc) and unseeded 13-93B3, B3 Cu-1, and B3 Cu-3 scaffolds
implanted in subcutaneous tissue for six weeks. Each type of scaffold, n=3, was stained
with Periodic Acid Schiff stain (PAS) and was analyzed as illustrated in Fig 9, where the
center of the scaffold was examined across its middle (dashed line) with a 200x objective.
The blood vessels in each track of tissue were counted and each blood vessel diameter
measured. The data from each scaffold was compared by the student t test. An example
of the PAS stained tissue is shown in Fig 10.
3.3.7.2 Blood Vessel Analysis – Minor Element Additions (H&E)
Three scaffolds of each composition (B3 Cu-3, CS, CSZ, CSZF) were stained
with H&E and the number of blood vessels seen in the soft tissue were counted. Three
lines from each histological tissue section (parallel to the thickness (2mm) direction and
at least 1mm apart) were viewed at 400x magnification and the blood vessels counted.
An example of one scaffold section and the three tracks of tissue analyzed are shown in
Fig 11 and the remaining sections are shown in the appendix.

3.4.

RESULTS

3.4.1

Scaffold Removal
Photographs of the unseeded, copper containing scaffolds taken as they were

removed after two weeks in subcutaneous tissue are shown in Fig 2. It is apparent from
these pictures that the release of copper from the glasses, especially B3 Cu-3 to B3 Cu-5,
produced a noticeable increase in the number of blood vessels growing toward and into
the scaffolds when compared to the copper-free 13-93B3 scaffold. The B3 Cu-5 scaffold
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has at least six blood vessels growing toward the scaffold and blood vessels are visible
inside the scaffold are marked with arrows. The blue color of the scaffolds containing,
0.2 to 2wt% CuO is still visible, which indicates that some portion of the copper ions are
still in the glass fibers.
After four weeks in-vivo, there appears to be more blood vessels surrounding the
scaffolds with 0.1wt% CuO (B3 Cu-1) than the copper free 13-93B3 scaffold, which have
been circled for easier viewing (Fig 3). There are a few visible vessels at the surface of
the 13-93B3 scaffold, but the B3 Cu-1 scaffold had three red areas (arrows) which
indicate the presence of red blood cells and likely blood vessels. The B3 Cu-3 scaffold in
Fig 3 has two areas (dark spots) that are attributed to numerous blood vessels. The side
of the B3 Cu-3 scaffold that was attached to the subcutaneous tissue was separated and
lifted from the tissue, and in doing so, the blood vessels were cut which extended from
the subcutaneous tissue into the scaffold (arrows), which may account for the dark spots.
Several blood vessels surround the B3 Cu-4 and B3 Cu-5 scaffolds, and in four weeks,
fibrous tissue appears to have formed around the scaffolds containing greater than 1wt%
CuO.
Based on the results from the four week scaffolds, four scaffolds (13-93B3 as the
control, B3 Cu-1, B3 Cu-3, and B3 Cu-5) were chosen for a six week in-vivo experiment.
Each of these four scaffolds had a set, n=4, that were seeded with 50,000 MSCs and a set,
n=4, that were unseeded, for a total of 32 scaffolds in eight rats. The scaffolds were
randomly implanted so that no rat contained a single set of scaffolds.
Representative images of scaffolds after six weeks in-vivo are shown in Fig 4.
The B3 Cu-3 scaffolds were more red than the 13-93B3 scaffolds indicating more blood
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vessels, and the MSC seeded scaffolds appeared to have more vessels present than the
corresponding non-seeded scaffolds. The fibers in the scaffolds after six weeks in-vivo
(13-93B3, B3 Cu-1 and B3 Cu-3) had lost their blue color which was present at two and
four weeks. This loss in color is considered to indicate that the fibers had fully reacted
with the body fluids and all of the copper ions originally in the glass fibers had been
released. There was also no significant change in diameter or thickness of the scaffolds.
After six weeks in-vivo, the B3 Cu-5 scaffolds (2wt% CuO) were not biologically
compatible. During removal, the B3 Cu-5 scaffolds were found to be surrounded by
tissue approximately 15mm in diameter (twice the original diameter of the scaffolds) as
indicated by the arrow in Fig 12A. The tissue was cut across the top (oval in Fig 12B),
and a thick yellow fluid was inside. Further dissection of the tissue revealed a wall about
4mm thick that surrounded the B3 Cu-5 scaffold (Fig 12C). The scaffold was removed,
Fig 12D, and had decreased in size to about 3mm in diameter. All eight of the B3 Cu-5
scaffolds, had the same appearance and reactions with the body as shown in Fig 12.
3.4.2

Histology

3.4.2.1 Histology – 4 Weeks (H&E)
After four weeks, many of the copper doped scaffolds had not fully reacted as
previously indicated, but it was possible to cut sections at the outer edge of the 13-93B3,
B3 Cu-1, and a B3 Cu-5 scaffolds. The stained section of the unseeded 13-93B3 scaffold
in Fig 13A shows that the fibers are fully reacted and several contain soft tissue. Figures
13B and 13C show two magnified areas of tissue adjacent to reacted 13-93B3 fibers (F)
with infiltrated soft tissue that contain blood vessels (arrows).
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A section of B3 Cu-1 scaffold after four weeks in-vivo is shown in Fig 14A.
There appears to be more blood vessels in the tissue at the outer edge of the scaffold in
Figs 14B and 14C as indicated by the arrows. The majority of the fibers toward the
center of the scaffold were not fully reacted as indicated by the presence of unreacted
glass fibers. The B3 Cu-5 scaffold had more vessels present than either the 13-93B3 or
the B3 Cu-1 scaffolds as shown by the histological section in Fig 15A. The magnified
images of the B3 Cu-5 scaffold in Figs 15B and 15C show several blood vessels (V) in
the soft tissue, and several of the blood vessels contain red blood cells (pink dots).
3.4.2.2 Blood Vessel Analysis – 6 Weeks (H&E)
After six weeks in-vivo, the number and diameter of the blood vessels were
measured in a randomly chosen, seeded section of a 13-93B3, B3 Cu-1 and B3 Cu-3
scaffold to estimate the blood circulation inside the scaffolds. The color of the box on the
tissue H&E stained sections indicates the number of vessels counted, so a green box is 1
to 2 vessels, yellow 3 to 4, light blue 5 to 6, orange 7 to 8, dark blue 9 to 10, and red 11 to
12. Examples of blood vessels in an H&E stained section shown in Fig 8 where each
blood vessel has an arrow showing its location. For reference, the image in Fig 8 is from
spot three in the B3 Cu-3 scaffold (Fig 7C). The total number of blood vessels found in
the 20 spots from the 13-93B3, B3 Cu-1 and B3 Cu-3 scaffolds, were 66, 92, and 145,
respectively (Fig 7).
3.4.2.3 Histology and Vessel Analysis – 6 Weeks (PAS)
The PAS staining technique is useful for a blood vessel analysis because it stains
tissue light blue that is high in glycogen. Glycogen is a material that is carried by red
blood cells and distributed throughout the body for cell metabolism. It diffuses through
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the lining of blood vessels; therefore blood vessels tend to be relatively high in glycogen.
Connective tissue stains light green, red blood cells bright green, blood vessel lining blue,
and macrophages yellow or brown.
The results of the statistical analysis for the blinded blood vessel study using the
PAS staining technique are given in Table 2 and an example of the PAS stained tissue is
shown in Fig 10. The blood vessel area was measured as area percent of the entire
section analyzed. The data for each scaffold is shown in Fig 16 along with selected
comparisons which are indicated by the brackets and the p values shown.
3.4.2.4 Blood Vessel Analysis – Minor Elements Addition (H&E)
An example of the H&E histology sections used for the blood vessel analysis is
shown in Fig 11. Several blood vessels throughout the three tissue sections have been
identified by arrows to guide the reader. The average number of blood vessels counted in
each of the scaffold types (Cu-3, CS, CSZ, and CSZF), n=3, are plotted in Fig 17 and
were compared by the student t test for statistical significance (Table 3). There was a
statistically significant increase in the total number of vessels in the zinc containing
scaffolds (CSZ and CSZF) when compared to the Cu-3 scaffold, see Table 3. The CS
scaffold had no statistically significant improvement over the Cu-3 scaffold although the
average number of blood vessels increased about 30%. The addition of iron in the CSZF
scaffold showed no significant increase in blood vessels as compared to the CSZ scaffold.
The addition of the zinc to the scaffold (0.4wt% CuO) produced the most significant
improvement in the angiogenic effect of the scaffolds.
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3.5.

DISCUSSION

3.5.1

Scaffold Removal and In-vivo Biocompatibility
During the removal of the scaffolds from the rats, it was apparent that the

mechanical strength was decreased. The scaffolds were soft to the touch indicating that
the fibers had reacted significantly with the animal fluids. The relatively high number of
blood vessels present in the soft tissue surrounding the scaffolds and the change in color
of the fibers were signs that the trace elements released from the scaffolds had an
angiogenic effect. Subcutaneous skin tissue has relatively few blood vessels compared to
other tissues like muscle or bone [35].
There were no signs of inflammation surrounding the scaffolds, infection at the
implant site, or rejection of the scaffolds from the rats except the previously mentioned
B3 Cu-5 scaffolds after six weeks in-vivo, which were doped with 2wt% CuO. These
scaffolds are thought to have had the negative biological response due to the release of
excessive copper to the surrounding tissues. Bioactive borate glasses not doped with
CuO have been implanted in hard and soft tissue of rats, and there were no reports of
necrotic tissue, increases in the presence of macrophages, or inflammation [12, 34, 3639]. The systemic internal organs of rats such as the kidney and liver have also been
screened for lesions and other tissue degeneration after implantation of 13-93B3 borate
fiber scaffolds [40]. There was no marked difference between the rats implanted with
sixteen (70mg) scaffolds versus the control rats, and any recorded finding was at the
lowest severity and considered normal in adult rats [40].
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3.5.2 Angiogenic Analysis of In-Vivo Scaffolds - Blood Vessel Analysis Six Weeks
(H&E) and (PAS)
The diameter of each blood vessel in the three scaffolds described in Fig 7 was
measured to find the average blood vessel diameter in each scaffold type. The average
blood vessel diameter was calculated by measuring the diameter of each vessel at its
smallest diameter, summing the diameters, and dividing by the total number of blood
vessels. The shortest distance across each blood vessel was measured to have a
conservative and consistent measurement technique for blood vessels that were cut at an
angle different from perpendicular to the longitudinal axis in the histological sections.
The total blood vessel area for each scaffold was calculated by assuming the
blood vessels were circular, so the area of a circle was used. The average blood vessel
diameters were used to calculate the average area for the blood vessels for the 13-93B3,
B3 Cu-1 and B3 Cu-3 scaffolds which were 205, 175, and 283µm2, respectively. Figure
18 shows the average blood vessel area (dashed line) plotted vs. the left y-axis and the
total number of vessels (dash and dot line) plotted vs. the right y-axis.
After six weeks in-vivo, the number of blood vessels in the B3 Cu-1 scaffold
(0.1wt% CuO) increased ~50% over the 13-93B3 scaffold, but the average blood vessel
diameter decreased by 30µm2 (~15%). The decrease in blood vessel diameter from the
13-93B3 to the B3 Cu-1 could be coincidental to the scaffolds analyzed since n=1 for this
analysis. Another possibility could be that the copper ions stimulated formation of
vessels at more locations, but not enough copper was present to recruit significant
amounts of endothelial cells that were required to increase the average blood vessel
diameter.
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The total vascular area was calculated by multiplying the average blood vessel
area by the total number of vessels per scaffold type. The total vascular areas for the 1393B3, B3 Cu-1 and B3 Cu-3 scaffolds, were ~13,000, ~17,000, and ~40,000µm2,
respectively, as shown in Fig 19. The addition of 0.4wt% CuO to the B3 Cu-3 scaffold
increased the vascular area by ~300%, which is assumed to increase the blood flow
through the scaffold by a similar amount.
The blinded analysis of the six week in-vivo PAS stained sections of 13-93B3, B3
Cu-1 and B3 Cu-3 scaffolds, n=3, confirmed the findings of the H&E blood vessel
analysis that the release of copper from a bioactive glass promoted angiogenesis in the
surrounding tissues. The B3 Cu-3 scaffold with and without seeded MSCs had
significantly more vessels (p<0.05) than the unseeded 13-93B3 scaffold. Copper is
known to have a role in blood vessel formation as Harris et al reported copper as a
requirement for angiogenesis [41], and the addition of copper in various forms to calcium
phosphate scaffolds [21] and a hyaluronan based hydrogel [22] stimulated blood vessel
formation. This however, is the first time that copper had been released from a bioactive
glass and stimulated an angiogenic response in-vivo.
The addition of MSCs to the 13-93B3 bioactive borate fiber scaffolds also
significantly improved the vascular growth (p<0.05) over the unseeded 13-93B3
scaffolds (Fig 16) without the expense of multiple surgeries or growth factors.
Mesenchymal stem cells can differentiate into a variety of connective tissues including
blood vessels, cartilage, and bone given the correct combination of biological signals and
growth factors [35]. From this analysis, it was apparent that the 13-93B3 scaffolds
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seeded with MSC’s were in the presence of the correct combination of biological signals
in-vivo to differentiate into blood vessels.
As additional evidence that copper released from bioactive glass is angiogenic,
Brown et al counted the number of blood vessels present in the soft tissue that infiltrated
porous 13-93 silicate scaffolds, 13-93B3 scaffolds, and B3 Cu-3 scaffold containing
0.4wt% CuO after two weeks in rat subcutaneous tissue [42]. The scaffolds were not
fully reacted, particularly the slower reacting 13-93 silicate scaffolds, so the scaffolds
were mounted in PMMA for sectioning and stained with Sanderson Bone Stain to
differentiate the blood vessels from the other soft tissue. Ten random locations were
analyzed from each scaffold section as shown by the arrows in Fig 20. Data from each
scaffold type, n=2, was compared by the student t test to determine any significant
statistical differences (p<0.05). There was no statistically significant difference in the
number of blood vessels found (p<0.6535) in the copper free silicate (13-93) and borate
(13-93B3) scaffolds, but the difference between B3 Cu-3 scaffold containing 0.4wt%
CuO and copper free 13-93 was statistically significant as p<0.0021. After only two
weeks in-vivo, copper released from borate glass was stimulating vascular growth better
than a silicate based bioactive glass.
3.5.3

Blood Vessel Analysis of Scaffolds Doped With Selected Metal Ions
The bioactive borate scaffolds composed of B3 Cu-3 glass fibers contained a

larger number of blood vessels when compared to 13-93B3 glass fiber scaffolds. Since
copper had such a dramatic effect on vascular growth, copper was added to all of the
minor element doped scaffolds to see what the effect, if any, occurred by the addition of
strontium, zinc, or iron. Both scaffold types containing zinc (CSZ and CSZF) proved to
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significantly increase the number of blood vessels (p<0.05), when compared to the B3
Cu-3 scaffold (Table 3). Having two sets of scaffolds (CSZ and CSZF), both containing
equal amounts of zinc, and both statistically outperforming the B3 Cu-3 scaffold acts as a
check and secondary data point confirming that the addition of zinc to the glass promoted
an increased angiogenic response.
Zinc is well known to promote soft tissue reactions such as keratinocyte migration during
wound healing which promotes re-epithelialization [28]. Keratinocytes are the cells that
make up the majority of the epidermis [35], which includes blood vessels, so assuming
the release of zinc from the scaffold increased the migration rate of the keratinocytes and
promoted epithelialization inside the scaffold, the increase in blood vessels may be
explained by the overall promotion of tissue growth.

3.6.

CONCLUSIONS
The present work shows that ions important to stimulating angiogenesis can be

released from bioactive glass to promote the important biological function. Scaffolds
composed of bioactive borate glass fibers doped with copper, strontium, zinc, and iron,
were used to promote angiogenesis in the subcutaneous tissue of rats. The copper doped
borate glass (0.4wt% CuO) seeded and unseeded with MSCs produced significantly more
blood vessels when compared to the copper free 13-93B3 glass fiber scaffold.
The addition of zinc to bioactive borate scaffolds doped with copper significantly
increased the number of blood vessels in the subcutaneous tissue of rats when compared
to bioactive borate scaffolds doped with copper only after six weeks in-vivo. Of the
materials added for the promotion of angiogenesis, strontium and iron had little impact,
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but copper and zinc significantly increased the vascularity in the scaffolds they were
added. It was also found that the addition of MSCs to a scaffold further enhanced the invivo angiogenic response.
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TABLES

Table 1 -Compositions of Bioactive Glasses (wt%)
MgO

P20 s

Si0 2

CuO

SrO

ZnO

Fe20 3

0

0

6.00

45.00

0

0

0

0

20.00

12.00

5 .00

4. 00

53.00

0

0

0

0

21.50

21.50

0

0

4.00

53.00

0

0

0

0

53.00

6.00

20.00

12.00

5 .00

4. 00

0

0

0

0

0

B3 Cu-1

52.95

5.99

19.98

11.99

5.00

4.00

0

0.1 0

0

0

0

B3 Cu-2

52.89

5.99

19.96

11.98

4.99

3.99

0

0.20

0

0

0

B3 Cu-3

52.79

5.98

19.92

11.95

4.98

3.98

0

0.40

0

0

0

B3 Cu-4

52.47

5.94

19.80

11.88

4.95

3.96

0

1.00

0

0

0

B3 Cu-5

5 1.94

5.88

19.60

11.76

4.90

3.92

0

2.00

0

0

0

cs

51.73

5.86

19.52

11.71

4.88

3.90

0

0.40

2.00

0

0

csz

51.20

5.80

19.32

11.59

4.83

3.86

0

0.40

2.00

1.00

0

CSZF

50 .88

5.76

19.20

11.52

4.80

3.84

0

0.40

2.00

1.00

0 .40

Glass

Bp 3

Na 20

CaO

45S5

0

24. 50

24.50

13-93

0

6.00

S53P4

0

13-93B3

K20
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FIGURES

Figure 1– Examples of as-made bioactive borate glass scaffolds doped with CuO in
amounts from 0.1wt% to 2wt%. Each scaffold was 7mm in diameter and 2mm thick.
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Figure 2 –Appearance of bioactive borate scaffolds doped with CuO, after two weeks in
subcutaneous sites in rats, for evaluation of vascular growth (unseeded).
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Figure 3 – Bioactive borate scaffolds doped with increasing amounts of CuO, implanted
in subcutaneous sites in rats (four weeks) for evaluation of vascular growth (unseeded).
The circles are to guide the eye.

128

Figure 4 – Appearance of 13-93B3, B3 Cu-1, and B3 Cu-3 borate glass fiber scaffolds
with and without 50,000 seeded mesenchymal stem cells after a six week implantation in
a subcutaneous site.
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Figure 5 – Digital micrographs of borate glass scaffolds (original dimensions – 7mm
diameter, 2mm thick) doped with 0.40% CuO, 2.0% SrO, 1.0% ZnO, and 0.4% Fe2O3
(wt%) after six weeks in a subcutaneous site. The top row of scaffolds was seeded with
50,000 mesenchymal stem cells (MSC) and the bottom row was unseeded.
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Figure 6 – Optical micrograph of the cross section of an as-made randomly oriented fiber
scaffold infiltrated with PMMA. The due to the fiber orientation, many of the fibers look
ellipsoidal, and several fibers fused together during the heat treatment.
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Figure 7 – H&E stained sections of the six week subcutaneously implanted 13-93B3 (A),
B3 Cu-1 (B), and B3 Cu-3 (C) scaffolds seeded with 50,000 mesenchymal stem cells.
The colored boxes (left) are an indication of the number of blood vessels present in each
of the areas.
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Figure 8 – An example of an H&E stained tissue section with blood vessels marked
(black arrow), and often have red blood cells inside (red or pink). Blood vessels have a
purple defining edge.
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Figure 9 – Schematic showing how the PAS stained tissue sections (CuO doped) were
analyzed. The dashed line represents the section of tissue analyzed, typically close to the
center of the section, used for blood vessel analysis. As indicated by the schematic,
reacted fibers (white) were often in the line of tissue analyzed and since the scaffolds
were approximately the same porosity, no correction was required.
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Figure 10 – Optical micrographs of PAS stained tissue section from a B3 Cu-3 bioactive
glass fiber scaffold implanted six weeks. The arrows point to blood vessels (purple ring)
and the objects in the vessels are stained red blood cells (green).
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Figure 11 – Example of an H&E section used for the blood vessel analysis (H&E). The
dashed lines in the top image show the areas across the scaffold that were analyzed, and
the total number of vessel for each line of tissue are shown (72, 73, and 32, respectively).
The individual tissue sections are shown below (A to C) and several of the largest blood
vessels are pointed out with arrows to guide the reader. Bar = 1mm.
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Figure 12 – Optical images showing a B3 Cu-5 scaffold after six weeks walled off in
subcutaneous tissue, Fig 12A. A thick fluid was present inside the site, Figs. 12B and
12C, and the remainder of the scaffold removed from the site is shown in 12D. All
images come from the same rat.
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Figure 13 – Optical micrographs of stained sections (H&E) from a 13-93B3 scaffold after
four weeks in-vivo. Many of the fibers (F) are reacted, and some contain tissue.
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Figure 14 – Optical micrographs of B3 Cu-1 scaffold sections (H&E) that were removed
from rat subcutaneous tissue after four weeks in-vivo and stained with H&E stain. Many
of the fibers (F) are hollow, and some contain tissue.
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Figure 15 – Optical micrographs of B3 Cu-5 scaffold sections (H&E) that were removed
from rat subcutaneous tissue after four weeks in-vivo and stained with H&E stain. Large
blood vessels (V) have been identified throughout the tissue.
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Figure 16 – Area % of blood vessels measured from PAS stained tissue sections from
bioactive borate glass scaffolds (doped with CuO) after six weeks in-vivo. N=3.
Differences considered significant if *(p<0.05).
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Figure 17 – Total number of blood vessels measured for H&E stained borate glass
scaffold tissue sections doped with minor elements (Cu of C = copper, S = Strontium, Z =
Zinc, and F = iron) after six weeks in-vivo. * p<0.05, N=3.
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Figure 18 – Average area for vessels in 20 randomly selected boxes across an H&E
stained histology section for the borate glass fiber scaffold, 13-93B3 (no CuO), B3 Cu-1
(0.1wt% CuO), and B3 Cu-3 (0.4wt% CuO) (left side, red triangle). The total number of
vessels measured for each scaffold is plotted on the right hand y-axis (black diamonds).
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Figure 19 – Total vascular area calculated from 20 randomly chosen areas in H&E
stained sections for the 13-93B3 (0wt% CuO), B3 Cu-1 (0.1wt% CuO), and B3 Cu-3
(0.4wt% CuO) scaffolds.
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Figure 20 – Cross section of a 13-93 fiber scaffold that had been implanted in
subcutaneous tissue of a rat for two weeks. Ten areas of tissue examined for blood
vessels are indicated by the arrows. The section was stained with Sanderson Bone Stain.
Personal communication [42].
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4.1 ABSTRACT:
Bone growth was investigated on bioactive borate glass fiber scaffolds and was
assessed by two models, the rat calvaria model for osteoconduction and a subcutaneous
rat model for osteoinduction. Porous bioactive glass scaffolds composed of randomly
oriented fibers and loose particulates (100 to 200µm) were placed in calvaria defects
(4mm diameter) of rats for 12 weeks to compare borate, borosilicate, and two silicate
based bioactive glasses (45S5 and 13-93) effect on bone growth. Micro-CT analysis of
the scaffolds after 12 weeks showed that on average, n=4, the borate glass scaffold had
the highest bone coverage of the four glasses tested on both the top and bottom of the
scaffold. Histomorphometry analysis of the calvaria implanted scaffolds showed that the
borate glass scaffold had significantly more bone (p<0.05) than the borosilicate or silicate
based bioactive glass scaffolds.
In a separate experiment, borate based bioactive glass scaffolds doped with minor
elements present in bone (copper, strontium, zinc, and iron) were seeded with
mesenchymal stem cells and implanted in subcutaneous tissue of rats to determine if the
scaffolds could foster osteoinductive bone growth. No inflammation or infection was
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observed at any of the implant sites. Upon retrieval of the scaffolds, significant numbers
of blood vessels were present in the adjacent tissues. Analysis of the tissue for
mineralized bone-like material showed that none of the unseeded scaffolds formed
osteoid or bone-like tissue. At least one of every type of the MSC seeded scaffolds
stained positive for mineralized bone-like tissue indicating that the bioactive borate
scaffolds are osteoinductive.

4.2

INTRODUCTION
Bioactive glasses such as 45S5 (Table 1) have been known to bond with hard and

soft tissue since 1969 [1, 2]. Bioactive glasses and glass-ceramics have been used in
clinical applications including periodontal repair [3], replacement of bones in the inner
ear [4], and filler for bone cement [5, 6]. Three dimensional scaffolds composed of
bioactive glasses in a variety of microstructures have recently been under investigation
for bone defects for load bearing and non-load bearing applications [7-11]. Silicate based
bioactive glasses however have been shown to react relatively slowly in-vivo taking
months to years to fully react to hydroxyapatite (HA) [12].
Due to the relatively slow reaction of silicate based bioactive glasses, a new
family of faster reacting bioactive glasses was developed. Borate based bioactive glasses
submerged in phosphate solutions convert to HA similar to silicate based bioactive
glasses [13-15]. For example, an in-vitro study comparing the reaction rate of silicate
based bioactive glass (45S5) to two borosilicate glasses (1/3 and 2/3 of silica replaced by
boron) and a borate based bioactive glass (all silica from 45S5 replaced by boron), the
borate glass converted to HA five times faster than the silicate glass [13, 16].
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Richard et al was the first to implant particles of a 45S5 borate analog (complete
exchange of boron for silica) in rat femurs. The glass converted to HA at a significantly
accelerated rate and bone grew in and attached to the borate glass particles [17]. No
negative immune response was reported from the histological analysis of the borate based
particles.
Jai et al. [18] made pellets from borate glass particles (<50µm) mixed with
teicoplanin (4 and 8wt%) for the treatment of osteomyelitis. In-vitro experiments showed
that approximately 80% of the teicoplanin was released within 15 days. The compressive
strength of the scaffolds decreased from 22 MPa to 12 MPa after being submerged for six
days in PBS solution. In-vivo experiments with New Zealand White rabbits confirmed
the previously described in-vitro work, as the teicoplanin exhibited a controlled release
and the implants had sufficient load bearing strength. There was no reported in-vivo
toxicity in the bone adjacent to the bioactive borate glass as the glass converted to HA
and supported the growth of new bone in the scaffolds.
Liu et al. [19] treated osteomyelitis located in the tibia of New Zealand White
rabbits with a scaffold made of bioactive borate glass particles bonded together with a
polymer binder loaded with Vancomycin. After eight weeks in-vivo, the implant sites
had no observable tissue damage or inhibition of bone growth. After eight weeks,
approximately 80% of the osteomyelitis infected tibia tested negative for the infection.
Vascular growth adjacent to the scaffolds was reported to have been participating in the
bone regeneration.
Bioactive glass 13-93B3 (Table 1) was used to make porous scaffolds composed
of randomly oriented fiber which were implanted in the subcutaneous tissue of Sprague

148
Dawley rats for four weeks [20]. The 13-93B3 fibers fully reacted to carbonated
hydroxyapatite, and the fibers formed porous tubes [20]. Soft tissue and blood vessels
were present in the open pores of the scaffold and at the center of many of the reacted 1393B3 fibers. There was no noticeable inflammation due to the implantation of the
scaffold indicating that the 13-93B3 glass was compatible with rat subcutaneous tissue
[20].
In the present work, porous scaffolds made from randomly oriented fibers
composed of borate glass fibers, borosilicate glass fibers, silicate based bioactive glass
fibers (13-93) and loose particles of 45S5 glass were implanted in 4mm rat calvaria
defects to compare bone growth between scaffolds and loose particles, and to determine
if silicate or borate glasses promote the most bone growth. Additionally, a series of
bioactive borate glass scaffolds doped with copper, strontium, zinc, and iron were seeded
with mesenchymal stem cells (MSC’s) and implanted in subcutaneous tissue to determine
if the scaffolds were osteoinductive. The amount of each of the minor elements was
based off the relative abundance of the trace elements in human bone [21].

4.3

MATERIALS AND METHODS

4.3.1

Glass Melting, Scaffold Preparation, and Sterilization
The borate glass compositions present in Table 1 were made from reagent grade

chemicals and melted in a platinum crucible. The batch materials were melted at 1050 to
1400oC for one to two hours depending upon the composition. Fibers of each glass with
a diameter ranging from 100 to 300µm were pulled from the melt. The fibers were
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broken into 2 to 3mm lengths for the preparation of porous randomly oriented fiber
scaffolds.
For the subcutaneous implants, approximately 70mg of fiber was placed in a
cylindrical ceramic mold with an internal diameter of 7mm. The molds were placed in an
oven preheated to 575oC and heated for 45 minutes, after which the molds were removed
and cooled to room temperature. Once cool, the scaffolds were removed from the molds
and were ready for use. The nominal dimensions of the as-made scaffolds were 7mm in
diameter and 2mm thick.
The scaffolds for the calvaria implantation experiment were made using a
graphite mold (~50mm long) with 4mm diameter holes machined longitudinally. The
holes were filled with glass fibers, placed in an oven at room temperature, and heated to
the bonding temperature of; 575oC, 625oC, and 690oC for the 13-93B3, 13-93B1, and 1393, respectively, at a rate of 20oC/min and held for 20 minutes. After the heat treatment,
the mold was removed from the oven and cooled to room temperature. Once cool, the
scaffolds (~40mm long) were removed from the mold and infiltrated with molten wax.
Once the wax solidified, the scaffolds were cut with a slow speed saw with a diamond
wafer blade to a nominal thickness of 1.5mm. After cutting, the scaffolds were
submerged in xylene to dissolve the wax and were stored in a desiccator until needed.
Prior to implantation or seeding with MSCs, the as-made scaffolds were dry heat
sterilized. The scaffolds were placed in a glass vial, covered with a loose fitting
aluminum foil top, heated to 300oC for four hours, and cooled to room temperature.
Once cool, the scaffolds were ready for seeding with MSCs or implantation.

150
4.3.2

Calvaria Defect Model

4.3.2.1 Scaffold Porosity
The interconnected open porosity of the scaffolds used for the calvaria
implantation experiment was measured by a liquid displacement method. The equation
used to calculate the open porosity (Po) is shown as Eqn 1. The dry weight of the
scaffolds was measured with a digital scale (Mettler Toledo XS105 ±0.00001g) to obtain
a dry weight (M1). The scaffolds were submerged in kerosene and placed under vacuum
for one hour to fill the open, interconnected, pores and then weighed while suspended in
kerosene (M2) and while saturated with kerosene in air (M3). The open porosity (Po) of
the scaffold was calculated from Eqn 1.

Po =

M 3 − M1
× 100%
M3 − M2

(1)

The average open porosity from an n=12 from eqn 1 for each type of scaffolds was 47 ±
4%, 47 ± 3%, and 51 ± 2% for the 13-93, 13-93B1, and 13-93B3, scaffolds, respectively.
4.3.2.2 Scaffold Implantation in Rat Calvaria
Fiber scaffolds of 13-93, 13-93B1, and 13-93B3 glasses (see Table 1) and 100 to
200µm diameter loose particles of 45S5 were implanted in 4mm diameter calvaria
defects of rats for 12 weeks. The rats were anesthetized with intravenous drugs prior to
the surgery. Two 4mm diameter defects were made with a high speed dental bur and
placed on each side of the sinus as shown in the schematic in Fig 1. The fiber scaffolds
or loose particles of 45S5 were implanted in the defects, and the skin was closed. The
calvaria implantation and micro-CT measurements were done at the University of
Missouri – Kansas City School of Dentistry. Histomorphometry of the 12 week scaffolds

151
and loose particles for quantization total bone growth was compared by one-way analysis
of variance (ANOVA).
4.3.2.3 Micro-CT Analysis of In-Situ Scaffolds
After 12 weeks the rats were sacrificed and the bone growth across the top and
bottom of the implanted scaffolds was determined with micro-CT. The rats were
anaesthetized and the implant areas scanned to determine bone growth at the implant
sites.
4.3.3

Subcutaneous Model

4.3.3.1 Scaffold Seeding with Mesenchymal Stem Cells
Mesenchymal stem cells were recovered from the long bones of sacrificed Fisher
344 rats. The cells were cultured in-vitro to separate the stem cells from bone marrow
prior to seeding the scaffolds. Half of the scaffolds were seeded with 50,000 MSCs, the
other half were unseeded. The cells were cultured on the scaffolds for approximately 12
hours prior to the implantation to allow the cells to attach to the scaffolds/fibers.
4.3.3.2 Scaffold Implantation
Five scaffolds of each type (Cu-3, CS, CSZ, CSZF, Table 1) were seeded with
MSCs and five were left unseeded. These scaffolds were implanted in subcutaneous sites
of Fisher 344 rats for a total of 40 implants in 10 rats. The scaffolds were implanted
randomly to remove any bias from a single rat. A schematic of the implant sites is shown
in Fig 2. Each rat had four implant sites, two above the shoulders and two above the back
legs, where a single scaffold was implanted for a total of four scaffolds per rat. The back
of each rat was shaved with clippers and washed with iodine and then 70% ethanol to
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disinfect the skin prior to the surgery. During the surgery, the rats were anesthetized with
isoflourine.
An incision was made about 20mm in length completely through the cutaneous
tissue, perpendicular to the spine, with a pair of surgical scissors. Next, a surgical clamp
was inserted into the incision and opened to separate the cutaneous tissue from the
skeletal muscle. The implant site was made approximately 15 to 20 mm long. The
scaffold was then placed at the back of the cutaneous opening and the skin closed. Any
air that entered the implantation site was removed by gently pressing the cutaneous tissue
against the skeletal muscle. The wound was closed by mechanically bonding the skin
with super glue.
After scaffold implantation, the rat was injected with 0.2ml of penicillin (0.1ml
per hind leg) and placed on a heating pad in a clean cage with access to fresh air to
recover. The ears of each rat were marked to differentiate the rats. Two rats were caged
together during the length of the experiment and had free access to food pellets and tap
water and the light schedule was 12 hours light, 12 hours dark.
4.3.3.3 Scaffold Removal and Tissue Processing
After six weeks, the rats were sacrificed by CO2 inhalation and the scaffolds were
removed for analysis. The scaffolds were placed in 5ml of 10% formalin solution for
four days to fix the tissue. Once the tissue attached to the scaffolds was chemically fixed,
the scaffolds were dehydrated with a series of ethanol solutions by a microwave
dehydration technique [22]. The microwave used was a microwave tissue processor
(EBSciences H2850 Microwave Processor). The microwave was set to 70% power, the
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sample temperature was set to 37±4oC, and microwave was on for 2.5 minutes for each
solution. A scaffold was in each ethanol solution for a minimum of 15 minutes.
4.3.3.4 Histology Slide Preparation and Histological Assessment
The dehydrated scaffolds were placed in a tissue processor (AutoTechnicon
Model 2A) filled with fluid paraffin mounting wax (Paraplast Tissue Embedding
Medium, McCormick Scientific LLC) at 45oC for four hours for wax infiltration of the
scaffold and tissue. Each scaffold was mounted in wax for histological sectioning with a
paraffin mounting system (Leica EG 1150H). Sections 18µm thick were cut with a
histological microtome (Leica RM 2235 microtome) with TBS Shur/sharp blades,
(Triangle Biomedical Sciences, Durham NC). The cut sections were floated on a water
bath (Lipshaw Electric Tissue Float, model number 375, Detroit MI) (40oC) prior to
mounting on a glass slide (Fisher Brand Superfrost microscope slides, St. Louis MO).
Three to four tissue sections were placed on a single glass slide, and dried overnight on a
slide warmer (Fisher Scientific slide warmer, St. Louis MO). Slides were stained with
Sanderson Rapid Bone Stain to determine if the scaffolds were osteoinductive. Stained
slides were viewed with a microscope (Olympus BX50, Olympus Optical Co) at
magnifications of 40, 100, and 400X and imaging software (DP Controller, Olympus
Optical Co) was used for image capture.
A scaffold composed of randomly oriented and self bonded fibers was embedded
in PMMA for use as a reference for the fibers present in the cross sectioned histology
sections. The plastic embedded randomly oriented fiber scaffold was sectioned with a
slow speed saw and a diamond coated blade and polished with 320, 400, 600, 800, and
1200 grit silicon carbide paper. The polished cross section of a scaffold is shown in Fig 3
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The fibers appear round if the longitudinal axis of a fiber is perpendicular to the plane of
the image and ellipsoidal if the fiber is oriented at an angle to the section.
4.3.3.5 Bone-like Material Analysis
Sections from four scaffolds of each type, seeded and unseeded with MSC’s, were
stained with Sanderson Rapid Bone Stain at 50oC for 60 to 75 seconds. The sections
rinsed with DI water and checked under a microscope to ensure the tissue stained to an
appropriate level. The sections were counter stained with an acid fuchsin solution (99mL
DI water, 1mL concentrated acetic acid, 1.0 gram of acid fuchsin) at room temperature
(22oC) for 30 to 45 seconds. The sections were viewed under the microscope again to
check the counterstain. The sections were then coated with a transparent resin and
coverslipped. Each section was viewed at 10X and 40X with an Olympus MI transmitted
light microscope (Olympus Corporation, Japan).
4.3.3.6 Scanning Electron Microscopy Analysis (SEM)
An FEI environmental scanning electron microscope ESEM (FEI, Hillsboro, OR)
was used for SEM imaging of cross sectioned scaffolds. Each scaffold was embedded
with poly methyl methacrylate (PMMA) and sectioned in half with a slow speed diamond
saw. The surface imaged by SEM was polished with silicon carbide polishing paper to
1200 grit, coated with ~100nm of Au/Pd for conduction prior to SEM analysis.
Backscattered SEM was used to identify areas of mineralized bone-like material.
4.4

RESULTS

4.4.1

Calvaria Defect Experiment
Micro-CT was used to image the bone that had grown across the top and bottom

of each scaffold as shown by Fig 4. The area of scaffold not covered by bone was

155
subtracted from the original defect area to determine the defect closure. The average
percent closure for each implant type is shown in Fig 5. The 13-93B3 glass had the
highest average percent bone regeneration on top and bottom of the scaffold when
compared to the other implants. The 45S5 silicate glass had the least amount of bone
regeneration on the top and bottom after 12 weeks.
4.4.2 Bone Growth in Bioactive Glass Scaffolds Implanted in Rat Calvaria (12
Weeks)
Total bone growth in the 12 week calvaria scaffolds was quantified by a
histomorphometric analysis [23] and the results are shown in Fig 6. The 13-93B3 borate
scaffolds contained the most new bone of any of the glasses, about twice as much bone as
the 13-93 and 13-93B1 scaffolds. A one-way ANOVA analysis of the histomorphometry
data concluded that the 13-93B3 scaffolds contained significantly more bone (p<0.05)
than the 13-93 or 13-93B1 scaffolds.
4.4.3

Subcutaneous Implantation Experiment – Doped Scaffolds

4.4.3.1 Scaffold Removal
After six weeks in-vivo, each scaffold was removed from the subcutaneous tissue
of each rat. None of the rats died during the experiment, and none exhibited any signs of
sickness or infection. The images in Fig 7 show the appearance of seeded (MSC’s) and
unseeded scaffolds, while still attached to the subcutaneous tissue. Several blood vessels
were visible in the tissue adjacent each scaffold. Most scaffolds had what appeared to be
a red or pink tissue inside the scaffold indicating that blood vessels had grown inside the
open and interconnected pores in the scaffold.
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4.4.3.2 Osteoinductivity of Scaffolds (Sanderson Rapid Bone Stain)
The ability to foster the differentiation of stem cells to a bone-like material is
known as osteoinductivity. Half of the scaffolds implanted in the subcutaneous tissue
were seeded with 50,000 MSCs recovered from rat femurs. If MSCs differentiate into a
bone-like material in the presence of the scaffold that has been implanted away from a
bone site, then the scaffold may be considered an appropriate device for bone
regeneration in a bony defect. Sections stained with Sanderson Rapid Bone Stain (SBS)
appear as follows: cell nuclei are dark blue for bone and soft tissue, cytoplasm stains a
light blue, osteoid (bone precursor composed of proteins secreted by osteoblast cells) is
purple, mineralized bone and hydroxyapatite is pink to red, and soft tissue is dark blue.
4.4.3.3 Histology of Un-Seeded Scaffolds
An example of each unseeded scaffold type stained with the Sanderson Rapid
Bone Stain (SBS) is shown in Fig 8 and the tissue analysis results are present in Table 2.
All of the scaffolds were filled with soft tissue (dark blue) in the interconnected pore
space. No osteoid (bone precursor) or mineralized bone-like material was detected in any
of the unseeded scaffolds as expected. The arrows in Fig 8B point to air bubbles that
formed when the cover slip was glued to the section. The color of the stained sections
varied as the sections were stained individually by hand and were not stained as precisely
as they would have been in an automated system.
4.4.3.4 Histology of MSC Seeded Scaffolds
A cross section of a representative Cu-3 scaffold seeded with MSCs, and stained
with SBS is shown in Fig 9A. Soft tissue (dark blue) is visible throughout almost the
entire scaffold, filling the interconnected pores between the reacted Cu-3 fibers (red).
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The area magnified in Fig 9B was chosen because it shows several reacted fibers (F) with
purple osteoid tissue (O) that grew adjacent with the surface of the reacted Cu-3 fibers
(red). Several blood vessels are indicated with white arrows showing the integration of
blood vessels within the osteoid. Figure 9C shows a mixture of bone-like (red) and
osteoid tissue (purple) next to reacted Cu-3 fibers at the outer edge of the scaffold. The
bone-like material was located toward the outer surface of the scaffolds. Osteoid was
present throughout the seeded (MSC) scaffolds and was often intermixed with tissue that
stained positive for bone-like material. The osteoid material contained blood vessels
which is important for bone metabolism.
Figure 10A is the backscattered SEM micrograph of a seeded Cu-3 scaffold after
six weeks in subcutaneous tissue. The fibers are significantly reacted as most have
formed hollow voids toward their center. The pore space between the fibers appears
black since the soft tissue filling the interconnected pores has a low average atomic
number. The ellipsoidal fibers in the image are due to the random orientation of the
fibers as previously mentioned. There is a material surrounding some of the reacted
fibers as indicated by the arrow in Fig 10A which has been magnified in Fig 10B. This
material could be bone matrix (calcium phosphate) as its contrast in the BSE image is
similar to the HA (calcium phosphate) of the reacted fiber. The material is not
recognizable as bone at this point, but the formation of this material could be from the
differentiation of the seeded MSCs.
The cross section of an MSC seeded CS scaffold is shown in Fig 11. There is
significant soft tissue (dark blue) infiltration of the once empty pores as shown in Fig
11A. Figure 11B is a magnified view of the outer portion (box B) of the CS scaffold that
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has a mixture of bone-like and osteoid tissues (B-O). The image in Fig 11C is a higher
magnified view of the bone-like and osteoid tissues adjacent to some reacted CS fibers
(F) in box C.
The fibers comprising the seeded CS scaffold in Fig 12 had reacted after six
weeks as most of the fibers had areas that appeared hollow near or at the center of the
fibers. Those fibers marked with an arrow at the bottom left of Fig 12, which were near
the center of the scaffold, had not fully reacted, but the majority of the fibers are fully
reacted. No recognizable bone-like material was found in Fig 12 since there was no
mineralized material attached to any of the reacted fibers or in the interconnected pore
space.
A section from a seeded (MSC) CSZ scaffold, implanted in rat subcutaneous
tissue for six weeks, and stained with SBS is in Fig 13. Soft tissue (dark blue) was
present throughout the scaffold as indicated in Fig 13A. The material in box B, Fig 13B,
contained bone-like (red) and osteoid material (purple) next to a reacted CSZ fiber (F)
that was close to the outer edge of the scaffold. The bone-like material (B) toward the
bottom of Fig 13B contains osteocytes (circled purple dots) surrounded by mineralized
matrix (red). Another area of the CSZ scaffold, box C, contains a mixture of osteoid and
bone-like material (B-O) and soft tissue (S) next to reacted CSZ fibers is shown in Fig
13C. There are several circular and ellipsoidal shapes indicative of blood vessels
between the two reacted fibers in Fig 13C (red arrows). The blood vessels adjacent to the
mixture of bone-like and osteoid tissue indicated that the adjacent tissues had sufficient
oxygen and nutrient supply needed for cellular metabolism.
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The backscattered SEM image in Fig 14 shows a MSC seeded CSZ scaffold after
six weeks in rat subcutaneous tissue. The outer edge of the scaffold is at the upper right
corner of the image and the center of the scaffold is located toward the lower left. Some
of the CSZ fibers were only partially reacted, as they contained residual glass at the
center (arrows) of the fiber. The fibers at the outer edge are reacted, but, did not form
hollow fibers as was observed for the Cu-3 and the CS fibers. The center of many of the
reacted fibers had a calcium rich core (horizontal arrows) that has been described in detail
elsewhere [24]. There was no detectable bone-like material attached to the reacted fibers.
A section from a seeded (MSC) CSZF scaffold, implanted in rat subcutaneous
tissue for six weeks, and stained with SBS, is shown in Fig 15. The only section of the
four seeded CSZF scaffolds to stain positive for a bone-like material when stained with
SBS is shown in Fig 15A. Soft tissue was present throughout the scaffold, but the only
bone-like material was present near the outer surface of the scaffold, boxes B and C. A
mixture of osteoid and mineralized bone-like tissue formed along the outer portion of the
scaffold, and two examples of tissue that stained positive for osteoid and bone-like
material next to reacted CSZF fibers are shown in Figs 15B and 15C.
Figure 16 is a SEMBSE micrograph of the reacted cross section of a seeded CSZF
scaffold implanted in rat subcutaneous tissue for six weeks. The fibers are all reacted
since the once homogeneous fibers are now composed of noticeably different layers as
can be seen in Fig 16. The reacted CSZF fibers have white cores similar to the CSZ
fibers in Fig 14. There was no evidence of any mineralized bone-like material attached to
the reacted fibers as there was no mineralized material surrounding any of the fibers or
present in the interconnected pore space.

160
4.5

DISCUSSION

4.5.1

Calvaria Bone Regeneration
The present study is the first to compare similar scaffold microstructures

composed of borate and silicate glasses. On the average, the scaffold with the most bone
regenerated across the scaffold top and bottom surfaces after 12 weeks as measured by
micro-CT was the 13-93B3, and 13-93B3 the only scaffold type to have bone completely
cover the bottom side of a scaffold. The 13-93B3 scaffold had significantly more bone
than the 13-93 or 13-93B1 scaffolds by histomorphometry analysis (1 way ANOVA).
The 45S5 glass was implanted in particulate form because the glass is difficult to
heat treat and form a porous scaffold without crystallization [9]. The objectives of the
calvaria experiment were to determine the effect of glass composition on bone growth
and to determine if a scaffold with interconnected pores was better for bone growth than
loose particles. The facts of the experiment are that the borate glass had significantly
more bone (p<0.05) than the borosilicate or silicate glass scaffolds and the borate scaffold
had on the average more bone than the 45S5 loose particles (Fig 6). Porous, three
dimensional scaffolds are becoming popular for tissue engineering of bone and soft tissue
because they can be made with a tailorable porosity, pore structure, and some bioactive
glass scaffolds can withstand considerable load (~140MPa) which loose particles can not
[25].
4.5.2

Gene Expression Triggered By Bioactive Glass
Several researchers have studied the effect of the dissolution products from 45S5

glass on bone cells in-vitro and in-vivo and found that extracts containing calcium and
silica promote the up-regulation or activation of seven families of genes associated with
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the osteoprogenitor cell and these activities lead to enhanced bone growth [26]. The
families of genes that are activated belong to transcription factors and cell cycle
regulators, DNA synthesis, repair and recombination, apoptosis regulators, growth factors
and cytokines, cell surface antigens and receptors, signal transduction molecules, and
extracellular matrix compounds. Each of these families of genes contains multiple genes
that have been reported to be stimulated between 160 and 700% when in the presence of
the 45S5 dissolution products [26].
Glasses such as 45S5, 13-93, and the 13-93B1 all contain silica and calcium,
which has been shown to stimulate genes and promote bone growth [27]. The absence of
SiO2 in the 13-93B3 glass does not disprove the importance of SiO2 in bone regeneration,
but in the present work, the borate based 13-93B3 scaffolds promoted bone growth
statistically better than the silicate containing scaffolds. This promotion of bone growth
comes as no surprise because boron has been hypothesized to have several biological
roles including bone mineralization and development [28].
Animals fed boron deficient diets had decreased or inhibited bone growth when
compared to animals fed a normal diet [29]. There has been no study done to prove that
boron can promote bone growth or activate genes if administered at levels above
physiological levels. Boron does not affect the calcium or phosphorus levels in bone, but
affects the levels of trace elements in bone such as zinc, magnesium, copper and
potassium [29]. Therefore, boron indirectly affects bone formation by altering the
physiological levels of other elements that have direct roles in bone formation [29].
The reaction rate of the 13-93B3 glass is ~10 times faster than 13-93 in-vivo
based on data from glass fibers reacted in rat subcutaneous tissue [7, 20]. Calcium was
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also previously mentioned as a gene stimulator, so assuming the boron had no effect on
bone growth, the increased rate in calcium released from the 13-93B3 scaffold could be
one reason why more bone grew in the borate scaffold than in the silicate (13-93) glass
scaffold.
The 13-93B1 scaffold is an interesting data point because if boron was stimulating
the bone growth, then the borosilicate glass arguably should have had the most growth
since it was releasing silica, calcium, and boron. The 13-93B1 glass and the 13-93 glass
grew almost identical amounts of bone after 12 weeks (Fig 20). From in-vitro reaction of
45S5 glass particles modified with boron [13], the weight loss of the borosilicate glass
(1/3 replacement of silica with boron) and the silicate glass were almost identical, so a
similar reaction rate and release of calcium from the 13-93B1 and 13-93 glasses would be
expected. This is more evidence that the release of calcium may have been the driving
force behind the increased bone growth.
In-vitro testing of MC3T3-E1 pre-osteoblast cells with added calcium ions
showed that the calcium ions (up to 4.8mM) stimulated DNA synthesis and chemotaxis
(cellular movement caused by a chemical gradient) of the cells [30]. The local release of
calcium from a material such as a bioactive glass is thereby hypothesized to stimulate
migration and proliferation of osteoblasts in-vivo.
Fast reacting bioactive glasses such as the 13-93B3 glass release calcium at a
higher rate than 13-93 or 45S5 and increase the chemical gradient of calcium in the
adjacent tissue. The increase in chemical gradient could potentially increase cellular
migration which could increase the rate of bone regeneration. The increased release of
calcium due to the faster reaction rate of the silica-free 13-93B3 scaffold is therefore
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offered as an explanation as to why the 13-93B3 scaffold had more bone present after 12
weeks than the slower reacting silica containing scaffolds.
4.5.3

Potential Toxicity of the Boron Containing Glasses
Borate glasses tested in-vitro have inhibited cell proliferation and decreased cell

number during static culture [31]. Dynamically cultured cells [31] or pre-reaction of the
borate glasses [32] have improved the in-vitro proliferation as these techniques have been
done to more closely mimic the in-vivo environment. The boron released from the
borate scaffolds in the rat calvaria caused no increase in macrophages or other
inflammatory cells in the adjacent tissue, and no necrotic tissue was reported [23]. No
necrosis was expected in systemic organs such as the kidney and liver since rats with up
to sixteen 13-93B3 scaffolds (70mg each) were implanted in a single rat and there were
no pathological differences between the control rats and those implanted with sixteen
scaffolds. Any recorded finding was at the lowest level of severity and considered
normal in adult rats [33].
4.5.4

Osteoinductive Bone-like Tissue Formation Analysis
The SBS sections of the doped scaffolds indicated that at least one of the analyzed

scaffolds from all four scaffold types seeded with MSCs promoted the differentiation of
the MSCs to a bone-like material when implanted in rat subcutaneous tissue. The bonelike tissue formed at the outer edge of the scaffolds according to the SBS staining. There
was no SEMBSE evidence to confirm the presence of a mineralized material except in
the Cu-3 scaffold. It is unknown why there was little bone-like tissue formation toward
the center of the scaffolds, but it may have to do with where the MSC cells attached
during the initial cell seeding or perhaps there was insufficient supply of nutrients at the
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center of the scaffolds after the initial implantation to sustain the MSC’s. The MSC’s
may also still have been in the process of differentiating, although previous work with
13-93 fiber scaffolds seeded with MSC’s and implanted in rat subcutaneous tissue had
bone-like material present after four weeks [34].
Blood vessels present next to soft and bone-like tissues, as shown in Figs 9B and
13C are examples of blood vessels adjacent to the osteoid and or bone-like tissues. Jung
et al modified the 13-93B3 glass composition with CuO to release copper ions to the
surrounding tissue similar to copper salts, but in a controlled manner [35]. The addition
of 0.4wt% of CuO to the 13-93B3 glass increased the amount of vessels present in rat
soft tissue that had infiltrated the open pores of the scaffolds [35]. It took the scaffolds
approximately six weeks to fully react in the subcutaneous tissue of the rats and there was
no negative immune response in any of the glasses containing 0.4wt% CuO or less [35].

4.6

CONCLUSIONS
Borate glass 13-93B3 scaffolds promoted bone growth in rat calvaria significantly

better than scaffolds with a similar microstructure composed of the silicate based 13-93
bioactive glass scaffolds after 12 weeks in-vivo. The explanation offered as to why the
borate scaffold had more bone present is because of the faster reaction of the borate glass
which increased the release rate of calcium, which is known to promote osteoblastic
migration and proliferation.
Borate based bioactive glass fiber scaffolds doped with small amounts of copper,
strontium, zinc, and iron, each of which is present in human bone, were seeded with
mesenchymal stem cells and incubated in a soft tissue site to allow for the differentiation
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of a bone-like material. Each of the types of doped scaffolds had at least one scaffold
that stained positive for bone-like material. Blood vessels were seen throughout the
infiltrated soft tissue, but it is unclear if the doped glasses promoted the differentiation of
mesenchymal stem cells into osteoblastic type cells able to make bone-like material.
All rats remained healthy during the course of their given experiment; there were
no signs of sickness in the rats, infection at the implant sites (bony or subcutaneous), or
increase in macrophages or other inflammatory cells in the rat calvaria. These favorable
results make borate based bioactive glasses and scaffolds important for future
development of biomaterials for hard and soft tissue applications.
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FIGURES:

Figure 1 – Schematic showing the scaffold placement in the calvaria of a rat. The
scaffolds implanted measured 4mm in diameter and 1.5mm thick as shown in Fig 1.
Each scaffold was placed between the surrounding sutures and the sinus was avoided to
reduce surgical complications.
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Figure 2 – Schematic showing the subcutaneous scaffold implant sites located on the
back of a rat. A scaffold was placed above each of the front shoulders and above both
hind legs as indicated. The incision (red line) made in the skin was approximately 20mm
wide and the pocket made under the skin (dotted line) is about 20mm long. The dashed
line represents the spine as a reference.
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Figure 3 – Optical micrograph of a cross sectioned randomly oriented bioactive glass
fiber scaffold. The fibers are gray and look like circular or elliptical depending on the
fiber orientation.
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Figure 4 – Micro-CT images of the top and bottom of porous randomly oriented fiber
scaffolds composed of bioactive glass fibers (13-93, 13-93B1, 13-93B3) and 45S5
particulates (100 to 200µm) after 12 weeks in 4mm rat calvaria defects. The scaffold and
bone are labeled for the 13-93 scaffold for the top, bottom, and cross sectioned views.
Note that the 13-93B3 scaffold is not visible in the bottom image (left). Bone had
completely grown across the bottom of the 13-93B3 scaffold [23].
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Figure 5 – Average bone growth across the top and bottom of the implanted scaffolds or
particulates (45S5) after 12 weeks in rat calvaria (4mm original defect). Scaffold
porosity was ~50% for each scaffold.
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Figure 6 – Total bone growth into porous bioactive glass scaffolds (S), (45S5 was in
particulate (P) form (100 to 200µm)) after 12 weeks in rat calvaria (n=4) as determined
by histomorphometry analysis. Statistical significance represented by *(p<0.05), [23].
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Figure 7 – Bioactive borate glass scaffolds doped with minor elements after six weeks in
rat subcutaneous tissue. The top row shows scaffolds seeded with 50,000 MSCs, and the
bottom row shows unseeded scaffolds.
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Figure 8 – Histological sections from a Cu-3 (A), CS (B), CSZ (C), and CSZF (D)
unseeded scaffold after six weeks in subcutaneous tissue, stained with Sanderson Rapid
Bone Stain and counterstained with acid fuchsin. The arrows in Fig 7B indicate the
presence of air bubbles.

178

Figure 9 – Fig 9A is a representative image of a Cu-3 scaffold, seeded with 50,000
MSCs, after six weeks in subcutaneous tissue, stained with Sanderson Rapid Bone Stain
and counterstained with acid fuchsin.
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Figure 10 - SEMBSE image of the cross section of a seeded Cu-3 fiber scaffold (Fig
10A) that had been implanted in the subcutaneous tissue of a rat for six weeks.
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Figure 11 – Fig 11A is a representative image of the cross section of a seeded CS scaffold
after six weeks in subcutaneous tissue, stained with Sanderson Rapid Bone Stain and
counterstained with acid fuchsin.
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Figure 12 - SEMBSE image of a cross section of a seeded CS fiber scaffold and
implanted subcutaneously in the back of a rat for six weeks. Arrows denote unreacted
glass.

182

Figure 13 – Fig 13A is a representative image of a CSZ scaffold, seeded with 50,000
MSCs, after six weeks in subcutaneous tissue, stained with Sanderson Rapid Bone Stain
and counterstained with acid fuchsin. Box B shows osteoid mixed with bone-like
material (B-O) next to a reacted fiber (F). The two circles in Fig 13B are surrounding
osteocytes that have become completely surrounded by mineralized matrix. The (B-O)
mixture in Fig 13C shows bone-like material in the presence of reacted fibers (F) and soft
tissue (S).
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Figure 14 - SEMBSE image of a cross section of a seeded CSZ fiber scaffold that was
implanted subcutaneously in the back of a rat for six weeks.
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Figure 15 – Fig 15A is a representative image of a seeded CSZ scaffold after six weeks in
subcutaneous tissue, stained with Sanderson Rapid Bone Stain and counterstained with
acid fuchsin.
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Figure 16 - SEMBSE image of a cross sectioned CSZF fiber scaffold that was seeded
with 50,000 mesenchymal stem cells (MSC) and implanted subcutaneously in the back of
a rat for six weeks. The majority of the fibers have fully reacted and formed a
multilayered fiber made of two distinct materials, center white and outer edge gray.
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5.1 ABSTRACT
The in-vivo reaction of three dimensional scaffolds composed of randomly
oriented, borate glass fibers doped with copper, strontium, zinc, and iron were
investigated after being implanted in a subcutaneous site in laboratory rats for up to six
weeks. No inflammation or infection was observed at any of the implant sites. Upon
retrieval of the scaffolds, blood vessels were observed adjacent to new tissue. Evidence
of the minor elements in the scaffolds after six weeks was confirmed by XRF. The minor
elements were either present in the adjacent tissues or in the reacted fibers. Analysis of
the reacted fibers by scanning electron microscopy (SEM) and x-ray diffraction (XRD)
showed that the majority of the un-doped fibers were fully converted to hydroxyapatite
(HA) after four weeks. The addition of the minor elements slowed the conversion of the
bioactive glass fibers to HA. The scaffold containing copper doped fibers converted to
HA, but at a slower rate than the un-doped glass. The addition of copper and strontium to
the glass significantly decreased the PO43- peak intensities associated with HA as
determined by micro-raman measurements, but still had broad peaks for HA according to
XRD. The addition of zinc to the copper and strontium caused the formation of calcium
carbonate in the form of calcite at the middle of the reacted fibers. Iron added to the
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fibers doped with copper, strontium, and zinc further decreased the amount of HA formed
in the fiber and increased the size of the calcite core in the reacted fibers. This is
believed the first instance where calcium containing bioactive glasses transformed in-vivo
into materials (calcite) other than HA.

5.2.

INTRODUCTION
Bioactive glasses such as 45S5 (Table 1) have been known to bond to hard and

soft tissues for more then four decades [1, 2] and have been used in clinical applications
for periodontal repair [3], repair of bones in the inner ear [4], and fillers for bone cement
[5, 6]. Bioactive glasses convert to the mineral known as hydroxyapatite (HA), whose
stoichiometric composition is Ca10(PO4)6(OH)2, when in contact with body fluids.
Carbonated hydroxyapatite (HCA), whose composition is Ca10(PO4,CO3)6(OH)2, is the
same mineral that is present in the inorganic part of bone, and bone will strongly bond to
synthetic HA or HCA. Three dimensional porous scaffolds composed of bioactive
glasses have recently been under investigation by several researchers to repair large bone
defects [7-11]. Silicate based bioactive glasses, however, have been shown to react
relatively slowly in-vivo, requiring several months to fully react [12].
Typically, calcium containing borate glasses submerged in phosphate solutions
convert to HA in a manner similar to silicate based bioactive glasses [13-15]. An in-vitro
study of the reaction rate of a bioactive silicate 45S5 glass, two borosilicate glasses, and a
bioactive borate glass, showed they all converted to HA, but at different rates [13, 16].
Richard et al implanted particles (300 to 355µm) of a 45S5 borate analog
(complete exchange of boron for silica) in rat femurs and the glass converted to HA at a
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significantly higher rate and bone grew around and attached to the glass particles [17].
Jai et al [18] made pellets of borate glass particles (<50µm) mixed with teicoplanin (4
and 8wt%) for the purpose of treating the bone disease osteomyelitis. The bioactive
borate glass converted to HA in-vivo and supported the growth of new bone.
A bioactive borate glass, designated 13-93B3 in Table 1, was used to construct
porous scaffolds composed of randomly oriented fibers which were placed in the
subcutaneous tissue of laboratory rats [19]. After four weeks, the 13-93B3 fibers had
fully reacted to form porous tubes composed of HCA which were filled with soft tissue
and blood vessels [19].
In the present work, four of the most abundant minor elements found in human
cadaver bone that have positive effects on bone formation were systematically added to
the 13-93B3 glass for subcutaneous implantation for the purpose of determining their
effect on the formation of HA in-vivo. The concentration of the minor elements selected
were chosen from the amount of copper found to have a stimulatory effect on blood
vessel formation from previous work [20] and the relative abundance of trace elements in
human cadaver bone [21]. The elements were added to the 13-93B3 glass in the order,
copper (C), copper + strontium (CS), copper + strontium+ zinc (CSZ), and copper +
strontium + zinc + iron (CSZF). After six weeks, the scaffolds were removed from the
subcutaneous tissue of Fisher 344 rats and evaluated by XRD, SEMBSE and SEMEDS,
and XRF.
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5.3

MATERIALS AND METHODS

5.3.1

Glass Melting and Scaffold Preparation
Bioactive borate glasses, whose compositions are given in Table 1, were made

from reagent grade chemicals and melted in a platinum crucible. The melts were heated
to 1065oC for one hour in a furnace. Fibers of each glass, with a diameter ranging from
100 to 300µm, were hand pulled from the melt. The un-annealed fibers were broken into
2 to 3mm lengths which were used to prepare porous scaffolds composed of randomly
oriented fibers.
Approximately 70mg of fiber (Fig 1A) was placed in a cylindrical ceramic
(mullite) mold (Fig 1B) with an internal diameter of 7mm. The mold was placed in an
oven preheated to 575oC for 45 minutes, after which the mold was removed and cooled to
room temperature. Once cool, the scaffold was removed from the mold and was ready
for sterilization.
An example of an as-made 13-93B3 and Cu-3 scaffold are shown in Figs. 1C and
1D, respectively. The scaffolds had nominal dimensions of 7mm in diameter and 2mm
thick. The doped scaffolds such as Cu-3 are blue due to the addition of CuO to the glass.
The three dimensional scaffold composed of randomly oriented and self bonded fibers
had an open, interconnected porosity of 50±2% [22].
Prior to implantation the scaffolds were dry heat sterilized. The scaffolds were
placed in a silica glass vial, covered with a loose fitting aluminum foil top, heated in an
oven to 300oC for four hours, and cooled to room temperature. Once cool, the scaffolds
were ready for implantation.
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5.3.2

Scaffold Implantation
Each type of bioactive borate scaffold (five types total) was implanted in

subcutaneous tissue of Fisher 344 rats, n=5, for either four or six weeks. The scaffolds
were implanted randomly to remove any bias from a single rat. A schematic of the
implant sites is shown in Fig 2. Each rat had four implant sites, two above the shoulders
and two above the back legs, where a single scaffold was implanted in each site, for a
total of four scaffolds per rat. The back of each rat was shaved with clippers and washed
with iodine and then 70% ethanol to disinfect the skin prior to surgical work. During the
surgery, the rats were anesthetized with isoflourine.
An incision 20mm in length was made through the cutaneous tissue perpendicular
to the spine with a pair of surgical scissors. The cutaneous tissue was separated from the
skeletal muscle by inserting a clamp and gently opening it to make an opening ~20 mm
long. A scaffold was inserted at the back of the cutaneous opening of the skin and closed
with super glue. Once all four scaffolds were implanted; the rat was injected with 0.2ml
of penicillin (0.1ml per hind leg) prior to complete recovery. The rats had free access to
food pellets and tap water and were on a light schedule of 12 hours light, 12 hours dark.
5.3.3

Scaffold Removal
After either four or six weeks, the rats were sacrificed by CO2 inhalation and the

scaffolds were removed for analysis. The scaffolds were placed in 5ml of 10% formalin
solution for four days to fix the tissue.
5.3.4

Scaffold Processing
Once the scaffolds were fixed, they were dehydrated with ethanol solutions by a

microwave dehydration technique [23]. A microwave tissue processor (EBSciences
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H2850 Microwave Processor) was set to 70% power, the sample temperature was set to
37±4oC, and microwave was on for 2.5 minutes for each solution. Each scaffold was in
each ethanol solution for at least 15 minutes.
The recovered scaffolds were embedded in poly methyl methacrylate (PMMA) by
first submerging them in methyl methacrylate (MMA) monomer for 24 hours which was
stirred with a magnetic stir bar. Next, the scaffolds were infiltrated with MMA
containing 50% of the polymerizing agent Perkodox 15 for 24 hours. The final
infiltration with MMA containing all of the required polymerizer, and was stirred for four
hours. The scaffolds were removed from the MMA, placed on a pre-polymerized bed of
PMMA, and covered with the final solution of MMA. The MMA was polymerized at
low temperature, ~4oC until solid.
An unreacted as-made scaffold composed of randomly oriented fibers was
embedded in PMMA for use as a reference for the fibers present in the cross sectioned
histology sections. The PMMA embedded scaffold was sectioned with a slow speed saw
with a diamond coated blade and polished with silicon carbide paper from 320 to 1200
grit. The fibers appear round or ellipsoidal depending on the fiber orientation.
5.3.5

X-Ray Diffraction (XRD)
X-ray diffraction patterns of the recovered scaffolds after four or six weeks in-

vivo were obtained with a PANalytical X’Pert Multipurpose diffractometer. Cu Kα
radiation (0.15418 nm) was used with a counting time of 150 seconds and a step size of
0.0263 degrees. The scaffolds were placed in the diffractometer after dehydration and xrayed in their as-recovered form rather than being ground to a powder.
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5.3.6

Scanning Electron Microscopy Analysis (SEM)
An environmental scanning electron microscope (ESEM) (FEI, Hillsboro, OR)

was used for SEM imaging of cross sectioned scaffolds. The 13-93B3 scaffold implanted
for four weeks was not embedded with polymer or wax but was instead sectioned with a
razor blade. Each scaffold doped with the selected metal ions was embedded with
PMMA and sectioned in half with a slow speed diamond saw. The surface examined by
SEM was polished with silicon carbide polishing paper to 1200 grit, and coated with
~100nm of Au/Pd to SEM analysis. Backscattered SEM, SEMBSE, energy dispersive
spectroscopy (EDS), and SEM phase mapping were used to the characterize the scaffolds.
5.3.7

Micro-Raman Analysis
Micro Raman spectroscopy was used to analyze fibers that had been in-vivo for

six weeks, LabRAM ARAMIS (Horiba Jobin Yvon). A 50x objective was used to view
the fibers and the LABSpec5 software was used to capture the image and analyze the
spectra. A diode laser (785nm) was used with and the collection time was five seconds.
5.3.8

X-ray Fluorescence (XRF)
X-ray fluorescence spectra of as-made glass and scaffolds implanted for six

weeks were obtained with a SPECTRO XEPOS XRF (Spectro Analytical Instruments,
Germany). The scaffolds were ground to a fine powder and pressed into a 30mm tablet.
Spectra were collected for 300 seconds from 6.0 to 10.5 E/kV using a molybdenum target
at 40kV and 0.88mA. Spectra between 13.0 and 17.0 E/kV were collected using an
aluminum target at 49.5kV, 0.70mA for 300 seconds. The XRF software used for peak
analysis was X-LAB Pro software.
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5.4

RESULTS

5.4.1 Sectioned As-Made Scaffold Composed of Randomly Oriented Fibers for
SEM Reference
A scaffold composed of randomly oriented glass fibers embedded in PMMA is
shown in Fig 3. The fibers are dark gray and the PMMA is light gray. Depending on the
fiber orientation, the fibers are circular (longitudinal axis perpendicular to the plane of the
image) or ellipsoidal (not perpendicular to the plane of the image) shapes. During the
heat treatment at 575oC the glass fibers, soften and fuse (bond) together forming a three
dimensional scaffold of self bonded randomly oriented fibers. This is evident from Fig 3
as there are several instances where multiple fibers have bonded. The light gray area
between the fibers is the interconnected open porosity. This cross section of an unreacted
as-made scaffold serves as a guide for the changes that occurred to both the glass fibers
and the interconnected pore space during the in-vivo experiment.
5.4.2

Evaluation of Scaffolds As Recovered from Subcutaneous Tissue
None of the rats died during four or six week experiments, nor did any exhibit

signs of sickness or infection. The images in Fig 4 show the appearance of each scaffold
type while it was still attached to the subcutaneous tissue. Several blood vessels are
visible in the tissue adjacent to each scaffold. The scaffolds containing the copper were
blue prior to implantation (Fig 1D), so the darker color of the reacted scaffolds could be
due to some un-reacted glass or an increase in the number of blood vessels. Most of the
scaffolds had what appeared to be red or pink tissue inside the scaffold indicating that
blood vessels had grown inside the open pores.
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5.4.3

X-ray Diffraction (XRD)
The XRD patterns obtained from the scaffolds implanted in rat subcutaneous

tissue for four to six weeks are shown in Fig 5. The patterns for the 13-93B3, Cu-3 and
CS scaffolds contained identifiable peaks for HA (powder diffraction file (PDF) 721243), but, the peaks were broad and diffuse, most likely due to the nanocrystalline HA
[19]. The HA peak heights decreased in the Cu-3 and CS scaffold patterns. The CSZ
scaffold had broad peaks attributed to HA and much smaller peaks associated with
calcium carbonate in the form of calcite (pdf card 05-0586). The XRD pattern for the
CSZF scaffold contained stronger peaks for calcite only, and no peaks for HA were
detectable. A second CSZ and CSZF scaffolds was x-rayed and the presence of calcite
was confirmed in both scaffolds (patterns not shown).
5.4.4

Microstructure Analysis of Reacted 13-93B3 Fibers (Four weeks In-Vivo)
An SEMBSE image in Fig 6 shows the cross section of a 13-93B3 scaffold after

four weeks in-vivo. The soft tissue that had grown into the scaffold is dark gray, while
the reacted fibers are a lighter gray. Several of the reacted fibers were broken into
smaller pieces during the sectioning procedure; but many of the fibers remained intact.
The center portion of a fully reacted 13-93B3 fiber is shown in Fig 7. The image
in Fig 7A shows the inside surface of the exposed end of a reacted fiber. The center of
the fiber has a relatively rough surface and no original glass is detectable. Figure 7B is a
magnified view of the interior surface of the hollow fiber where nodules can be seen
covering the inside surface of what is believed to be HA (from XRD pattern in Fig 5).
The magnified view of the nodules in Fig 7C, shows that the nodules are composed of a
porous network of nanocrystals, which are magnified in Fig 7D. The needle-like
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structure of the crystals is consistent with that of HA. The crystals are ~50nm in length,
and the microstructure of the crystals is highly porous.
Figure 8 shows another area of the cross section of a reacted 13-93B3 scaffold.
Many of these fibers have a hollow core as was found for the fibers in Fig 7. The two
fibers in the box in Fig 8, marked with arrows, were magnified to examine their cross
sections in more detail. The reacted fiber in Fig 9A, overall diameter of ~170µm, is
surrounded by soft tissue (dark material) and has a layered structure that is especially
prevalent close to the center. The magnified view of the layered structure in Fig 9B
shows ~50 layers in the ~40µm of fiber perpendicular to the hollow center. Ten to
twelve layers are magnified in Fig 9C, and it is apparent that the layers are composed of a
nanocrystalline material. The box in Fig 9C is magnified in Fig 9D, and the individual
layers, ~500nm thick) have a system of struts ~20nm in diameter (arrows) that are
oriented perpendicular to the layers that connect the entire nanostructure.
A magnified view of the smaller fiber (~100µm) in the box in Fig 8 shown in Fig
10 reveals a layered microstructure that is different from that of the fiber in Fig 9. The
layers are thicker and fewer are present. As shown in the magnified view in Fig 11A, the
layers are ~1µm thick and the distance between is ~1µm. Each layer is connected by a
series of struts (~1µm thick) oriented perpendicular to the layer orientation as indicated
by the arrow in Fig 11A. A single layer is magnified in Fig 11B and the crystals look
similar to those seen in the reacted fiber in Fig 7D.
5.4.5

Chemical Analysis of Reacted Scaffolds (Four or Six Weeks In-Vivo)
The cross section of reacted scaffolds shown in Fig 12 is the backscattered SEM

micrograph of the Cu-3 scaffold after six weeks in subcutaneous tissue. The fibers are
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significantly reacted and many appear partially hollow at the center. The ellipsoidal
fibers in the image are due to the random orientation of the fibers.
The fibers composing the CS scaffold in Fig 13 had reacted significantly after six
weeks. Some of the fibers in the bottom left corner of the image in Fig 13, (white
arrows) had a reacted surface that surrounded unreacted glass (gray center), but the
majority of the fibers were fully reacted. Most of the CS fibers had voids at their center
similar to the Cu-3 fibers in Fig 8.
A randomly selected fiber located at the outer edge of the CS scaffold is
magnified in Fig 14. The fiber has reacted with body fluids and has a relatively dense
outer surface, but a less dense center where a layered structure similar to an onion skin or
spider web is visible. The three spots (numbered) in Fig 14 were analyzed by SEM EDS.
Calcium and phosphorus were formed at each spot and the calcium to phosphorus (Ca/P)
ratio for spot 1, 2 and 3 is 1.86, 2.00, and 1.71, respectively (Fig 14). These Ca/P ratios
are reasonably close to that for stoichiometric HA (1.67).
The backscattered SEM image in Fig 15 shows a CSZ scaffold after six weeks invivo. The outer edge of the scaffold is on the right side of the image, and the center of the
scaffold is located toward the lower left. The CSZ fibers at the outer edge of the scaffold
are significantly reacted as there is no detectable glass remaining, but they did not form
partially hollow fibers as did the Cu-3 and the CS fibers. There is a distinct white
material located at the center of many of the CSZ fibers. The CSZ fibers toward the
center of the scaffold (lower left of Fig 15) are not fully reacted, consist of a reacted
surface layer surrounding a solid glass core (black arrows).
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One of the partially reacted CSZ fibers with three distinctly different regions was
chosen (see box in Fig 15) for further analysis (Fig 16). The outer surface of the fiber is
solid (light gray), then there is a relatively thick region that is more porous and has some
layers present (darker gray and layered). The center of the fiber contains a white
material. The Ca/P ratios for the spots 1, 2, 3, and 4 were 27, 2.67, 3.00, and 1.56,
respectively (Fig 16). Spot 4 was the only spot where the Ca/P ratio (1.56) was similar to
that for HA (1.67).
The CSZF fibers shown in Fig 17 were all significantly reacted since the fibers
contained a white material at their center similar to the CSZ fibers. There appears to be
more of the white material in the CSZF fibers, Fig 17, than in the CSZ fibers, Fig 15.
The fiber in the box in Fig 17 was arbitrarily selected for further analysis and a EDS
phase map for calcium, phosphorus, potassium, magnesium, and strontium is shown in
Fig 18. Calcium is present in a thin layer on the outer surface of the fiber, but the
strongest calcium signal is at the center of the fiber. The phosphorus map shows a
similar strong ring close to the outer edge of the fiber, but decreases toward the center,
which contains noticeably less phosphorus.
The elements mapped were magnesium, potassium, and strontium, but none of
these elements were present in detectable amounts. The CSZF fibers only contained
2wt% SrO, so the strontium concentration may have been too low to detect. However,
the absence of the much larger amounts of sodium, potassium, and magnesium in the
CSZF fibers is attributed to their being leached from the fibers while in-vivo.
The fiber in the box in Fig 17 was analyzed by EDS at four spots. The Ca/P ratios
for spots 1, 2, 3, and 4 were 29, 1.60, 1.40, and 1.28, respectively. Spot 2 was in the
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range of Ca/P ratio for HA found in the body (~1.5 to 1.7), but spots 1 was mostly
calcium, and spots 3 and 4 were similar to the Ca/P ratio for octacalcium phosphate
(OCP), Ca8H2(PO4)6-5(H2O), which is 1.33.
5.4.6

Micro-Raman of In-Vivo Reacted Fibers
A 13-93B3 fiber that had been reacted four weeks in-vivo was analyzed at four

points by micro raman across the cross section of the fiber diameter as shown in Fig 20.
A dashed line has been added to outline the perimeter of the fiber to guide the reader. The
micro-raman spectra for the four spots are shown in Fig 21. Spot 1 is at the outer edge of
the fiber and spot 4 is at the center of the reacted fiber. Since the scaffold was mounted
in PMMA, many of the peaks, denoted by the solid vertical lines, are from PMMA [24],
but peaks reported for HA were also present [25]. The peaks associated with HA
(431cm-1 (PO43- v2), 965cm-1 (PO43- v1), 1065 to 1070cm-1 (CO32- v1) and 1076cm-1
PO43- v3) [24] are denoted by dashed lines.
Spots 3 and 4 located near the center of the reacted 13-93B3 fiber in Fig 20 have
the highest intensity for the phosphate and carbonate peaks of the four spots analyzed.
Spot 1 was intended to measure the edge of the fiber, but the measured spot may have
been partially off the fiber (on the PMMA) which would have decreased the intensity of
the peaks associated with the fiber and magnified the intensity of the PMMA peaks. The
presence of a carbonate peak at 1065 to 1070cm-1 (CO32- v1) indicates that the fibers are
carbonated, similar to the HA in natural bone.
The Cu-3 fiber (six weeks in-vivo) shown in Fig 22 was analyzed by micro-raman
at seven spots across the fiber cross section. As shown by the spectra in Fig 23, the
intensity of the HA peaks in spectra 1 to 5 are almost identical indicating no significant
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change in the material from the outer edge to the center. The phosphate peaks in spectra
6 and 7 are noticeably smaller than the other peaks in spectra 1 to 5, which is likely due
to the measurements being made in the partially hollow center of the fiber. There was
also an increase in the intensity of the PMMA peak at 600cm-1 in spectra 6 and 7 further
providing evidence that the beam was in contact with more of the PMMA than the fiber
itself. The presence of CO32- peaks in the spectra indicate that the HA is carbonated
similar to natural bone.
As shown in Fig 24 the CS fiber was analyzed by micro-raman at five spots
across the fiber. The spectra in Fig 25 may have low intensity peaks for HA located at
428cm-1 (PO43- v2) and the broad peak at 1065-1080 which encompasses 1065 and
1070cm-1 (CO32- v1), and 1076cm-1 (PO43- v3), but the 965cm-1 (PO43- v1) peak for HA
was not present in any of the spectra.
The CSZ fiber was measured in ten spots as indicated in Fig 26 and the spectra
are in Fig 27. Spectra 1 to 5 are from the outer edge to the interface between the porous
calcium phosphate and the calcium rich center had no detectable peaks associated with
HA present in the micro-raman spectra. Two new peaks are present in spectra 6 to 10, at
711cm-1 and 1085cm-1. These peaks are associated with CO32- in calcium carbonate in
the form of calcite [26].
The CSZF fiber was analyzed at six spots by micro-raman (Fig 28) and the
spectra are shown in Fig 29. Again, no peaks associated with HA were observed in the
spectra. The peaks for calcite at 711cm-1 and 1085cm-1 were detected at the points inside
the calcium rich center (spots 4 to 6).
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5.4.7

X-ray Fluorescence (XRF) of Fibers After In-Vivo Reaction
The as-made glass fibers were analyzed with XRF to verify the presence of the

minor elements (copper, strontium, zinc, and iron). The spectra for the four as-made
glasses verify the presence of iron, copper, and zinc (Fig 30A) and strontium (Fig 30B).
The amount of copper was almost identical for all four glasses as expected. Iron was
only added to the CSZF glass, but it was detected in each glass due to impurities in the
batch materials. The spectra for zinc in the CSZ and CSZF glasses overlap as shown in
Fig 30A. The amount of strontium present in the three glasses it was added overlap in
Fig 30B. The peak at 7.4E/kV, marked with an arrow, was due to the organic binder in
which the samples were pressed.
The XRF spectra for the six week implanted scaffolds are shown in Figs 31A and
31B. Copper, strontium, zinc and iron were all detected in the scaffolds in which they
were originally added after six weeks in-vivo. The Cu-3 scaffold, which contained small
amounts of strontium, zinc, and iron as impurities (Fig 30), contained similar
concentrations for each impurity after six weeks in-vivo. Copper was almost completely
absent from the Cu-3 scaffold reacted in-vivo (Fig 31A), the copper concentration had
decreased by over 90% of the original concentration (Fig 30A).
The as-made CS scaffolds contained low concentrations of zinc or iron as
impurities in the as-made scaffolds as shown green lines in the XRF spectra in Fig 30.
After six weeks in-vivo, the copper and strontium concentrations in the CS scaffold
decreased by ~90% (blue lines in Fig 31) while the zinc and iron (impurities) remained
similar to the original concentrations.
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Prior to implantation, the as-made CSZ scaffolds contained a low concentration of
iron as an impurity which did not change after the six weeks in-vivo. The concentration
of copper and strontium decreased by 75%, and the zinc concentration decreased by only
~20% from the as-made scaffolds.
The as-made CSZF scaffold had nearly identical concentrations of copper,
strontium, and zinc when compared to the as-made CSZ scaffold, but the iron
concentration (red lines in Figs 30 and 31) was significantly higher than the impurity
levels from the other three scaffolds (Fig 30). After six weeks in-vivo, the metal ion
concentration in the CSZF scaffolds had decreased ~80% for copper, ~75% for strontium,
and ~5% for zinc. The iron concentration was nearly the same in the as-made glass. The
release of metal ions (copper, strontium, and zinc) from the CSZF and the CSZ scaffolds
were similar in comparison.
5.5

DISCUSSION

5.5.1

Scaffold Evaluation and Tissue Analysis during Scaffold Removal
During the removal of the scaffolds from the rats, it was apparent that the

mechanical strength had decreased. The originally rigid scaffolds were soft to the touch
indicating that the fibers had reacted with the body fluids and became pliable. There
were no signs of inflammation or infection at the implant site, or rejection of the scaffolds
from the rats.
Previously, bioactive borate glasses have been studied in-vitro with osteoblasts
for cell proliferation, and the number of cells decreased with increasing time [27]. The
most toxic environment for the cells was observed in static in-vitro cultures. A dynamic
culture of MC3T3-E1 osteoblast cells on disks of bioactive borate glass showed a much
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milder effect on cell proliferation which is thought to be more similar to the in-vivo
environment [27].
Experiments with bioactive borate glasses in-vivo have shown excellent
integration of bone into defects filled with particles of bioactive borate glass [17, 18, 28,
29]. Scaffolds composed of the 13-93B3 glass fibers had significantly more bone
(p<0.05) after 12 weeks in rat calvaria defects than scaffolds with the similar
microstructure and interconnected porosity composed of 13-93 bioactive glass fibers
(Table 1) [22, 30]. No necrotic tissue or increase in macrophages or other inflammatory
cells was reported in the bone tissue encasing the reacted bioactive borate glass fibers
[22, 30]. Systemic toxicity of the kidney and liver has also been studied by in-vivo by
implantation of up to sixteen (70mg each) 13-93B3 fiber scaffolds in Sprague Dawley
rats. No pathological changes were reported in the liver when compared to the control,
and only incidental changes normal in adult rats were reported in the kidney [31].
The relatively high number of blood vessels present in the soft tissue surrounding
the scaffolds upon removal after six weeks in-vivo (Fig 4) can be explained by the release
of copper and zinc from the metal ion containing scaffolds. Jung et al. showed that
scaffolds doped with copper and zinc significantly increased the number of blood vessels
in tissue adjacent to bioactive borate glass fiber scaffolds implanted in the soft tissue of
rats for six weeks [20].
5.5.2. Reaction of Metal Ion Doped Borate Scaffolds In-Vivo
This is believed to be the first time that bioactive glasses containing calcium have
been found to convert to a material other than a calcium phosphate such as HA when
reacted in-vivo. Conzone and White reacted rare earth containing borate glasses in-vivo
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and formed rare earth phosphate materials, but those glasses contained no calcium [29,
32]. The XRD patterns of the reacted scaffolds in Fig 5 show a progressive change from
HA to calcite as the strontium, zinc, and iron were added to the bioactive borate glass.
The minor elements having the largest negative effect on the conversion of the glass to
HA were zinc and iron. The first XRD peaks for calcite appeared with the addition of
zinc in the CSZ scaffold. With the addition of 0.4wt% Fe2O3, there were no detectable
peaks for HA in the XRD pattern for the CSZF scaffold, Fig 5. The only detectable
crystalline material present was calcium carbonate (calcite).
Calcite is a polymorph of calcium carbonate that can be found in nature in both
seashells and coral [33]. Degradable scaffolds composed of calcite have been shown to
promote bone marrow induced osteogenesis better than a comparable hydroxyapatite
scaffold [33]. Calcite has been reported to remodel at a faster rate than natural or
synthetic HA [34] and tricalcium phosphate [35] through in-vitro osteoclast excavation
experiments. Bone cement filled with calcite powder has also been made for biomedical
use [36]. The presence of calcite in the reacted CSZ and CSZF fibers is therefore
thought in general to be good for tissue engineering of bone and other tissues.
The copper addition to 13-93B3, Cu-3 glass, increased the time required to fully
convert a scaffold of similar size and microstructure from four weeks to six weeks, but
the micro-raman spectra for the Cu-3 glass showed carbonate and phosphate peaks
indicative of HCA [25]. The increase in time required for the conversion of the glass
may be explained by previous work by Madsen where copper was found to slow the
formation of calcium phosphates in-vitro [37]. The addition of strontium to the CS glass
completely eliminated the 965cm-1 (PO43- v1) raman peak (Fig 28) indicating that the
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formation of calcium phosphate was being inhibited. The addition of zinc eliminated the
remaining phosphate peaks in the CSZ fiber. Instead of becoming partially hollow like
the Cu-3 and CS fibers, the CSZ fibers formed a calcite center. This change in reaction
may be explained by the strong inhibition zinc has on HA formation [38]. The CSZ glass
contained copper which likely caused the decreased formation of calcium phosphate
initially, and the addition of strontium and zinc further inhibited HA formation (Fig 5).
The combination of these three elements (Cu, Sr, Zn) could also have enhanced the
inhibition of HA formation due to multiple mechanisms of inhibition working together.
The CSZF fibers contained more calcite present in their center than the CSZ fibers. This
is likely due to the addition of a fourth known calcium phosphate inhibiting element Fe2+
and/or Fe3+ [38].
The formation of calcium carbonate at the center of the CSZ and CSZF fibers is
not surprising if there are free calcium ions that are not bonded to phosphorus. There are
carbonates in body fluids [39], and in aqueous solutions, calcium carbonate is sparingly
soluble (6.6mg/L) in aqueous solutions like body fluids [40]. Hydroxyapatite has a
solubility of ~5mg/L at pH = 7.3, and there are no other calcium compounds with a
calcium solubility between HA and calcite [40].
The pH that is present in the fluids inside the reacted fibers is not known, but as
with calcium phosphate crystallization, pH is a factor in the material formed (example,
calcium carbonate) or the phase of the material (example, calcite, aragonite, or vaterite).
Calcite and aragonite have the same reported aqueous solubility (6.6mg/L) [40] but
calcite is the favored phase at pH 7.3. Vaterite has a solubility of 11mg/L [40], and
therefore is a less preferable phase for precipitation than either calcite or aragonite.
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The scaffolds that converted to a mixture of HA and calcite (CSZ and CSZF)
retained most of the metal ions in either the soft tissue or the reacted fibers as determined
by XRF. The EDS spectra for calcium rich portion of the CSZ and CSZF fibers (not
shown) had small peaks for strontium. A solid solution of strontium calcium carbonate
does exist, and has its highest intensity XRD peak is at 29.879 degrees 2θ (PDF card 840591) as opposed to 29.430 degrees 2θ for calcite (PDF card 05-0586). A slight shift in
the XRD pattern of the CSZ and CSZF patterns would be difficult to interpret since the
patterns were relatively low in intensity and the peaks were broad (Fig 5). Therefore,
strontium may have been substituting in the calcium sites in the calcite structure and
forming a solid solution.
The release of the elements into the surrounding soft tissue would be an important
finding as the doped glasses could be used to promote healing of wounds by controlled
ion release. Evidence that the ions were released from the glass and promoted a positive
biological response in the surrounding tissue is shown by the vascular growth adjacent to
and inside the minor element doped scaffolds (Fig 4).
5.5.3 Microstructure Analysis of Reacted Bioactive Borate Glass Fibers (Layered
Microstructure)
After four weeks in-vivo, the 13-93B3 fibers were fully reacted and converted to a
carbonated HA. The reaction of the fibers is interesting in that the microstructure of the
calcium phosphate changes from forming a thick monolayer of HA to a multilayered
structure. The thickness and periodicity in the layered structure also appear to be linked
to the original fiber diameter. The larger the fiber diameter (~170µm) had about 50
layers (500nm thick) with a ~500nm periodicity (Fig 9). The smaller diameter fiber
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(~100µm) had only about seven to eight layers with a layer thickness of ~1µm with a
~1µm distance between the layers (Fig 10).
The microstructure similar to those in Figs 8 to 11 and Fig 14 has been seen in
reacted bioactive borate glasses in-vivo [17, 19, 29] and in-vitro [29, 41]. Conzone [29]
suggested the formation of the layered structure could result from convection currents of
fluids at the glass to dysprosium phosphate (DyP) layer interface. After ~ 3 to 5µm of
layer formation, the glass core was hypothesized to detach from the DyP layer and start
the layer forming process again.
A reaction similar to that reported by Conzone [29] occurred in the fiber shown in
Fig 9, but the layer thickness was only ~500nm and there are struts connecting the layers
which contradict the shell formation by convection current model. The layers in Fig 10
are also connected, but with larger struts than in Fig 9. The well defined thickness of the
nanocrystalline layers and the almost fixed distance between the layers could be due to
the deposit of an amorphous calcium phosphate gel that, in the process of crystallizing,
shrinks in size while the next layer of calcium phosphate gel has already started forming.
The formation of the struts could be due to epitaxial growth of crystals from the
crystallized layer to the amorphous gel layer since the surface of the crystallized layer
could promote crystal growth from its surface. The strut could also act as a seed crystal
for the crystallization of the next layer.
The process of deposition and precipitation through a porous material should
remain similar as the body fluids flow and could be an explanation for the layered
microstructure. The difference in the layer thickness for different diameter fibers could
be due to the differences in diffusion of phosphate from the body fluids through the fiber.
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As the fiber diameter increases, thinner layers might be expected if the phosphate had to
diffuse a longer distance. The smaller diameter fibers would have more phosphate
available in a shorter distance, hence form fewer and thicker layers.
Both the Cu-3 and CS fibers reacted to form microstructures similar to 13-93B3
in-vivo. Evidence that a change had occurred in the reaction of the minor element doped
glass fibers was first noticed in the microstructure of the CSZ fibers. The distinctly
different material at the center of the fiber as shown by the SEMBSE image in Fig 15 and
the diffuse calcium phosphate layers surrounding it was different from any reacted
bioactive glass microstructure seen before.
The reacted CSZF fiber in Fig 32 had a similar structure to the CSZ fiber in Fig
15 in that it first formed a surface layer of calcium phosphate, but only about 2µm thick,
and then began forming a highly porous and low density calcium phosphate that
eventually changed to a porous layered structure. This porous layered structure is
significantly different from the relatively thick mono layer at the surface of the 13-93B3
fiber (Fig 10). The layered structure started in the porous HA region of the fiber and
continued into the calcium rich center. The thicknesses of the calcium rich layers in the
CSZF fiber (Fig 35) were noticeably thicker than the calcium phosphate layers adjacent.
The varied thickness of the layers could be due to differences in the precipitation of HA
versus the calcite.
5.5.4

Reaction of Metal Ion Doped Bioactive Glasses
There is little published work in the area of bioactive glasses doped with metal

ions. Glasses such as the well known 45S5 have been doped with up to 20wt% zinc [42]
and after 30 days in simulated body fluid, two phases in separate calcium phosphate

208
layers were discovered, a normal HA layer, and a zinc containing calcium phosphate
phase CaZn2(PO4)2-2H2O [43]. Tape cast 45S5 bioactive glass soaked with a silver
containing solution formed HA [44]. Pan et al found that adding strontium to borosilicate
glass significantly reduced the cytotoxic effects of the glasses in-vitro, and the glasses
converted to HA. Fluorine has been added to silicate based bioactive glass but HA was
formed [45]. Boron has been added as a minor constituent (3wt%) to silicate based
bioactive glasses [2], as a glass former in a borosilicate bioactive glass [13, 46], and as
the major glass former in borate based bioactive glasses [13, 15, 19, 46], and all
converted to HA.
5.5.5

Role of Metal Ions in Calcium Phosphate Formation
Madsen studied the influence foreign metal ions had on the conversion of brushite

(CaHPO4-2H2O) to OCP and to HA. He found that several transition metal ions decrease
the conversion rate or significantly poison the reaction [38]. Both Cu2+ and Zn2+ were
found to be strong inhibitors to HA crystal growth. Sr2+, Fe2+, and Fe3+ were described as
intermediate as opposed to strong, but nonetheless act as inhibitors during HA
crystallization [38]. Bigi et al. found that Mg2+ and Sr2+ are important in determining
what calcium phosphate phase is formed as pH varies in a simulated aqueous solution
[47]. TenHuisen et al studied the effect Mg2+ on HA formation in-vitro, and found that
concentrations of Mg2+ below 1mM had no effect on HA crystallization [48].
Concentrations of Mg2+ between 1mM and 2.5mM changed the shape of the HA crystals
formed but not the kinetics, and concentrations greater than 2.5mM slowed the overall
reaction kinetics [48]. Madsen found that Cu2+ ions initially inhibit calcium phosphate
precipitation on a brushite substrate in dilute phosphate solution by surface adsorption
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[37]. The Cu2+ coated surface layer eventually diffuses into the interior of the brushite
crystal clearing the surface to nucleate and grow calcium phosphate [37].
Not all metal ions inhibit the growth of HA. Nickel and lead have been found to
promote HA formation in-vitro [38]. The Ni2+ and Pb2+ ions can substitute for calcium
ions in calcium phosphates and act as nucleating agents, however, Ni2+ ions have been
reported to promote the growth of irregular crystals [38]. Chromium ions (Cr3+) have
been suggested as both a strong inhibitor [38] and a strong promoter [49] of calcium
phosphate growth, but, the two experiments were completed at different pH values and
chromium concentrations.
To better understand why certain ions inhibit or promote HA formation, the ionic
radius of several ions (6 - coordinated) [50] were plotted against an arbitrary scale of 0 to
5 in Fig 33, where 0 represents no HA inhibition, and 5 represent severe HA inhibition as
reported in the literature [38]. The inhibition of HA appears to trend with decreasing
atomic radius as compared to the radius of calcium. This helps to explain why
aluminum, which has a small radius (0.53 Å) has been reported as a poison to HA
formation in bioactive glass [2], and why the CSZ and CSZF glasses from the present
work, which have zinc (0.75Å) and iron (0.61Å for Fe2+and 0.65Å for Fe3+) stopped
forming HA and formed another calcium compound, calcite.
5.6

CONCLUSIONS
Scaffolds composed of randomly oriented bioactive borate glass fibers, some

doped with copper, strontium, zinc and iron were implanted in subcutaneous tissue of rats
fully and reacted with body fluids for four to six weeks. Each rat remained healthy
during the course of the experiment; there were no signs of sickness in the rats or
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infection at the implant sites. The metal ions in the doped scaffolds were released to the
surrounding tissues and/or incorporated into the calcium containing reaction products as
the glasses reacted with body fluids.
For the first time, a calcium containing bioactive glass converted to a non-calcium
phosphate when implanted in-vivo. Calcium carbonate in the form of calcite was
deposited at the center of the CSZ and CSZF bioactive glass fibers. The calcite formation
was likely due to inhibition of calcium to bond with phosphorus caused by the addition of
the metal ions. The formation of calcite could be an improvement in scaffold resorption
as osteoblasts can remodel calcite faster that HA into new bone.
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TABLES

Table 1 - Bioactive Glass Compositions (wt%)

KzO

MgO

Si0 2

PzOs

C uO

SrO

ZnO

Fe 20 3

0

0

45.00

6.00

0

0

0

0

20.00

12.00

5.00

53.00

4. 00

0

0

0

0

6.00

20.00

12.00

5.00

0

4. 00

0

0

0

0

52 .79

5.98

19.92

11.95

4. 98

0

3.98

0.40

0

0

0

cs

5 1.73

5.86

19.52

11.7 1

4. 88

0

3.90

0.40

2.00

0

0

csz

5 1.20

5.80

19.32

11.59

4. 83

0

3.86

0.40

2.00

1. 00

0

CSZF

50.88

5.76

19.20

11.52

4. 80

0

3.84

0.40

2.00

1. 00

0.40

Glass

B z03

Nap

CaO

4585

0

24. 50

24. 50

13-93

0

6.00

13-9383

53.00

Cu-3
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FIGURES:

Figure 1 – Figure 1A shows some chopped fiber 2 to 3mm in length, 100 to 300µm in
diameter, used for making scaffolds. Figure 1B shows a ceramic mold used to hold the
fibers during the heat treatment. Figures 1C and 1D are examples of an as-made 13-93B3
and Cu-3 scaffolds that weighs 70mg and has dimensions of 7mm in diameter and 2mm
thick. Scaffold porosity is 50±2%.
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Figure 2 – Schematic showing the four subcutaneous scaffold implant sites located on the
back of a rat. The dashed line represents the spine as a reference.
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Figure 3 – Bioactive borate glass scaffolds doped with minor elements after implantation
in rat subcutaneous tissue. The images show a representative scaffold after six weeks in
subcutaneous tissue for the Cu-3, CS, CSZ, and CSZF scaffolds and a 13-93B3 scaffold
after four weeks.
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Figure 4 – Optical micrograph of a cross sectioned randomly oriented bioactive glass
fiber scaffold. The fibers are gray and look like circular or elliptical depending on the
fiber orientation. The scaffold was impregnated with PMMA as indicated to support the
fibers during the sectioning and polishing.
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Figure 5 – XRD patterns for randomly oriented borate bioactive glass fiber scaffolds with
added minor elements implanted in rat subcutaneous tissue for six weeks (13-93B3 was
implanted four weeks). Scaffolds had an original mass of 70mg and were 7mm in
diameter and 2mm thick. Cu or C = copper, S = strontium, Z = zinc, F = iron.
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Figure 6 – SEMBSE micrograph of a cross sectioned 13-93B3 scaffold after four weeks
in the subcutaneous tissue of a rat. The soft tissue (dark gray) is surrounding reacted
fibers are light gray.
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Figure 7 – High magnification SEM micrographs of reacted 13-93B3 fibers after four
weeks in the subcutaneous tissue of a rat. Figure 7A of a sectioned fiber showing the
hollow center and the wall of the reacted fiber. Figure 7B is a magnified view of the
surface of the hollow reacted 13-93B3 fiber in Fig 7A. Figure 7C is a magnified view of
the nodules in Fig 7B. Each nodule consists of a porous nanocrystalline structure as
shown in Fig 7D. Figure 7D shows the surface of a porous nodule.
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Figure 8 – SEM micrograph of a 13-93B3 scaffold cross section after four weeks in-vivo.
The cross sections of two reacted fibers (arrows) are further analyzed in Figs 9 to 11.

223

Figure 9 – SEM micrographs of a reacted 13-93B3 fiber in rat subcutaneous tissue for
four weeks.
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Figure 10 – Appearance of the cross section of the smaller reacted 13-93B3 fiber (four
weeks in-vivo) in Fig 8.
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Figure 11 – SEM micrographs of the layered microstructure present at the center of the
reacted 13-93B3 fiber in Fig 10. Figure 11A shows several layers, but here a thick strut
(arrow) is present connecting the layers. The image in Fig 11B is of a single layer, and it
is apparent that the layers are polycrystalline and composed of nanocrystals.
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Figure 12 - SEMBSE image of a cross sectioned Cu-3 fiber scaffold that had been
implanted in the subcutaneous tissue of a rat for six weeks.
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Figure 13 - SEMBSE image of a cross sectioned CS fiber scaffold implanted
subcutaneously in a rat for six weeks. A majority of the fibers are excavated (partially
hollow) from reaction with body fluids.
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Figure 14 - SEMBSE image of a CS fiber implanted subcutaneously in the back of a rat
for six weeks. The Ca/P ratio of the fiber at the three spots is shown in the figure.
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Figure 15 - SEMBSE image of a cross sectioned CSZ fiber scaffold that was implanted
subcutaneously in the back of a rat for six weeks.
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Figure 16 - SEMBSE image of a CSZ fiber implanted subcutaneously in the back of a rat
for six weeks.

231

Figure 17 – SEMBSE image of the cross section of a CSZF fiber scaffold that was
implanted subcutaneously in a rat for six weeks.
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Figure 18 - EDS phase map of CSZF reacted fiber after six weeks in rat subcutaneous
tissue. The SEMBSE image at the bottom right of the image is for reference.

233

Figure 19 - SEMBSE image of a CSZF fiber implanted subcutaneously in a rat for six
weeks.

234

Figure 20 – Optical image of a 13-93B3 fiber reacted in rat subcutaneous tissue for four
weeks, mounted in PMMA, and cross sectioned. The outer perimeter of the fiber is
denoted by a dashed line, and the center and outer edge of the fiber are labeled as
indicated. The four spots inside the fiber were analyzed by micro raman and the spectra
are shown in Fig 21.
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Figure 21 – Micro raman spectra for a 13-93B3 fiber that was implanted in rat
subcutaneous tissue for four weeks. The peaks associated with HA are indicated by the
dashed lines at (431cm-1 (PO43- v2), 965cm-1 (PO43- v1), 1065 to 1070cm-1 (CO32- v1) and
1076cm-1 PO43- v3) and the solid lines are for the mounting medium PMMA.
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Figure 22 – Micro-raman analysis of a Cu-3 fiber that reacted while in contact with rat
subcutaneous tissue for six weeks. The spot size of the laser was 2µm, and is
approximated by the size of the indicator diamonds.
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Figure 23 – Micro-raman analysis of a Cu-3 fiber that reacted while in contact with rat
subcutaneous tissue for six weeks. The light gray lines represent peaks associated with
PMMA, and the pattern for PMMA is at the top of the figure.
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Figure 24 – Micro-raman analysis of a CS fiber that reacted while in contact with rat
subcutaneous tissue for six weeks. The fiber was measured at five spots from the outer
edge (1) to the center (5) and the spectra are shown in Fig 25. The red line through the
image has no meaning and was an artifact of the micro-raman software. The spot size of
the laser was 2µm, and is approximated by the size of the indicator diamonds.
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Figure 25 – Micro-raman analysis of a CS fiber that reacted while in contact with rat
subcutaneous tissue for six weeks. The light gray lines represent peaks associated with
PMMA, and the spectrum for PMMA is shown at the top of the figure.
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Figure 26 – Micro-raman analysis of a CSZ fiber that reacted while in contact with rat
subcutaneous tissue for six weeks. The spot size of the laser was 2µm, and is
approximated by the size of the indicator diamonds.
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Figure 27 – Micro-raman analysis of a CSZ fiber that reacted while in contact with rat
subcutaneous tissue for six weeks. The micro-raman spectra for each of the 10 spots are
shown above, outer edge (1 E) to the center (10 C). The peaks associated with calcite,
(CaCO3), are indicated with a dashed line at 711/cm-1 and 1085/cm-1.
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Figure 28 – Micro-raman analysis of a CSZF fiber that reacted while in contact with rat
subcutaneous tissue for six weeks. The fiber was measured at six spots from the outer
edge (1) to the center (6). The red line through the image has no meaning and was an
artifact of the micro-raman software. The spot size of the laser was 2µm, and is
approximated by the size of the indicator diamonds.
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Figure 29 – Micro-raman analysis of a CSZF fiber that reacted while in contact with rat
subcutaneous tissue for six weeks. The micro-raman spectra for spots one to six are
shown above, outer edge (1 E) to the center (6 C). Calcite had peaks present in spectra
four to six which are indicated with a dashed line at 711/cm-1 and 1085/cm-1.
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Figure 30 – XRF spectra for the as-made bioactive borate glasses doped with minor
elements. Copper (Cu or C), strontium (Sr or S), zinc (Zn or Z), iron (Fe or F). The
arrow in Fig 30A is indicating a peak associated with the polymer binder used to mount
XRF sample. It is noted that the CS, CSZ, and CSZF patterns for Sr overlap in Fig 30B.
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Figure 31 – XRF spectra for each type of bioactive borate glass scaffold doped with
minor elements that were implanted in subcutaneous tissue of rats for six weeks. Copper
(Cu or C), strontium (Sr or S), zinc (Zn or Z), iron (Fe or F). The arrow in Fig 31A is
indicating a peak associated with the polymer binder used to mount XRF sample.
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Figure 32- High magnification SEMBSE image of the reacted CSZF fiber (six weeks invivo).
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Figure 33 – Schematic relating how hydroxyapatite formation is inhibited by the presence
of six coordinated ions in aqueous environments 37-38,50.
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6.1 ABSTRACT:
A pad of micron and submicron borate glass fibers was used to treat 15mm full
thickness cutaneous wounds of rats and by 15 days the wound area decreased by 85 to
90% of its original size. The dermal, epidermal, and subcutaneous tissues in all four of
the 93B3 fiber filled wounds were significantly regenerated by day 22 while only three
out of four wounds from the control group (untreated wound) regenerated the
subcutaneous tissue. There were no signs of infection present in either the control or
93B3 fiber filled wounds. The wound contraction, the thickness of the granulation tissue
and the gap present in the subcutaneous tissue layer after 22 days were all measured and
compared via the student t test. There were no statistically significant differences
between the control and 93B3 fiber filled wounds. No 93B3 fibers were identifiable in
the histological sections at 22 days, but there was evidence of 93B3 microspheres that
had reacted with the body fluids and formed hydroxyapatite (HA). Blood vessels were
seen adjacent to many of the reacted 93B3 microspheres indicating that the boron
released (dissolved) from the microspheres could be promoting an angiogenic effect that
is important to wound management and healing.
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The advantages of using the 93B3 glass fibers for wound healing are as follows:
• The 93B3 fibers are biocompatible and biodegradable
• The boron released from the glass is potentially angiogenic
• The release of lithium and sodium from alkali borate glasses has been shown to be
anti-bacterial
• The 93B3 glass reacts quickly with body fluids releasing calcium that has been
linked to regulating healing in skin
• There were no signs of inflammation surrounding any of the reacted 93B3 glass
fibers or microspheres

6.2.

INTRODUCTION
For decades bioactive glasses have been known to bond with both hard and soft

tissue 1. The majority of the research on bioactive glasses has been directed at the
regeneration of bone, but recently, there has been interest in the effects that bioactive
glasses may have on soft tissue. The promotion of soft tissue growth such as blood
vessels in the presence of bioactive glass has recently sparked interest in using bioactive
glass to regenerate soft tissue. Leach et al coated a polymer based, vascular endothelial
growth factor releasing scaffold with bioactive glass particles and successfully promoted
blood vessels growth in-vitro 2.
Soft tissue interactions with bioactive glass have been studied for soft tissue
augmentation and for understanding how bioactive glass interactions at the bone to soft
tissue interface. Fibers of a 13-93 glass, a silicate based bioactive glass, coated with
chitosan were implanted in rabbit soft tissue for up to 24 weeks 3. The immune response
was described as generally mild, and soft tissue was present throughout the bioactive
glass implants. Fu et al implanted mesenchymal stem cell seeded 13-93 bioactive glass
scaffolds in subcutaneous sites of rats for the purposes of bone growth, however,
significant vascular growth adjacent to the outer surfaces of the scaffolds was noted on
removal. Histological assessment from rats showed that significant soft tissue filled the
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inside of the open pores in the scaffold 4. Scaffolds composed of randomly oriented
fibers and scaffolds with a microstructure similar to trabecular bone composed of 13-93
glass implanted in rat soft tissue were reported to have significant soft tissue growth
inside the open pores at six weeks. No significant immune reaction was noted upon
removal of the scaffolds, and vascular growth adjacent to the outer surface of the
scaffolds was also noted 5.
Calcium, a significant component in most bioactive glasses has been reported to
be an important factor in the wound healing of skin 6. It is suspected that calcium is
required for the migration of epidermal cells and also plays an important role in the late
stages of healing 6. The presence of calcium in the immediate vicinity of an open wound
could help the body to regulate wound healing processes more effectively, especially in
open wounds. Human keratinocytes (main type of cells of the epidermis also known as
basal cells) require <0.5mM calcium to proliferate, but fibroblasts (cells that synthesize
extracellular matix and collagen) need a concentration >1.4mM. At higher calcium
concentrations, keratinocyte proliferation is suppressed, but other biological markers for
cell differentiation required for wound healing are promoted 6.
The use of growth factors for treating wounds has not been very successful 7. The
body needs growth factors at certain time intervals to be effective in faster healing, but it
is difficult to time the release effectively during treatment. The most effective treatment
for wounds has been covering the wound and allowing the body to naturally support the
delivery of growth factors or other required nutrients 7.
In an in-vitro study, borate glasses were found to have beneficial antibacterial
effects 8. Lithium borate glasses when placed in culture with several harmful bacteria
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such as escherichia coli (ecoli), salmonella typhimurium (salmonella), and
stapphylococcus aureus (staph), have all been shown to kill the bacteria due to the local
increase of pH from the release of alkali (Li) to the immediate surroundings 8. The
ability to reduce or eliminate bacterial growth at the site of an open wound would be
advantageous, especially without the need for antibiotics.
Traditionally, bioactive glasses have been silicate based and react relatively
slowly with the body fluids over a period of several months 3,9,10. Bioactive glasses
containing boron as the glass former have been shown to react with simulated body fluids
up to five times faster than silicate glasses in certain in-vitro experiments 11,12. Fibers (up
to 300µm in diameter) of the bioactive borate glass 93B3 have been shown to fully react
in four weeks in rat subcutaneous tissue with no noticeable immune reaction. Soft tissue
and blood vessels were present inside many of the reacted fibers.
Due to the faster reaction of the borate glass when in contact with body fluids, its
biological compatibility, its release of calcium in the immediate wound site, and its
potential antibacterial effect, an investigation of a bioactive glass in the form of
submicron fibers was undertaken. Borate glass fibers (300nm to 2µm diameter) were
made and used as a bandage material to treat full thickness cutaneous wounds. After 22
days, the rate of wound closure was similar between the treated and untreated wounds,
but there may be advantages in terms of wound quality (growth and functionality of
tissue) of the treated wounds as compared to the untreated wound.
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6.3.

MATERIALS AND METHODS

6.3.1

Preparation and Sterilization of Bioactive Glass Fibers
The glass fibers used as the wound dressing were made from a borate glass with a

nominal composition of 53 B2O3, 20 CaO, 12 K2O, 6 Na2O, 5MgO, 4 P2O5 (wt%)
denoted as 93B3. The glass was melted in a platinum crucible for one hour at 1050oC
and stirred every ten minutes prior to casting the melt on a cold copper plate. The 93B3
fibers (shown in Figs 1 and 2) were made by a proprietary process (Mo-Sci Corporation,
Rolla, MO). The bioactive 93B3 glass fibers were sterilized by placing ~150mg of fiber
in a silica glass vial with an aluminum foil top, heating the vial to 300oC in an oven (Ney
Vulcan 3-130) for four hours, and cooling the oven overnight to room temperature
whereupon the sterile fibers were ready for use.
6.3.2

Animals
Four male Sprague Dawley rats supplied by Fisher Scientific (St. Louis MO) were

used in the experiment. The rats were approximately four months old, and weighed about
250 grams each. The rats had free access to tap water and food pellets and were caged
individually.
6.3.3

Surgical Procedure
Each rat was shaved to remove the hair at the surgical site (Fig 3) and disinfected

with iodine and 70% ethanol solution prior to the surgical procedure. Two full thickness
cutaneous defects, 15mm in diameter, were made in the skin, one on each side of the
spine above the shoulders, see Fig 3. One defect was covered with a dry pad of bioactive
93B3 glass fibers (150mg) while the other defect was used as a control and left empty,
see Fig 4.
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The wound covered with the glass fibers was staggered, alternatively between the right
and left side for successive rats. After the surgery, bandages were placed over the glass
fiber pad at the wound sites for four days over the control wounds.
6.3.4

Cutaneous Wound Recovery, Fixation, and Dehydration
After 22 days, the animals were sacrificed by CO2 inhalation. A section of soft

tissue ~20mm by 20mm on an edge surrounding the wound was recovered for
histological assessment. The tissue was placed in a 10% formalin solution for four days
and then dehydrated by microwave dehydration with a series of ethanol solutions from
80% to 100% 13.
6.3.5

Sample Embedding and Slide Preparation
The dehydrated tissue sections were cut in half, one half stored in ethanol, and the

other half placed in a tissue processor (AutoTechnicon Model 2A) for wax embedding.
The tissue sample was infiltrated with wax (Paraplast Tissue Embedding Medium,
McCormick Scientific LLC) for a minimum of four hours at 45oC before being embedded
in a wax block with a paraffin mounting system (Leica EG 1150H). The wax block was
placed in a microtome (Leica RM 2235 microtome) and 18um thick sections were cut
with TBS Shur/sharp blades, (Triangle Biomedical Sciences, Durham NC). The sections
were floated on a warm water bath (Lipshaw Electric Tissue Float, model number 375,
Detroit MI) (40oC) to improve the flatness of the sections and then mounted on a glass
slide (Fisher Brand Superfrost microscope slides, St. Louis MO). The mounted slides
were placed on a slide drier (Fisher Scientific slide warmer, St. Louis MO) overnight to
dry the tissue sections.
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6.3.6

Wound Healing Assessment
The dimensions of the open wounds was measured periodically and the area of

the open wound (unhealed) was calculated as a function of time. An example of the
healing progression for a control wound and wound treated with 93B3 glass fiber pad is
shown in Fig 5. The wound area as a function of time, the gap in the subcutaneous tissue
(distance between the sides of the wound) at 22 days, and the average thickness of the
granulation tissue present at 22 days were measured and compared by the student t test to
determine statistical differences between the control and wounds treated with the 93B3
glass fiber pad.
6.3.7

Histological Staining – Hematoxylin and Eosin (H&E)
H&E staining of the histological sections was done with a Leica CV Autostainer

XL (Phelps Country Regional Medical Center, Rolla MO). Stained slides were viewed
with a microscope (Olympus BX50, Olympus Optical Co) at magnifications of 200, and
400x and imaging software (DP Controller, Olympus Optical Co) was used to capture
images.
6.3.8

Scanning Electron Microscopy (SEM)
Fibers of the 93B3 glass were imaged with a Hitachi S4700 FESEM (see Fig 2).

The fibers attached to an aluminum stub with carbon tape and were coated with ~100Å of
gold palladium prior to examination. The accelerating voltage was 10kV and the
magnification used varied from 70 to 7000x.
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6.4.

RESULTS

6.4.1

Histological Assessment of the Wound Sections (H&E)
All four of the H&E stained sections for the control wounds are shown in the

composite photos in Fig 6. The dark horizontal line (at the top of the sections) represents
the area of the wound where the two sides of the wound joined and were in the process of
healing. In Figs 6A, 6C, and 6D granulation tissue is present at the top of the wound
(black arrows). The wound in Fig 6B had healed to the point where the granulation tissue
had been replaced by dermal and epidermal tissue. The wound sections in Figs 6A and
6B have a band of subcutaneous tissue (bright pink) spanning the bottom of the entire
wound area. Figure 6C has subcutaneous tissue present on the right hand side of the
wound (black arrow), but there is no subcutaneous tissue present at the wound interface
(black line, top of image) or on the entire left side of the section. The gap in the
subcutaneous tissue (double ended arrow) in Fig 6C was the longest of any tissue section,
control or 93B3 glass fiber treated, at 12.7mm. The section in Fig 6D has a 4mm gap
(double ended arrow) located at the interface between the two sides of the wound.
A composite photo of the sections from the wounds filled with the pad of 93B3
fibers is shown in Fig 7. The black horizontal line shows the region were the two sides of
the wound came together. Granulation tissue present in Figs 7B, 7C, and 7D, as
indicated by the arrows. No granulation tissue was observed in Fig 7A as it had been
replaced with dermal and epidermal tissue. A small gap (<2mm) was present in the
subcutaneous tissue (double ended arrow) in Figs 7A and 7B, a larger gap (~4mm) was
present in Fig 7C and there was no detectable gap in the subcutaneous tissue in Fig 7D.
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No evidence was found of the 93B3 fibers in Fig 7, but the small fiber diameter would
make them difficult to see at the magnifications used for the histological analysis.
The 93B3 fiber filled wound in Fig 7A, was selected for histological analysis.
The entire tissue section and selected magnified areas are shown in Fig 8. The
approximate boundary of the original wound is indicated by the horizontal arrow in Fig
8A.
Evidence of the original wound is indicated by the presence of the larger, reacted
93B3 microspheres distributed throughout the subcutaneous tissue, see Figs 8B, 8C, 8D,
and 8E. In Fig 8B, the reacted microspheres are at the bottom left of the image, and
above them there are hair follicles (vertical arrows) and fat deposits (oval) that are
indications that the tissue has not scarred, but in fact returned to its original function. The
microspheres in Fig 8B are magnified in Fig 8C, and adjacent to the top of the reacted
microsphere is a blood vessel filled with red blood cells (white arrow). In the unhealed
portion of the wound in Fig 8A, boxes D and E, more reacted microspheres are present
along with blood vessels nearby (see Fig 8D and 8E). The two vertical dashed lines in
Fig 8A show the region where the subcutaneous tissue has yet to regenerate, but the
dermal and epidermal layers have completely replaced the granulation tissue.
6.4.2

Wound Healing Assessment
The wound area that remained open during the healing process was calculated as

a function of time as shown in Fig 9. The average wound area (n=4) for the control was
slightly less than that for the wounds treated with the 93B3 fiber pad up to day 11, but, by
day 15 the fiber treated wounds and the control wounds were almost the same. After 18
days, the control and 93B3 fiber filled wounds were >99% closed as shown in Fig 9 and
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all the wounds were completely closed by day 22. The wound closure data was
compared via the student t test, but there was no statistical difference (p<0.05) between
the control and the wounds treated with the 93B3 fiber pad (see Table 1).
The average gap between the subcutaneous tissue and the thickness of the
granulation tissue was also measured to differentiate any differences in healing between
the control wounds and the wounds treated with the 93B3 fiber pads. The average gap in
the subcutaneous tissue was 4.2±6mm for the control and 1.9±1.6mm for the 93B3 fiber
filled wounds. The average thickness of the granulation tissue for the control wounds
and 93B3 fiber filled wounds was 1.7±1.2mm and 1.7±1.3mm, respectively, see Fig 10.
There was no statistically significant difference between the control wounds and the
93B3 fiber filled wounds for the average gap in subcutaneous tissue or the thickness of
the granulation tissue when compared by the student t test (Table 1).
6.5.

DISCUSSION AND CONCLUSIONS
The composition of the bioactive 93B3 glass has already been discussed in some

detail for why it was chosen for a wound healing application. Borate glasses, specifically
lithium borate glasses, have been shown to have antibacterial effects when placed in the
presence of escherichia coli, salmonella typhimurium, and stapphylococcus aureus 8. The
high alkalinity of the aqueous environment was determined to be responsible for killing
the bacteria. The 93B3 glass fibers, also a high alkali containing borate glass, would be
expected to have a similar response on killing bacteria and would do so without the need
for antibiotics. The possible antibacterial effect, the release and benefits of calcium to
wound healing, the biological compatibility of the glass, and the fast reaction time all
were considered important to the performance of the 93B3 glass in wound healing.
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The 93B3 glass converts to hydroxyapatite (HA), the same material found in the
inorganic component of bone, when in contact with body fluids. Hydroxyapatite is a
compatible material with living mammalian tissues, and HA has considerable use as a
filler to increase skin thickness 14.
The micron and sub-micron sized fibers shown in Figs 1 and 2 are compressible
similar to cotton and are relatively easy to pack into open wounds. The 93B3 fiber did
not need to be changed like many traditional wound dressings as it is inorganic and the
likelihood of bacteria growing in the dressing was low due to the release of alkali from
the glass 8.
The presence of a scab-like material formed from the 93B3 fibers and the wound
secretions likely caused the wound to heal at a slower rate as the skin had moved the
layer of fibers out of the way to close the wound. In Fig 5A, the wound (right side) is
completely covered with a crusty layer composed of 93B3 fibers that reacted with body
secretions. The images in Fig 5B and 5C show the layer of fibers (right side) edges
curled as the wound contracted. The majority of the 93B3 fibers were removed when the
layer of fibers was discarded and the wound was already 85-90% closed (between days
11 and 15). The fact that the fibers stayed in place for ~90% of the wound closure is
good since covering the wound is desirable 7.
The granulation tissue that forms at the wound interface is where new capillaries,
macrophages, and fibroblasts congregate as soon as four days after the initial damage 7.
The macrophages secrete growth factors necessary for angiogenesis and promote new
tissue formation (fibroplasia) while also eliminating bacteria 7. The fibroblasts build a
network of extracellular matrix required for endothelial cell migration, and the vascular
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network supports all of the cells by supplying oxygen and the necessary nutrients needed
by the cells 7. As the wound is healed, the granulation tissue is replaced by functional
tissue, so the size of the granulation tissue is an indicator of how much tissue still needs
to be regenerated. The fact that the average granulation tissue thickness between the
control and the treated wound was not statistically significant suggests that the fiber was
not inhibiting the re-epithelialization process. No signs of immune reaction or other
adverse biological effects attributable to the 93B3 fiber were noticed during the wound
healing.
When reviewing the histological control sections, the tissue section of the control
wound shown in Fig 6C did not have any subcutaneous tissue present starting at the right
hand side of the granulation tissue all the way to the far left of the section. The thinned
dermis at the gap in 6C implies poor-quality scar formation and the dashed arrow on the
right side of Fig 6C denotes subcutaneous tissue present on the right side of the wound.
This was the only section from the control or fiber filled wounds that did not regenerate a
subcutaneous tissue layer. Sections of all of the 93B3 fiber filled wounds contained
regenerating subcutaneous tissue, therefore, the 93B3 glass fibers may offer an advantage
to the wound healing process by bridging the regenerating tissues.
The wounds treated with the pads of 93B3 glass contained blood vessels close to
the reacted 93B3 microspheres. Images from Fig 8B, 8C, 8D, and 8E all had vessels in
the immediate vicinity of the reacted 93B3 microspheres. The boron release from the
reacting fibers may have had a positive effect on the surrounding tissues. In-vitro work
by Dzondo-Gadet et. al 15 showed that low concentrations of boric acid in solution with
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human placental cells promoted the uptake of mRNA and had a stimulatory effect on cell
activity similar to a growth factor.
The presence of the 93B3 glass fibers and microspheres may have also acted as a
scaffold or guide for the new tissue to use to grow across the wound. After only four
days, the 93B3 fibers had reacted with secretions from the wound and formed a crusty
layer that looked similar to a scab. The presence of a fiber layer served to keep the
wound moist and keep bacteria and other pathogens from entering the wound. The
animals were kept in a relatively clean environment and were injected with penicillin to
reduce the chances of infection, therefore the benefits of a scab may not have been
noticeable.
The data in Table 1 indicate there was no statistically significant difference
between the healing time of the wounds covered with the 93B3 glass fiber pads and the
control (empty wound). The control and the fiber filled wounds healed at approximately
the same rate and were >99% closed by day 18. This outcome was not entirely surprising
as the size of the wounds was not of critical size and much of the wound closure was
caused by the contraction of the actin fibers in the skin. In humans, this sort of wound
closure is only present in young children, whereas, wounds typically close by epithelial
cells migration across the wound. Re-epithiliazation of the wound is a better indicator of
wound healing than just the rate of contraction 7. For the treatment of wounds in adult
humans, the most important factor is wound coverage 7. There are several skin
substitutes on the market for treating a variety of wound types, but often they are only
effective for a short period of the wound healing process by stimulating the production of
cytokines which the body uses in healing the wound 7.
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The next step with this work would be to alter the glass composition to release
specific metal ions that have been shown to promote endothelial cell migration in-vitro 16.
These trace elements-- copper, zinc, manganese, iron, and magnesium, have all been
identified as essential elements for skin healing at various times in the wound healing
process 6. The evidence for wound healing support is strongest for copper and zinc, and
these will be tried first. Another step would be to coat the 93B3 glass fibers with a
material such as a growth factor 17 or peptide 18 that promotes wound healing. There are
significant practical hurdles in adding degradable proteins to the glass composition. As
discussed previously, the bioactive glasses release ions in a controlled manner over a long
period of time (days to weeks), which may have benefits in the wound healing process
compared to a short burst of growth factor 7. A non-healing model would also be useful
especially in determining any differences between the control and the glass fiber during
the endothelial cell migration stage of healing.
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TABLES
Table 1. Statistical Significance Between the Control wounds and the 93B3 Filled
Wounds For Wound Closure, the Gap in Subcutaneous Tissue at 22 Days, and the
Thickness of Granulation Tissue at 22 Days as Determined by the Student t Test
Control

9383 Fiber

p value

Statistically
Significant

4 days

4 days

0.5743

No

7 days

7 days

0.3518

No

11 days

11 days

0.3459

No

15 days

15 days

0.2599

No

18 days

18 days

0.9657

No

Subcutaneous
Gap (22 days)

Subcutaneous
Gap (22 days)

0.4985

No

Granulation
Thickness
(22 days)

Granulation
Thickness
(22 days)

0.9488

No
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FIGURES

Figure 1 – Optical photograph of as-formed 93B3 fibers (300nm to 5µm diameter).
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Figure 2 – SEM micrographs of the as-made 93B3 fiber. The image in Fig 2B is a higher
magnification of the fibers, which range in diameter from submicron to micron (as
labeled).
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Figure 3 – Schematic of the wound placement on the rats.
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Figure 4 – Photograph of a Sprague Dawley rat showing the full thickness cutaneous
defects. Fig 4A shows both freshly formed wounds (15mm diameter) just posterior to the
front shoulders. Figure 4B shows the wound after being treated with 93B3 fiber (white
material).
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Figure 5 – Progression of wound closure for the full thickness subcutaneous wounds.
The times shown are (A) 4 days, (B) 7 days, (C) 11 days, (D) 15 days, (E) 18 days, and
(F) 22 days. The control is on the left side and the 93B3 fiber filled wound is on the
right. The approximate original wound size is shown by the dashed circles in Fig 5F.
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Figure 6 – Histological sections of the full thickness cutaneous control wounds after 22
days (H&E).
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Figure 7 - Histological sections of the full thickness cutaneous 93B3 bioactive glass filled
wounds after 22 days (H&E). The black line at the top of each tissue section denotes
where there is unhealed tissue. The double ended arrows show the gap in the
subcutaneous tissue and the vertical indicate granulation tissue.
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Figure 8 – Histological assessment of a 93B3 filled full thickness cutaneous wound after
22 days.
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Figure 9 – Comparison of the original wound (%) vs. time for the control (blue) and the
wound treated with the 93B3 fiber pad (red).
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Figure 10 – Average gap in the subcutaneous tissue and average thickness of the
granulation tissue present in the 22 day sections. The control is blue and the 93B3 fiber
treated (red).
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3. CONCLUSIONS
This section combines and summarizes the main conclusions from each of the six
manuscripts from the body of the dissertation.
1. Boron released from 13-93B3 scaffolds at an estimated concentration of
<126mg/kg/day (sixteen 70mg scaffolds reacting in four weeks) caused no invivo toxicity in adjacent tissue or systemic organs. The kidney and liver were
analyzed from sacrificed rats and no pathological changes beyond incidental
were reported. When a 13-93B3 scaffold was placed in a bone site, there was
no increase in macrophages or other inflammatory cells, and there was no
necrotic tissue in the new bone adjacent the 13-93B3 scaffolds after 12 weeks.
2. Scaffolds composed of 13-93B3 fibers had significantly more bone after 12
weeks in rat calvaria (p<0.05) than silicate based 13-93 scaffolds indicating
the borate glass was a better bone growth promoter. The reason behind the
increased bone regeneration in the borate scaffold is thought to be due to the
faster reaction of the scaffold which increased the rate of calcium release.
Calcium is known to act as a bone growth stimulator by promoting osteoblast
migration and proliferation.
3. Bioactive borate glass was doped with trace elements (copper and zinc) which
significantly improved angiogenesis (blood vessel formation) in the soft tissue
inside porous, randomly oriented fiber scaffolds. Angiogenesis is important in
sustaining tissue growth in scaffolds, and glasses doped with these elements
could be an important improvement in increasing the size of tissue
engineering scaffolds.
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4. For the first time, bioactive glasses containing calcium were made to form
non-calcium phosphates when reacted in-vivo. The conversion of the glass is
thought to be controlled by the size of the atom added as a trace element to the
glass. It is speculated that the smaller the ion, the more profound the effect on
the inhibition of hydroxyapatite.
5. Cutaneous soft tissue defects were successfully treated with nano fibers of 1393B3 glass, and the quality of the scar was better than the control (untreated
wound). Ions such as calcium are known to increase epithelial cell migration
in-vitro and are hypothesized to have several physiological roles in wound
healing. The reaction of the glass and release of ions such as calcium are
assumed to improve wound healing.
6. The hollowing of 13-93B3 fibers when reacted in-vivo often had soft tissue
and blood vessels present inside. The vessels grew along the length of the
fiber, so it is thought that bioactive glass fibers could be used as a method of
directing the growth of blood vessels or nerves.
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4. FUTURE WORK
1. Continue studies into the potential toxicity of boron in-vivo. The more data the
better. Collection of urine and subsequent measure of boron during the reaction
of the glass could be a good measure of how the glasses reacted in-vivo. Little is
known at this point about how boron is released or if it changes as a function of
time. Rats are a good model for boron toxicity since they are more sensitive to
boron that mice or rabbits.
2. Understanding more about calcium as the major bone promoter from bioactive
glass could be important, especially for future use and acceptance of silica free
bioactive glasses. In-vitro cell culture work on the migration and proliferation of
osteoblasts and other tissues in the presence of calcium, or in-vivo work with
additional silica free glasses with even faster release rates (CaLiB) could be
interesting for enhanced bone formation.
3. The angiogenic response of soft tissue with the doped bioactive borate glasses
(copper and zinc) could be important in improving bone and soft tissue scaffolds
and wound healing treatments. Blood vessel guides and treatment of diabetic or
non-healing ulcers could be made partially or wholly from these glasses and
significantly improve the treatment options.
4. The conversion of glasses to non-HA materials is a new area of work that has a lot
of possibilities. Calcium compounds such as calcite have been reported to be
degraded faster than HA by osteoclasts in-vitro. It may be possible to control the
calcium phosphate phase that forms and make tricalcium phosphate or brushite invivo. Calcium free glasses replaced with barium or strontium may have benefits
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in tissue engineering or other fields of study. In the past, in-vitro reaction has
simulated the in-vivo reaction; so much of this work may be possible in-vitro. In
addition, other trace elements could be added to the glass, singularly, or in
combination to see if phases can be shifted by straining the crystal structure and
how solid solutions affect the formation of new materials.
5. The change from a mono layer of HA to a layered structure in borate glasses such
as 13-93B3 is still not understood. Borate glasses have been reported to form
these layers for almost 15 years, and several reasons for the formation have been
suggested, but this phenomenon has never been formally studied. Controlling or
at least understanding this microstructural change could be beneficial for making
new devices for controlled drug release or other new technologies.
6. Wound healing is potentially a huge new area of study for bioactive glass. The
body is compatible with bioactive glass, and the controlled release of ions can be
achieved that can improve the rate of healing. The reaction products of bioactive
glasses also tend to be antimicrobial, so the glasses may be of use in treating
bacterial infections locally in people that are resistant to penicillin.
7. One tissue not studied in the present work was the avascular tissue cartilage.
Cartilage survives by diffusion of nutrients and oxygen to blood vessels that exist
outside of the tissue. Cartilage is also slow to heal is damaged and healing could
be enhanced by the addition of particles of fibers of the angiogenic glasses. A
vasculature inside the cartilage scaffold could enhance the rate of diffusion in the
scaffold and decrease healing time.
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APPENDIX A
POTENTIAL TOXICITY OF BORATE GLASSES IN-VITRO AND IN-VIVO
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Figure 1 - Photomicrograph of an H&E stained section of the renal cortex from a rat that
contains protein casts and tubular degeneration (Fig 1A). Figure 1B is a magnified view
of the renal cortex showing a folded glomerulus as indicated by the vertical arrow, renal
tubes (horizontal arrows) and mononuclear inflammation characterized as tubular
degeneration (dashed circle).
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Figure 2 - Photomicrograph of an H&E stained section of the renal medulla from a rat
that contains nephrocalcinosis (arrows) and a large blood vessel on the left of the image
(Fig 2A). Figure 2B is a magnified view of the renal medulla showing nephrocalcinosis
as indicated by the white arrow and renal tubules (horizontal arrows).
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Figure 3 - Photomicrograph of an H&E stained section of the renal cortex from a rat that
contains protein casts and tubular degeneration (Fig 3A). Figure 3B is a magnified view
of the renal cortex showing three protein casts (P), tubular degeneration due to loss of the
epithelial eosinophilia (dashed circle), and gold/brown pigment indicative of infiltrates of
mononuclear inflammatory cells.
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APPENDIX B
ANGIOGENIC BIOACTIVE BORATE GLASSES
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Figure 1 – H&E stained section of a Cu-3 scaffold (1 of 3) used for the blood vessel
analysis. The three strips counted in this section are indicated by the dashed lines in the
whole section and a magnified view of the strips is shown below. The number of vessels
from each strip were 14 (A), 8 (B), and 11(C), respectively. The original scaffold
diameter was 7mm.
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Figure 2 – H&E stained section of a Cu-3 scaffold (2 of 3) used for the blood vessel
analysis. The three strips counted in this section are indicated by the dashed lines in the
whole section and a magnified view of the strips is shown below. The number of vessels
from each strip were 24 (A), 32 (B), and 32(C), respectively. The original scaffold
diameter was 7mm.
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Figure 3 – H&E stained section of a Cu-3 scaffold (3 of 3) used for the blood vessel
analysis. The three strips counted in this section are indicated by the dashed lines in the
whole section and a magnified view of the strips is shown below. The number of vessels
from each strip were 33 (A), 35 (B), and 37(C), respectively. The original scaffold
diameter was 7mm.
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Figure 4 – H&E stained section of a CS scaffold (1 of 3) used for the blood vessel
analysis. The three strips counted in this section are indicated by the dashed lines in the
whole section and a magnified view of the strips is shown below. The number of vessels
from each strip were 32 (A), 27 (B), and 39(C), respectively. The original scaffold
diameter was 7mm.
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Figure 5 – H&E stained section of a CS scaffold (2 of 3) used for the blood vessel
analysis. The three strips counted in this section are indicated by the dashed lines in the
whole section and a magnified view of the strips is shown below. The number of vessels
from each strip were 11 (A), 45 (B), and 21(C), respectively. The original scaffold
diameter was 7mm.
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Figure 6 – H&E stained section of a CS scaffold (3 of 3) used for the blood vessel
analysis. The three strips counted in this section are indicated by the dashed lines in the
whole section and a magnified view of the strips is shown below. The number of vessels
from each strip were 47 (A), 45 (B), and 35(C), respectively. The original scaffold
diameter was 7mm.
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Figure 7 – H&E stained section of a CSZ scaffold (1 of 3) used for the blood vessel
analysis. The three strips counted in this section are indicated by the dashed lines in the
whole section and a magnified view of the strips is shown below. The number of vessels
from each strip were 64 (A), 38 (B), and 33(C), respectively. The original scaffold
diameter was 7mm.
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Figure 8 – H&E stained section of a CSZ scaffold (2 of 3) used for the blood vessel
analysis. The three strips counted in this section are indicated by the dashed lines in the
whole section and a magnified view of the strips is shown below. The number of vessels
from each strip were 72 (A), 73 (B), and 32(C), respectively. The original scaffold
diameter was 7mm.
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Figure 9 – H&E stained section of a CSZ scaffold (3 of 3) used for the blood vessel
analysis. The three strips counted in this section are indicated by the dashed lines in the
whole section and a magnified view of the strips is shown below. The number of vessels
from each strip were 51 (A), 34(B), and 52(C), respectively. The original scaffold
diameter was 7mm.
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Figure 10– H&E stained section of a CSZF scaffold (1 of 3) used for the blood vessel
analysis. The three strips counted in this section are indicated by the dashed lines in the
whole section and a magnified view of the strips is shown below. The number of vessels
from each strip were 58 (A), 45(B), and 45(C), respectively. The original scaffold
diameter was 7mm.
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Figure 11– H&E stained section of a CSZF scaffold (2 of 3) used for the blood vessel
analysis. The three strips counted in this section are indicated by the dashed lines in the
whole section and a magnified view of the strips is shown below. The number of vessels
from each strip were 59 (A), 80(B), and 78(C), respectively. The original scaffold
diameter was 7mm.
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Figure 12– H&E stained section of a CSZF scaffold (3 of 3) used for the blood vessel
analysis. The three strips counted in this section are indicated by the dashed lines in the
whole section and a magnified view of the strips is shown below. The number of vessels
from each strip were 37 (A), 51(B), and 52(C), respectively. The original scaffold
diameter was 7mm.
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BIOACTIVE GLASS SCAFFOLDS FOR SOFT TISSUE REGENERATION
By
Steven Jung, Missouri University of Science and Technology
ABSTRACT
Melt derived fibers of 13-93 glass have been made into three dimensional random
oriented scaffolds for soft tissue regeneration. The scaffolds were implanted in the
subcutaneous tissue of rats from two to twenty eight weeks. Significant vascularization
and tissue growth was evident after just two weeks in-vivo. The 13-93 glass fibers
reacted with the body fluids at a rate of approximately 3µm a week during the duration of
the experiment and formed a layer of hydroxyapatite (HA) at the fiber-tissue interface.
Collagen, the building block of both hard and soft tissue, was also found coating the
reacted glass fibers indicating that the 13-93 glass fibers may be a useful material for soft
tissue augmentation and wound dressing.

INTRODUCTION
Bioactive glasses have been known to bond to bone since 1969 [1, 2]. Treatment
of middle ear and periodontal defects led to the first investigations into soft tissue
bonding of bioactive glass [1, 2]. Wilson showed soft tissue interactions with silicate
based bioactive glasses were similar to interactions with bone, first forming a silica gel
layer followed by the precipitation of an amorphous calcium phosphate which then
crystallized to the crystalline material known as hydroxyapatite (HA) [1, 2]. These first
studies indicated that bioactive glasses may one day have use in the treatment of damaged
soft tissue.
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Like bone, damaged tissues such as skin, muscle, and internal organs need a
substrate to which they can attach and grow for effective healing. Scaffolds made of
degradable and bioactive materials are preferred as they provide a resorbable substrate
beneficial to tissue growth. Polymers alone are not bioactive; however, bioactive glasses
or composites of polymers and bioactive glasses show significant promise for treatment
of damaged soft tissue. Leu et. al. incorporated 45S5 bioactive glass into a collagen
substrate and found that the addition of the glass had a proangiogenic effect[3]. Leach
made a polymer scaffold with embedded 45S5 bioactive glass, and used it to release
vascular endothelial growth factor (VEGF) and studied the angiogenic effect for use in
hard and soft tissue applications [4].
The maximum distance tissue can survive is approximately 100 to 200µm from a
blood vessel, so new blood vessel formation is necessary for wounds to heal [5]. Specific
to placing artificial materials such as bioactive glass scaffolds in the body, tissues cannot
grow into and fill the scaffold until a network of blood vessels have first penetrated the
scaffold or at least are promoted to penetrate the scaffold as surrounding tissue infiltrates
the scaffold. The importance of vascularization to wound healing is significant and
should not be ignored [5]. Vascular endothelial growth factor has been isolated as one of
the most important signals for wound healing. Several growth factors natural to the body
have been identified as important to wound healing, however, none are as prevalent or
have the long-term stimulatory effects for vascular growth as VEGF[6].
The well known bioactive glass, 45S5, is difficult to heat treat to form scaffolds or
to pull into continuous fibers, so, other silicate based glasses have been developed with
longer working ranges for improved processing [7, 8]. Another bioactive glass known as
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13-93 has been used successfully to produce scaffolds with a variety of porosities and
microstructures [9-12]. Three dimensional scaffolds composed of 13-93 have been
shown to bond to soft tissue, and significant vascularization was observed when these
scaffolds were placed in a subcutaneous site [9, 11].
DISCUSSION
The present work describes the use of bioactive glass 13-93 (53 SiO2, 20 CaO, 12
K2O, 6Na2O, 5MgO, 4P2O5 in wt%) as a soft tissue scaffold material. The scaffolds used
in the present work were 7mm in diameter, 2mm thick, and weighed approximately
70mg. An example of a 13-93 glass fiber scaffold is shown in Figure 1. These scaffolds
were studied for soft tissue and vascular growth along with the reaction of the fiber with
body fluids. The scaffolds were made by breaking melt derived 13-93 glass fibers into 2
to 3mm lengths, placing the randomly oriented fibers in a ceramic mold, heating the
fibers to a temperature sufficient for thermal bonding, followed by cooling the scaffolds
to room temperature. The microstructure of a three dimensional glass fiber scaffold is
shown in Fig. 2a. During the bonding process, the fibers soften and the edges round.
The softened fibers stick together forming the three dimensional scaffold as shown in Fig
2b. The interconnected porosity of the scaffold is approximately 50%, and its
compressive strength is approximately 5 MPa.
Soft tissue growth into 13-93 fiber scaffolds has been studied extensively for
scaffolds implanted for times between two and twenty eight weeks in subcutaneous sites
in laboratory rats. Typically, four implant sites are used on a single animal as shown in
Fig 3. The implant site is just under the skin, and the scaffold is implanted by cutting the
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skin and sliding the scaffold under the loosely attached tissue. The picture in the lower
right hand corner of Fig 3 shows a scaffold being implanted in a subcutaneous site.
After two weeks in-vivo, the scaffold looks like the one shown in Fig 4. The
tissue at A is the subcutaneous tissue underneath the skin, B is the scaffold, and C is the
skeletal muscle. The scaffold has become infiltrated with soft tissue, and the scaffold is
visibly red from blood vessels that had grown into the scaffold. Prior to extraction, the
scaffold had become attached to the subcutaneous tissue indicating the tissue and glass
were compatible. There was no measurable change in the overall dimensions of the
scaffold.
Figure 5a is a H&E stained micrograph of the tissue present inside a 13-93
scaffold after two weeks in-vivo. The glass fibers are labeled with an ‘F’. The soft tissue
present between the fibers was healthy and vessels containing red blood cells (pink dots)
were present throughout the scaffold. The black vertical arrows denote some of the
vessels present in the scaffold in Fig 5a. Soft tissue had grown adjacent to the fibers and
no negative immune reaction, such as a walling off of the fibers, was observed. This
indicates that the 13-93 glass fibers are compatible with soft tissue and that the reaction
products of the glass fibers are not producing an inhospitable environment. The reaction
products may in fact be promoting growth as silica and other elements present in the
glass have been linked to growth factor release and promotion of tissue growth [13, 14].
Figure 5b is a section of the same two week 13-93 scaffold; however, it was
stained with PAS stain which stains red blood cells green and soft tissue purple. Tubule
lining such as in vessels appears as a purple ring or outline depending on the vessel
orientation. Examples of the vessel lining are shown by the black horizontal arrows. The
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vascularity is more evident in the PAS stained section than the H&E stained section as
denoted by the large number of vessels (vertical black arrows) throughout Fig 5b. The
distance between the vessels in the tissue present in Fig 5b range from ~50 to at most
~100µm, which is considered a sufficiently vascularized tissue [5]. Vascular growth into
the scaffold is important because the blood supply is the transportation system for
supplying nourishment and oxygen and removal of waste and carbon dioxide.
Insufficient vascular density can hinder tissue growth and slows the healing of wounds
such as with diabetic ulcers and bed sores.
Figure 6 shows the progressive reaction of the 13-93 glass fibers with the body
fluids for 4, 9, and 28 weeks in-vivo. After 4 weeks in subcutaneous tissue, the image in
Fig 6a, which is a SEMBSE (backscattered image) of a 13-93 fiber, shows a reaction
layer at the outer edge of the fibers. At higher magnification, three distinct layers are
present. Layer A is pointing to the 4µm layer hydroxyapatite, B is a 5 to 6µm thick silica
gel layer, and C is the unreacted glass. The total reaction layer is approximately 10 to
12µm thick.
Figure 6b is a SEMBSE image of a 13-93 fiber after nine weeks in-vivo. The
total reaction layer (HA and silica gel) is up to 30µm thick in some areas, and a nonuniform reaction layer is becoming evident. The non-uniform reaction layer has been
documented previously both in-vivo[11] and in-vitro[15], but no explanation for this
reaction has been suggested to date.
The SEMBSE image in Fig 6c shows the cross section of a fractured 13-93 fiber
after 28 weeks in-vivo. The fiber has nearly reacted completely with the physiological
fluids; the outer surface at A is a 30µm thick layer of HA. The silica gel layer designated
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by B is approximately 6 to 8µm thick, and the unreacted material at the center (C) is
composed of SiO2, CaO, and P2O5. None of the Na2O, K2O, or MgO from the starting
fibers was detected at 28 weeks indicating that they had diffused out of the glass and
were removed by body fluids. An interesting observation from these three fibers is that
the silica gel layer quickly reached a thickness of approximately 5 to 6µm (within four
weeks), and even while the HA layer continuously grew thicker; the gel layer thickness
remained constant.
An important observation from the in-vivo experiments using the 13-93 glass
fiber scaffolds was the formation of collagen on the reacted fibers and potential uses in
tissue engineering. The SEMBSE image in Fig 7a shows strands of collagen coating and
spanning the reacted 13-93 fibers in a scaffold that has been in-vivo for 28 weeks. A
magnified view in Fig 7b shows the collagen fibrils clearly, and the 64nm periodicity that
is unique to collagen molecules [16]. Collagen is the building block of nearly all human
tissue, hard and soft, so the interaction and compatibility with bioactive glass for tissue
regeneration is important.
Understanding the short and long term benefits of 13-93 bioactive glass scaffolds
with soft tissue make these scaffolds candidates for use in treating conditions such as
diabetic ulcers, severe burns, or other traumatized soft tissue. A material or scaffold that
promotes vascular growth and tissue guiding while promoting the natural healing
processes of the body will be an important advancement in the fields of both biomaterials
and medical science.
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CONCLUSION
Three dimensional scaffolds composed of randomly oriented fibers of the
bioactive 13-93 glass are compatible with subcutaneous soft tissue, promote significant
vascular and soft tissue growth within just two weeks in-vivo, and react to form HA when
in contact with soft tissue. The 13-93 fibers reacted at a rate of about 3µm a week during
the 28 week experiment. No immune reactions were detected during the histological
examination of the implanted scaffolds, and collagen, the building block of hard and soft
tissue, readily forms on the 13-93 fibers when implanted subcutaneously. Therefore,
scaffolds or composites composed of 13-93 bioactive glass are good candidates for future
soft tissue augmentation applications and wound dressings.
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FIGURES

Figure 1 – Image of a 13-93 random fiber scaffold. The scaffold measures 7mm in
diameter and 2mm thick and has an open porosity of 50% and a compressive strength of
5MPa.
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Figure 2 – SEM micrographs of a 13-93 random oriented fiber scaffold. Figure 2a shows
the random orientation of the fibers and the rounded end of the fibers due to the heat
treatment. Figure 2b is a higher magnification image showing the bonding between the
fibers.

Figure 3 – Schematic showing the scaffold placement in the subcutaneous tissue. Image
in lower right hand corner shows a scaffold being implanted under the skin.
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Figure 4 – Image of a 13-93 scaffold after two weeks in-vivo. The tissue under A is the
subcutaneous tissue under the skin, B is the scaffold, and C is the skeletal muscle. The
scaffold has no changed dimensions from the original, and is now red from soft tissue and
vascular growth.

Figure 5 – Histology sections from the 13-93 scaffold implanted two weeks in
subcutaneous tissue. Fig 5a is a H&E stained section showing the soft tissue (pink)
surrounding the glass fibers (white and labeled with an F). The vertical arrows are
pointing out blood vessels with red blood cells inside of them (pink dots). Fig 5b is a
PAS stained tissue section, and here the soft tissue is purple and the tubules of the vessels

306
is a dark purple (horizontal arrow). The red blood cells are green making the vessels more
visible (vertical arrows). The glass fibers are labeled with an F.

Figure 6 – SEMBSE images of 13-93 glass fibers implanted in a subcutaneous site for
four, nine, and twenty eight weeks. Fig 6a shows the reacted edge of the four week
implanted fiber where A is the hydroxyapatite layer, B is silica gel, and C is unreacted
glass. The total reaction layer is 10 to 12µm thick. Fig 6b is an image of a nine week
implanted fiber showing a reaction layer of non-uniform thickness of about 30µm. Fig 6c
is an image of a fractured fiber that was implanted for 28 weeks. The total reaction layer
is approximately 90µm. The surface layer A is the HA, B is a silica gel layer, and C is
residual material consisting of SiO2, CaO, and P2O5.
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Figure 7 – SEMBSE images of a 13-93 scaffold implanted in subcutaneous tissue for 28
weeks that is coated with collagen fibrils. Fig 7a shows a fractured scaffold surface with
collagen strings coating and connecting the glass fibers. Fig 7b is a higher magnification
image of the collagen showing the unique 64nm periodicity of the material.
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ABSTRACT

Three dimensional assemblies of fibers made from bioactive glass compositions
were investigated to determine their usefulness as scaffolds for the repair and
regeneration of hard and soft tissues. The microstructure, properties and in-vivo
performance were measured for scaffolds (7mm diameter and 2mm thick) made from an
interconnected network of discontinuous fibers of bioactive glasses such as 45S5 and 1393 that were arranged in a random oriented geometry. Scaffolds, made from fibers whose
diameter ranged from approximately 100 up to 300 microns, were implanted
subcutaneously in laboratory rats for up to four weeks. Scaffolds comprised of randomly
oriented fibers seeded with mesenchymal stem cells prior to implantation contained
significant new bone-like material after four weeks in-vivo. No bone-like material was
observed in un-seeded scaffolds as expected, but these scaffolds were completely
penetrated by new soft tissue with noticeable amounts of new vascularization.
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Histological staining techniques were used to asses the quality of the infiltrating
soft tissue and to identify cells and tissues of interest. Biological staining and scanning
electron microscopy back scattered imaging (SEM-BSI) showed new bone tissue had
formed throughout the scaffolds seeded with mesenchymal stem cells. Scanning electron
microscopy electron dispersive spectroscopy (SEM-EDS) analysis of the cross-section of
a 13-93 and 45S5 fiber implanted four weeks was used to measure the compositional
change of each fiber type to calcium phosphate, demonstrating the reactivity of both
materials in-vivo.

INTRODUCTION

Bone density, especially in women, has been documented to decrease with age 1.
Biologically compatible replacement materials of variable strength are needed to deal
with this problem 2,3. Cortical bone is the strongest type of bone, with a compressive
strength that ranges from 117 to 167 MPa 2,3. Cervical vertebrae and lumbar bone, are
weaker having a range of compressive strength between 5 to 10 MPa 3, while cancellous
bone, a spongy bone material, has a compressive strength of only 0.2 to 4MPa 2,3.
One idea for the regeneration of bone has been to use ceramic materials for bone
scaffolds. This option has been widely researched in terms of both materials and
processing techniques 1,4-16. The end result is often a sintered ceramic three-dimensional
scaffold with high porosity (70-90%) and relatively low compressive strength (<0.4MPa)
5,7-8

. Ceramics most often studied for bone scaffold use are stoichiometric hydroxyapatite

(HA) with the ideal composition of (Ca10(PO4)6(OH)2) 5,7,9,11,15, other crystalline ceramics
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such as CaSiO3 or CaCO3 3,9,10, bioactive glasses like the silicate based 45S5 or 13-93
glasses 1,7,11,13,14,17, and glass-ceramics like bioactive glass-ceramic apatite wollastonite
(A/W) 1. All of these materials have been shown to promote significant cell attachment
and tissue growth.
Glassy materials have unique properties that make them attractive for use as
biological implants and for three dimensional porous scaffolds. It has been shown that
the chemical composition can greatly affect the rate at which a glass either dissolves in
liquids similar to those found in the body 18-19 or reacts to form HA. Homogeneous
nucleation and crystal growth, such as that of bioactive glass 45S5, makes it possible to
engineer glass-ceramic materials with improved mechanical properties such as bending
strength, hardness and elastic modulus when properly heat treated 20-24. Other bioactive
glasses, such as the silicate based 13-93, have compositions that are more resistant to
crystallization 13,25. The decreased tendency for crystallization is due to compositional
changes that reduce the nucleation and crystal growth rate, which results in a wider
working range. This change increases the ability to pull fibers from a melt, which can be
self-bonded to form bioactive glass scaffolds of a reasonable mechanical strength with a
significant fraction of interconnected porosity 13,14,25.
The scaffolds investigated in the present work consisted of a network of randomly
oriented self-bonded glass fibers. Scaffold designations are with respect to the weight
fraction of 13-93 glass fibers in each scaffold, so S100 scaffolds were composed of 100
wt% 13-93 glass fibers and S30 was 30 wt% 13-93 and 70 wt% 45S5. The preparation of
the scaffolds, porosity, compression strength, and in vitro cell growth of MC3T3-E1 preosteoblast cells have been previously described for the present scaffolds 26-27.
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The main objective of the present research was to compare the in-vivo response of
the S100 scaffold versus the S30 scaffold by seeding the scaffolds with mesenchymal
stem cells prior to subcutaneous implantation. The evaluation of the scaffolds included
determining the scaffold’s ability to support bone tissue formation and growth from an
initial mesenchymal stem cell seeding, a visual examination for breakdown of the
bonding between the fibers to assess the structural capabilities in-vivo, and a comparison
of reactivity between the different glass fiber types in body fluids. These aforementioned
criteria should give useful insight into the suitability of a scaffold composed of randomly
oriented bioactive glass fibers for the growth and regeneration of bone.

MATERIALS AND EXPERIMENTS

Scaffold Preparation and Physical Properties
Continuous fibers (100 to 300 μm in diameter) of the 45S5 and 13-93 bioactive
glass (Table 1) were hand pulled from a melt and broken into 3mm lengths. Fibers for
each scaffold were individually weighed for a total of 70mg, so S100 scaffolds contain
70mg 13-93 fiber and S30 contained 49mg 45S5 and 21mg 13-93 fibers. The bioactive
glass fibers were placed in a mold consisting of an alumina substrate and a mullite
cylindrical tube with a 7mm inside diameter. The molds were then placed inside a box
furnace that was pre-heated to 720oC. After 45 minutes of heating, the molds were
removed from the furnace and cooled to room temperature. The self bonded scaffolds
were removed from the molds and were ready for use 27.
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The S100 and S30 scaffolds were previously measured for compression strength
and open porosity 26-27. The S100 scaffold had a compressive strength of 5.3MPa and an
average open porosity of approximately 44%, while the S30 scaffold had an average open
porosity of 63% and compressive strengths of approximately 0.6MPa.

Table 1. Compositions of Some Bioactive Glasses in mol% and wt% (parentheses
denote wt%)

Scaffold Sterilization and Seeding with Mesenchymal Stem Cells
All scaffolds were washed twice with ethyl alcohol and heat sterilized at 250oC
for 2.5 hours in a small box furnace prior to cell seeding or implantation. Half of the
scaffolds were seeded with 150,000 mesenchymal stem cells harvested from Fisher 344
rats (Fisher Scientific, St. Louis, MO). The cells were harvested from the femur of
previously sacrificed rats and cultured for 24 hours in glass dishes with Sigma α-MEM
0644 media (Sigma Aldrich, St. Louis, MO): (10% fetal calf serum, 1% penicillin/strep
antibiotic, 50mg/ml ascorbic acid, and 10-8 molar dexamethasone) at 37oC and in 95%
air/5% CO2 atmosphere.
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Animal Experiments
A total of eight male and female Fisher 344, rats ranging in age from eight to ten
weeks, were used to assess the biological response of the S100 and S30 scaffolds after
being implanted for three and four weeks. The back of each rat was shaved just prior to
surgery, sterilized with iodine, and then washed with 70% ethanol to ensure a clean and
sterile working area. Each rat was anesthetized with a mixture of isoflourine and medical
grade oxygen. The implanted scaffolds are hereafter referred to in by the following
designations; scaffold S100 seeded with mesenchymal stem cells is designated S100+,
scaffold S100 without mesenchymal stem cells is designated to as S100, scaffold S30
with mesenchymal stem cells is designated S30+ and scaffold S30 without mesenchymal
stem cells is designated S30.
One scaffold of each type, S100, S100+, S30, and S30+ was implanted for a total
of four scaffolds per animal for a total of 32 scaffolds. Each scaffold was implanted
subcutaneously in a pocket that was formed in the back of each rat, one above each
shoulder and one above each hind leg, between the skin and the muscle as shown in Fig.
1. The pockets were approximately 15mm wide and 15mm long to ensure that each
scaffold was inserted away from the incision site. The incisions were closed with super
glue (Krazy® Glue, Elmers Products inc. Columbus, OH). After implantation, 0.1 mL of
Penicillin G Procaine was injected into each thigh of the rat to prevent infection. The rats
were placed on a heating pad in a cage with fresh air during recovery.

315

Top of head
Spine

Subcutaneous
Pocket

Incision Sites

Figure 1. Schematic showing implantation sites for subcutaneous implantation of the
S100 and S30 scaffolds in the back of a rat.

Removal of Scaffold from Rats and Scaffold Dehydration
After the allotted three or four week period, the rats were sacrificed in a chamber
of CO2. Each scaffold was surgically removed from the subcutaneous site of each rat
and placed in a 10% formalin solution at room temperature (22oC) for 96 hours to fix the
tissue. At this point, each scaffold was visually examined as described later.
Each scaffold was dehydrated with a series of seven ethanol solutions ranging
from 80 to 100% ethanol using a solution volume ratio of ten times that of the scaffold
(~5mL solution/scaffold) 28. Each scaffold was placed in glass vial and submerged in the
ethanol solution. The glass vials were placed in a plastic tray, which was packed in ice to
keep the ethanol solution from over heating, microwave irradiated at 80% power at 37oC
for two minutes and was continuously submerged in each of the alcohol solutions for a
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total of fifteen minutes. After dehydrating, each scaffold was placed in xylene for 24
hours to make any tissue present transparent.

Impregnating Scaffolds with Polymethyl Methacrylate (PMMA)
Each scaffold was infiltrated with a series of three solutions for 48 hours each
(0%, 50%, and 100% polymerizing agent perkodox mixed with methyl methacrylate
monomer (MMA)) to ensure monomer penetration and controlled polymerization. Just
prior to infiltration of the 100% MMA solution, the scaffold was attached to a bed of
partially polymerized PMMA. The scaffold was then covered with a layer of MMA and
slowly polymerized over a four day period at 4oC.

Scaffold Separation, Sectioning, and Polishing
Each scaffold was sectioned at its center, perpendicular to the 7mm diameter
using an IsometTM slow speed saw (Model 11-1180, Buehler LTD. Evanston, IL) with a
LECO® diamond coated blade (LECO® Corporation, St. Joseph, MI) . The cross section
of the scaffold was polished with silicon carbide papers ranging from 320 to 1200 grit.
The polished surface was attached to a glass slide with superglue and polished to a final
thickness of 50 ±10μm.

Scaffold Cross-section Staining
The 50μm section of each scaffold was stained using Sanderson’sTM Bone
Staining method (Surgipath Canada inc, Winnipeg, Manitoba). The mounted scaffold
cross sections were dipped in the preheated stain (50oC) for two minutes, rinsed with
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distilled water, and blotted dry with a paper towel. The stained sections were then
counter stained with a solution consisting of one gram of acid fuchsin, 99mL of distilled
water, and one mL acetic acid for 40 seconds at 22oC to differentiate the soft tissue as
blue and bone tissue as red. The cell nuclei of both the soft and bone tissue appear as
dark blue dots, cytoplasm (a watery substance that fills cells) is light blue, osteoid seam
(a mixture of proteins which is secreted by osteoblast which when mineralized becomes
bone) is a purple color, bone matrix material is red, and soft tissue is blue. Each stained
section was examined at 10X and 40X magnification using an Olympus MI transmitted
light microscope (Olympus Corporation, Japan).

SEM Imaging and EDS Compositional Analysis In-vivo Scaffolds
Scanning electron microscopy backscattered imaging SEM-BSI, (Hitachi S-570
SEM) was used to determine the compositional change from the center to the outer edge
of reacted fibers of 13-93 and crystallized 45S5 fibers (45S5c) that had been four weeks
in-vivo. Cross sectioned scaffolds were polished with silicon carbide papers to 1200 grit.
The scaffolds were sputter coated with gold palladium and attached to aluminum stubs
with carbon tape to eliminate charging. For standard-less EDS, there is no set error, as it
depends on the elements analyzed and the accelerating voltage used for generation of the
EDS spectra. For this EDS analysis, the data plotted is shown to give a general idea of
the reaction and leaching of the fibers.

RESULTS AND DISCUSSION
Scaffolds Prior to Implantation (As-Made)
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Figure 2 shows a high and low magnification image of the as-made S100 (Figs 2a
and b) and S30 (Figs 2c and d) scaffolds prior to implantation. Figures 2a and Fig. 2c
show the random orientation of the fibers in the as-made scaffolds. An example of the
bonding developed between the fibers after heat treatment is shown in Figs. 2b and 2d.
An important difference in the 13-93 and 45S5 fibers after self-bonding is that the 13-93
fibers remain glassy and smooth, whereas the 45S5 fibers crystallize and a rough surface
is formed as shown in Fig. 2d. Previously, 45S5 glass has been reported to crystallize
into combeite 7, whose stoichiometric composition is shown in Table 1.

Figure 2. SEM images of the 13-93 fibers in the S100 scaffold (a), and S30 scaffold (c)
after 45 minutes at 720oC. The bonding between 13-93 glass fibers in a S100 scaffold is
shown in (b) and a 13-93 fiber bonded to 45S5c fiber in S30 scaffold in (d). [26].

319
Evaluation of Scaffolds Implanted in Rats
Upon removal, the first evaluation was a visual assessment of robustness of the
scaffold. Figure 3 shows three scaffolds, (a) an as-made S100 scaffold prior to
implantation, (b) a S100+ scaffold after four weeks in-vivo, and (c) a S30+ scaffold after
four weeks in-vivo. The diameter of the two implanted scaffolds was essentially
unchanged from the as-made control, and both scaffolds had sufficient strength to remain
intact after four weeks in-vivo.
Significant soft tissue had infiltrated both scaffolds after four weeks in-vivo as is
clearly evident from Figs. 3b and 3c. Healthy tissue had grown into the scaffolds, and
there was no evidence of infection or inflammation in the surrounding tissue to suggest
rejection of the scaffolds. Another interesting observation was that several blood vessels
had grown into the S100 and S30 scaffolds; see black circles in Figs. 3b and 3c. The
remaining scaffolds, not shown, at three and four weeks, with and without seeded
mesenchymal stem cells, all looked similar to those in Fig. 3 in terms of tissue infiltration
and the presence of blood vessels.
The reaction products of these two bioactive glasses may be causing an
angiogenic effect, which in this case is positive, as the penetrating blood vessels are
providing nourishment to the interior of the scaffolds. Previous work completed by
others on the angiogenic effect of 45S5 glass found that there may be a link between
bioactive glasses and angiogenesis in-vitro 29-30. No one to date has reported on
proangiogenic effects for 13-93 glass, in-vivo or in-vitro, but this work shows compelling
evidence that there may be a positive angiogenic effect in-vivo.
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Figure 3. Appearance of glass fiber scaffolds before and after subcutaneous in vivo
implantation for four weeks. (a) S100 scaffold prior to implantation, (b) S100+ after four
weeks in- vivo, (c) S30+ after four weeks in-vivo. Red circle is 7mm in diameter and
denote the starting diameter of the scaffolds.

Evidence of Bone Formation in Implanted Scaffolds
Regions of red tissue in the histology sections were assumed to be bone tissue,
therefore, the results of the scaffold cross sections stained for bone tissue identification in
both the S100 and S30 scaffolds are as follows. None of the non-cell seeded scaffolds
contained any bone tissue as expected since they had no mesenchymal stem cells seeded
on them, and were not adjacent to any natural bone tissue. All of the S100 and S30
scaffolds seeded with mesenchymal stem cells and implanted for three and four weeks
had red tissue present after being stained and was assumed to be bone tissue.
The 13-93 fibers in the non-seeded S100 scaffolds in Fig. 4 are the white elliptical
regions surrounded by a dark line. None of the non-seeded S100 scaffolds contained any
detectable bone tissue (red stained region) after three or four weeks in-vivo, as is evident
in Figs. 4a and 4b. However, soft tissue had penetrated the outer portion of the unseeded
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scaffolds and was often present in the center of the scaffold. The presence of this tissue
is an indication of the biocompatibility between the soft tissue and the 13-93 fibers.

Figure 4. Optical micrograph of randomly selected location in the stained cross section of
scaffolds after three or four weeks in-vivo. Soft tissue (blue) and bone tissue (red)
formation. (a) S100 three weeks, (b) S100 four weeks, (c) S100+ three weeks, (d) S100+
four weeks.

The seeded S100+ scaffolds all contained regions of bone tissue (red regions)
after three and four weeks in-vivo, as is evident in Figs. 4c and 4d. There is a mix of
both soft (blue) and bone (red) tissue present in the three and four week S100+ scaffolds.
The amount of bone tissue in the week four scaffold, Fig. 4d, appears to be slightly more
than in the three week scaffold, Fig. 4c.
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Figure 5 is as enlarged view of Fig. 4d to better show the regions of soft and bone
tissue after four weeks in-vivo. The blue dots within the blue matrix are nuclei of soft
tissue, and the blue dots in the red matrix are nuclei of osteocytes which have
incorporated into the bony matrix. In several areas of the scaffold, pockets of bone tissue
are attached and growing on the 13-93 fibers. There is a visible reaction layer present on
the surface of the 13-93 fibers that formed as the 13-93 fibers reacted with the body fluids
of the rat. The reaction layer is the darker gray layer that outlines the 13-93 fibers, and
will be described in more detail later.

Figure 5. Optical micrograph (100X) of the cross-section of a S100+ scaffold seeded with
mesenchymal stem cells after four weeks in-vivo. Tissue has been stained where blue
denotes soft tissue and red denotes bone (hard) tissue.

The boxed area in Fig. 5 labeled (a) is shown at higher magnification in Fig. 6.
The reacted surface layer on the 13-93 fibers varies in thickness between ~10 to 20μm.
The dark circles in Fig. 6 encircle osteocytes (blue dots surrounded by a white halo) that
are incorporated into the newly formed bone tissue. Only a few examples of the
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osteocytes in the bony matrix material are shown in Fig. 6, but osteocytes were seen
throughout the new bone as shown in Fig. 5. This is important because it shows that the
MSC cells have differentiated to become mature bone and that the S100 scaffold is
promoting osteogenesis. The osteoid seam (purple tissue) represents un-mineralized
secreted proteins of osteocytes and is the growth front for new bone, as pointed out with
arrows at both the far right and lower left of Fig. 6.

Figure 6. Optical micrograph (400X) of S100+ scaffold cross-section. S100+ scaffold
was seeded with mesenchymal stem cells and implanted four weeks subcutaneously in
the back of a rat and stained for soft (blue) and bone (red) tissue.

Representative examples of the seeded and non-seeded S30 scaffolds after three
of four weeks in-vivo are shown in Fig. 7. These cross-sections look significantly
different than those for the S100 scaffolds, see Fig. 4. The 45S5c fibers are dark and
crystallized as opposed to the glassy white 13-93 fibers. Again, none of the non-seeded
scaffolds contained any evidence of bone tissue (red), as is evident from Fig. 7a (S30
three weeks), and Fig. 7b (S30 four weeks). The soft tissue (blue) in Figs. 7a, 7b, and 7c
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stained relatively light making it difficult to see, however the cell nuclei stained dark
blue. The abundance of nuclei through out the cross-sections indicates significant
infiltration of soft tissue. Soft tissue (blue) is visible throughout areas of the scaffold
cross-section in Fig. 7d, indicating that it had penetrated and survived within the scaffold
environment provided by the mixture of 13-93 and 45S5c fibers.

Figure 7. Optical micrograph (100X) of the cross-section of S30 scaffolds after three and
four weeks in-vivo and stained for soft (blue) and bone (red) tissue formation. (a) S30
three weeks, (b) S30 four weeks, (c) S30+ three weeks, (d) S30+ four weeks.

Figures 7c and 7d are representative sections of the S30+ scaffolds in which bone
tissue had formed. There is a mixture of both soft and bone tissue present in these
scaffolds, and again the total amount of bone tissue is estimated to be slightly higher after
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four weeks in-vivo. In Figure 7d, new bone tissue is seen surrounding both the 13-93 and
45S5c fibers. This suggests that both materials are biocompatible and suitable for bone
growth. To the author’s knowledge, this is the first time that 13-93 and 45S5c fibers have
been placed in-vivo in the same site, and from this analysis, both fibers appear to interact
positively with the living tissue, and there does not appear to be any significant advantage
from a biological point of view between the two fibers.
The surface of the 13-93 and 45S5c fibers differs greatly as the 13-93 fibers are
smooth, while the surface of the 45S5c fibers are noticeably rougher as shown in Fig. 2d.
The cause of the rough surface is unknown, but one possible explanation is that as the
45S5 glass crystallized and the crystals began to grow together, a liquid or viscous phase
surrounding the crystals was pushed out causing the rough surface. The microstructure in
Fig. 7 shows bone tissue on both the smooth 13-93 and rough 45S5c surfaces, but a
determination of which surface is preferred for tissue attachment and growth cannot be
made from the present work.
The enlarged view of Fig. 7d shown in Fig. 8, better shows the seeded S30+
scaffold after four weeks in-vivo. The high level of crystallization that occurred in the
45S5c fibers when they were heated to form a scaffold is evident from the small irregular
grains that are present throughout the fibers in Fig. 8. The 45S5c fibers have visible
reaction regions surrounding them, light gray to white in color, that is attributed to their
being in contact with the body fluids of the rat. Two examples of the bonding between
the 45S5c fibers and a 13-93 fiber are shown on the right hand side of Fig. 8. Both fibers
labeled as ‘13-93’ in Fig. 8 are attached to two 45S5c fibers. The attachment appears to
be from 13-93 fibers softening and sticking to the 45S5c fibers.
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Figure 8. Optical micrograph (100X) of S30+ scaffold cross-section after four weeks invivo. The S30+ scaffold was seeded with mesenchymal stem cells and implanted four
weeks subcutaneously in the back of a rat and stained for soft (blue) and bone (red)
tissue. The darker, textured fibers are crystallized 45S5c fibers, where the glassy 13-93
fibers are transparent and featureless.

An expanded view of the region inside the box labeled (9) in Fig. 8 is shown in
Fig. 9. A region of new bone tissue is seen between two 45S5 fibers that are bonded to a
13-93 fiber. Osteocytes are visible in the newly formed bone, as observed in the S100+
scaffolds. New bone tissue appears to be attached to both the 13-93 fiber and the 45S5c
fiber, with no apparent preference for either fiber. This indicates that both fibers promote
new bone growth. Again, as mentioned about the S100 scaffold, the S30 scaffold has
osteocytes embedded throughout the new bone indicating that the MSC cells have
differentiated and are forming new bone.
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Figure 9. Optical micrograph (400X) of cross-section of the box labeled (9) in Fig. 8.
S30+ scaffold was seeded with mesenchymal stem cells and implanted four weeks
subcutaneously in the back of a rat and stained for soft (blue) and bone (red) tissue.

The thickness of the reacted region of the 45S5c fiber on the left hand side of Fig.
9 appears to be ~20 to 30μm, which is thicker than the regions seen surrounding the 1393 fibers. This suggests that the 45S5c fibers react faster than the 13-93 fibers which is
consistent with the higher alkali and lower silica content of the 45S5 fibers.
The region, in the box labeled (10), in Fig. 8, is shown as a transmitted light
image in Fig. 10a and as a SEM-BSI image in Fig. 10b. Figures 10a and 10b have 45S5c
fibers on the left and at the top of the image as denoted by the arrows, and a fiber labeled
13-93 to the right. The X’s in Figs. 10a and 10b show regions of the fibers that had
reacted in-vivo. These regions are rich in both calcium and phosphorus. The Y’s
correspond to areas of new bone, stained red in Fig. 10a, and the light gray material
attached to the edge of the fibers in Fig. 10b. Soft tissue infiltrated with PMMA, labeled
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Z, corresponds to the blue tissue in Fig 10a, and the darkest portion of the image in
Fig.10b. Figures 10a and 10b look slightly different because the section used for Fig. 10a
was stained for histology and the adjacent section of scaffold was prepared for imaging
with the SEM. Subsequent polishing removed material from the surface of the scaffold
section, which slightly altered the image, but the representative areas of the scaffold are
still the same as previously described.

Figure 10. Seeded S30+ scaffold after four weeks in-vivo. (a) Optical micrograph (400X)
of a portion of the cross-section of a S30+ scaffold. (b) SEM-BSI of same area as shown
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as (10a). The X’s indicate reacted regions on the fibers, the y’s indicate areas of new
bone, and the Z’s are areas of PMMA infiltrated soft tissue.

The new bone tissue found after three weeks in-vivo in the seeded scaffolds in the
present work is consistent with prior work10 completed on porous HA and porous calcium
carbonate constructs seeded with marrow cells and subcutaneously implanted in rats for
two to six weeks. In the prior work10, three weeks was the minimum time for new bone
to become recognizable in the porous HA and porous calcium carbonate constructs.

Analysis of 13-93 and 45S5c Fiber after Four Weeks In-vivo
A 13-93 fiber after four weeks in-vivo was imaged with SEM-BSI and also
measured for compositional change with SEM-EDS. The dotted line in Fig 11a
illustrates the boundary between the adjacent new bone and the calcium rich layer of the
13-93 fiber. The new bone is in direct contact with the outer edge of the 13-93 fiber.
Figure 11a is an SEM-BSI image of the cross-section of a 13-93 glass fiber that was part
of a S100+ scaffold after four weeks. The calculated oxide weight percent, as measured
by SEM-EDS, present at the three positions (A,B, and C) shown in Fig. 11a is shown
graphically in Fig. 11b. The change in gray scale across the fiber cross-section in Fig.
11a indicates a change in composition from the unreacted glass; position A, to the outer
edge at position C. The unreacted portion of the fiber at position A has a composition
close to that of starting 13-93 glass (Table 1). Position B is a silica rich layer containing
almost 90 weight percent SiO2, the rest being CaO and P2O5. The CaO and P2O5 content
increased significantly at the outer edge (position C), indicating a calcium phosphate
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layer had formed. The K2O, MgO, and Na2O content decreased to near zero at position C
as these constituents are soluble in body fluids and leached from the fibers.

Figure 11. (a) SEM-BSI of a 13-93 glass fiber after four weeks in-vivo. (b) Composition
(weight % oxide) obtained from SEM-EDS of a reacted 13-93 fiber at the locations A, B,
and C. Composition for 13-93 glass given in Table1.

Stoichiometric HA (Ca10(PO4)6(OH)2) has a Ca/P molar ratio of 1.67, and the
Ca/P ratio at the outer edge of the 13-93 fiber at position C in Fig. 11b was measured
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with EDS to be 1.38. This increase in Ca/P ratio at position C indicates that a calcium
phosphate material has formed and verifies earlier statements about the formation of a
calcium phosphate surface layer on 13-93 fibers due to interactions with body fluids. The
formation of a calcium phosphate layer was expected as it has been detected by in-vitro
testing in SBF 1,11,13, 25, 31 and in-vivo in various animal models 1,17.
A 45S5c fiber, after four weeks in-vivo and seeded with msc cells, was imaged
with SEM-BSI and also measured for compositional change with SEM-EDS. Figure 12a
shows an SEM-BSI image and Fig. 12b shows the corresponding plot of composition
across a 45S5c fiber after four weeks in-vivo. This fiber has undergone significant
reaction after four weeks as is apparent by the thick light gray layer that surrounds an
easily distinguishable darker core. The variation in composition across the fiber, as
determined by EDS, is shown graphically in Fig. 12b. All of the Na2O has been leached
from the 45S5c fiber, even from the core. This leaching of Na2O has been previously
documented for in-vitro conversion of 45S5 glass to HA in dilute phosphate solutions 19.
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Figure 12. (a) SEMBSI of 45S5c fiber four weeks in-vivo (from an S30 scaffold seeded
with msc cells). (b) Compositional analysis (weight % oxide) obtained from SEM-EDS
of reacted 45S5c fiber as a function of position. Composition of 45S5 glass is shown in
Table 1.
The dark core at the center of the fiber in Fig. 12a is greater than 90 weight
percent SiO2. The silica core found in reacted 45S5c fibers in the present work has been
similarly described previously with 45S5 glass particles to make calcium phosphate
shells in-vitro 32 and reacting 45S5 glass fibers with phosphate solutions in-vitro 18. The
previous report on calcium phosphate shells32 stated that all of the SiO2 was eventually
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released from the 45S5 glass spheres, and lead to a hollow shell of calcium phosphate 32.
It is unclear from the present work if the SiO2 will be totally dissolved from the center of
the reacted 45S5c fibers, but it has been shown that it may, given the right physiological
conditions 32.
The calcium phosphate rich layer present at position four of the fiber in Fig. 12a,
contains only 17 weight percent SiO2 while the remaining components are CaO and P2O5
at ~40 weight percent each. The Ca/P molar ratio is 1.18 and there are high levels of both
CaO and P2O5 at position three and four relative to other the other oxides which indicates
that a relatively thick (25μm) calcium phosphate layer has formed on the outer edge of
the fiber in only four weeks. The formation of the calcium phosphate material at the
outer edge of the 45S5c fiber does verify earlier statements about a calcium phosphate
reaction region, and should be expected as 45S5 has been documented numerous times to
form HA both in-vitro with SBF 18,19,23,24, and in-vivo in animal models 1,17.
CONCLUSIONS
New bone tissue formed in both the S100 and S30 fiber scaffolds seeded with
mesenchymal stem cells at both three and four weeks in-vivo. Soft and bony tissues were
found in the interior of the cell seeded scaffolds after extraction. Cell seeded scaffold
cross-sections showed osteocytes were present in the regions of newly formed bony
tissue indicating that the MSC cells were differentiating into mature bone. From this
analysis, no preference in fiber composition (45S5c or 13-93) was distinguishable for the
soft or bone tissue to grow. Therefore, both materials are excellent for tissue engineering
applications.
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Several blood vessels which penetrated the scaffolds provided nourishment to the
tissues inside both the S100 and S30 of scaffolds. Integration of blood vessels into the
interior of the scaffolds could be an indicator that the reaction products from 13-93 and
45S5c fibers could be beneficial in terms of triggering angiogenesis (blood vessel
formation) in-vivo. Proangiogenic glasses and porous self-bonded bioactive glass
scaffolds could be beneficial for new soft tissue repair applications.
Compositional SEM-EDS analysis of 13-93 and 45S5c fibers after four weeks invivo indicated that calcium phosphate rich layers had formed on the surface of the fibers
while other glass components had been resorbed in the body fluids of the rats. The
reaction layer thickness present on the 45S5c fibers was in the range of 20 to 30μm while
the 13-93 reaction layer was only 10 to 20μm.
Neither scaffold type showed signs of mechanical failure or degradation after four
weeks in-vivo. Based on these observations and the compressive strength measured
previously, both S100 and S30 scaffolds are considered sufficiently strong for in-vivo use
for cancellous bone applications or for soft tissue. Therefore, the present results indicate
that self bonded bioactive glass fiber scaffolds constructed of 13-93 and 45S5c with
average porosity measurements between 44 and 63% and compressive strengths between
0.6 and 5.3 MPa have the ability to function in-vivo, promote bone tissue formation,
possibly promote angiogenesis, and be biologically converted to calcium phosphate or
resorbed by body fluids.
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Abstract
Bioactive 45S5 glass has been studied extensively both in vivo and in vitro, and it is
relatively well known that when placed in a phosphate containing solution the glass will
react to form the bone-like material hydroxyapatite (HA). In the present work, a kinetic
analysis of previously measured weight loss data was done to determine reaction rate
constants for four bioactive glasses; one silicate glass, two borosilicate glasses, and one
borate glass, via the contracting volume model. The reaction rate increased with
increasing B2O3 content, with the borate glass reacting nearly five times faster than the
silicate 45S5 glass. The three silica containing glasses all deviated from the contracting
volume model after approximately 50-70% of the total weight loss; however, when
compared to the 3-D diffusion model, the normalized data were in good agreement to
100% of the total weight loss. The deviation from the contracting volume model to the
slower 3-D diffusion model indicates a change in conversion model for the silica
containing glasses and can likely be attributed to the formation of a silica rich layer of a
certain thickness that began controlling the release of ions from the unreacted glass by
diffusion.
.
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1. Introduction
Bioactive glass 45S5 was first reported to bond to bone by Hench in 1971.(1) Ever since,
45S5 has been used extensively in both research and clinical use for the repair of bone
and other living tissues. Silicate based bioactive glasses, such as 45S5, and ceramics
have served as important biomedical materials because it has the ability to bond to
surrounding hard and soft tissues and enhance bone formation.(2-9)
Borate glasses have only recently been explored for use in biomedical
applications. Richard was the first to investigate replacing SiO2 with B2O3 in the 45S5
glass composition.(10) The borate based 45S5 immersed in a K2HPO4 solution at body
temperature (37oC) formed a layer of hydroxyapatite (HA), Ca10(PO4)6(OH)2, similar to
that formed by the silicate based 45S5.(10) The in vitro formation of HA from the borate
based 45S5 led to further investigation in vivo. Particles of the borate based 45S5 glass
were placed in a rat tibial defect, and not only promoted bone formation, but did so at a
faster rate than the silicate based 45S5 glass.(10)
Possible reaction mechanisms have been described by Huang et. al.(11-12) for the
silicate 45S5 glass and the borate analog of 45S5 (all SiO2 replaced by B2O3). The borate
glass fully converted to HA by the glass dissolving, the B2O3 and Na2O going into
solution, and the CaO reacting with PO43- from the phosphate solution. The silicate glass
was described to partially convert to HA, while leaving a sodium depleted core
surrounded by a silica rich layer.
According to the results of previous studies(10-12), the borate based glass most
closely follows a contracting volume type of behavior, where the HA first forms at the
outside of the glass particle, and then continually reacts inward toward the center until
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completely reacted. The silicate glass forms HA at the outer edge of the particle initially;
however it is not clear how the formation of the silica gel layer affects the movement of
ions. Therefore, if the silica gel layer becomes the rate controlling mechanism, the
weight loss reaction might follow 3-D diffusion kinetic behavior.
The main objective of the following work was to determine if there was a
mechanistic difference in the way silicate, borosilicate, and borate bioactive glasses
converted to HA. The relative reaction rates of the silicate, borate, and two borosilicate
based 45S5 glasses were determined by comparison with the contracting volume model.
Finally, the normalized weight loss data was compared to the 3-D diffusion model to see
if the conversion reaction changed models during the weight loss experiment.

2. Experimental
2.1 Glass Preparation and Weight Loss for the Silicate, Borate, and Borosilicate Based
45S5 Glasses
The glasses used were based on the bioactive 45S5 glass composition, and the
composition of each glass is shown in Table I. The weight loss data used in this analysis
and an in-depth experimental procedure was reported by Huang et. al.(11-12)
2.2 Kinetic Evaluation of the Weight Loss Data
In the previous work by Huang(11-12), the weight loss for the glass particles was
measured for hundreds of hours beyond a measurable change to make sure the
experiment has indeed ended, and is shown in Fig.1. The maximum weight losses for the
0B, 1B, 2B, and 3B were 42%, 35%, 42%, and 57% respectively. The weight loss data
reported by Huang et. al(12) were converted to fractional weight change (α) by dividing
the measured weight loss values by the maximum weight loss value (Fig.2). The

342
maximum weight loss was determined by the difference of the mass of the starting glass
and that of the end product.
The contracting volume model (CVM) is a geometrical model that is used to
theoretically describe the reaction rate of a solid sphere of some material and a reactant
(gas or liquid). In this experiment, the CVM was used to model the weight loss from the
glass particles suspended and the 0.02M phosphate solution data measured by Huang(11. The values of α vs. time for the four glasses were fitted using the CVM shown as

12)

equation (1).(13-14)
Contracting Volume Model

1-(1-α)1/3 = kt

(1)

The 3-D diffusion model, equation (2)(14), is a diffusion model that describes the
diffusion of material through some rate controlling medium in three dimensions. The 3D diffusion model was compared to the normalized weight loss data just as the CVM to
see if a change in the glass conversion model could be detected from the weight loss for
any of the four glasses.
3-D Diffusion Model

[1-(1-α)1/3]2 = kt

(2)

Terms present in equations (1) and (2) are the normalized weight loss (α), which
is calculated by dividing the measured weight loss by the total weight loss for the
reaction, rate constant (k), and time (t).

3. Results
3.1 Weight Loss of Silicate, Borate, and Borosilicate Based 45S5 Glasses
The weight loss data measured by Huang et. al.(11-12) for the four glasses tested for the
first 1800 hours of reaction is shown in Fig. 1. The 0B and 1B glasses reacted at nearly
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the same rate for the first 200 hours while the 2B and 3B glasses reacted significantly
faster. At the time the experiment was stopped, the 0B, 1B, and 2B glasses had stopped
losing weight, however the measured weight losses were less than the theoretical weight
losses for the three glasses (Table 1). Theoretical weight loss for these glasses was
calculated by assuming the end product would be HA, and all the rest of the components
(Na2O, B2O3, and SiO2) would be in solution. Silica rich cores were found at the center
of the 0B, 1B, and 2B glass particles at the end of the experiment, indicating that the
silica had not fully dissolved in the phosphate solution.(11) The final (maximum) weight
loss of the 3B glass was 57%, which was within 2% of its theoretical limit, and therefore
assumed to have gone to completion.
3.2 Isothermal Reaction Kinetics for the Silicate, Borate, and Borosilicate Based 45S5
Glasses
The accumulated weight loss percent data shown in Fig. 1 were converted to α by
dividing the measured weight loss by the maximum weight loss for each glass. The solid
lines in Fig. 2 show that the normalized weight loss (α) vs. time curves for each glass had
similar shapes. The k values used to fit equation (1) to the curves in Fig. 2 are listed in
Table 1. The k values ranged from as low of 0.0045 for 0B to as high of 0.0220 for the
3B glass, indicating that the 3B glass reacts approximately five times faster than the 0B
glass. The CVM model is a good fit for all four glasses for the first 30 hours of reaction.
After about 50 hours, the normalized weight loss deviated from the CVM model.
The reaction rate of the 0B, 1B, and 2B particles decreased from that initially described
by the CVM. After 50 hours, the normalized weight loss data is in good agreement with
the 3-D diffusion model, indicating a change in reaction model for the three silica
containing glasses.
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4. Discussion
4.1 Reaction Model of the Glasses with 0.02M Phosphate Solution
The reaction model for the four glasses was determined by plotting α vs. time along with
fits of equations (1) and (2) for each glass. A plot with the normalized weight loss data
for the four glasses (points) compared to the CVM (solid line) and 3-D diffusion equation
(dashed line) is shown in Fig. 3. The first 30 hours of data, for all four glasses, were in
good agreement with fits of the CVM, indicating that the HA formation was due to
dissolution of the glass in the phosphate solution.
The normalized weight loss data for the 0B, 1B, and 2B glasses deviate from the
CVM after about 50 hours. The normalized weight loss after 50 hours fit well fitted by
the 3-D diffusion model until the end of the reaction (~600 hours). One explanation for
this behavior is that the silica gel layer in the silica containing glasses had reached a
thickness such that the movement of ions was controlled by diffusion through the silica
gel. The first glass to change from the CVM to the 3-D diffusion model, in terms of
normalized weight loss (α), was 0B which contained the most silica, and was followed by
the 1B and 2B glasses. It is reasonable to suggest that if the change in model was caused
by the formation of a silica gel diffusion layer, then the glass containing the most silica
(0B) would form a silica gel diffusion barrier first and so on as seen with the 1B and 2B
glasses.
4.2 Effect of B2O3 Content on the Reaction Rate Constant
In previous analysis of the 0B, 1B, 2B, and 3B glasses, the general relationship between
higher B2O3 content and increased reaction rate was identified(11), but no mathematical
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relationship was determined that related the B2O3 content of the glasses and the rate of
conversion to HA. Figure 4 shows the mol% B2O3 plotted versus the rate constant k
(Table 1) for each of the glasses. There is a measurable change in k between all four
glasses, shown by the solid curved line in Fig. 4. This may be a method for accurately
determining the effect B2O3 is having on the reaction rate constant.
The equation shown in Fig. 4 describes the reaction rate constants of the four
glasses in the 0.02M phosphate solution versus the B2O3 content. Comparing the
phosphate concentration of 0.02M to the ~0.001M phosphate concentration in body
fluids(11), the equation would seem irrelevant for practical use as 0.02M phosphate
solution is not a standard solution concentration. The possible importance of the equation
shown in Fig. 4 comes from finding a relationship between B2O3 content and the reaction
rate constant k. A similar experiment between the 45S5 glasses and a solution such as
simulated body fluid (SBF) could be done to develop a similar equation that is more
applicable when trying to model a bioactive glass conversion reaction in a real system,
such as in the body.

5. Conclusions
The conversion of the 0B, 1B, 2B, and 3B glasses was described using both the
contracting volume model and the 3-D diffusion model. The CVM fits the data for the
3B glass over the entire range of α, while the data for the 0B, 1B, and 2B glasses are only
fitted well by the CVM for the first 30 hours of reaction. The 0B, 1B, and 2B glasses at
long times are better fitted by the 3-D diffusion model, probably due to the formation of a
rate controlling silica gel layer in the glass particles. The relative reaction of the 3B glass
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was five times faster than the 0B glass, with k values which range from 0.0045 for 0B to
0.0220 for 3B.
The reaction rate constant of 45S5 type bioactive glasses immersed in 0.02M
phosphate solution was shown to depend on the B2O3 content, and thus warrants
additional work to find a similar relationship for a more common solution such as SBF.
Simulated body fluid would more accurately model the in vivo environment and could be
used to tailor glass compositions for desired in vivo reaction rates.
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Table 1. Nominal Composition of Glasses Used in Weight Loss Experiment(11-12)

Figure 1. Accumulated weight loss percent(11-12) for the 0B, 1B, 2B, and 3B glasses
during the first 1800 hours of reaction in 0.02M K2HPO4 solution at 37oC. The dashed
horizontal lines denote the maximum weight loss for each glass. The 0B and 2B glasses
lost 42%, 1B lost 35%, and 3B lost 57%, respectively.
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Figure 2. Normalized weight loss (α) vs. time for the 0B, 1B, 2B, and 3B glasses.(12)

Figure 3. Normalized weight loss (α) vs. time for the 0B (crosses), 1B (triangles), 2B
(squares), and 3B (diamonds) glasses compared with the Contracting Volume Model
(solid lines) and 3-D Diffusion Model (dashed lines). The CVM is a good fit of the data
for the first 30 hours for all four glasses, but after 50 hours, the 3-D Diffusion Model is a
better fit for the slower reacting 0B, 1B, and 2B glasses (dashed lines).
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Figure 4. Reaction Constant (k) vs. Mole % B2O3 for the 0B, 1B, 2B, and 3B glasses
reacted at 37oC in 0.02M K2HPO4 solution.
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